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1. EXPOSURE TO XENOBIOTICS 
1.1 Exposure to xenobiotics and relation to cancer 
People living in the industrialized countries are continually exposed to a large 
number of different chemicals. Many of such chemicals cause acute effects, but 
long-term exposures are those that are most interesting in terms of potential 
delayed consequences, such as cancer (Pelkonen & Sotaniemi EA, 1987). In the 
actual situation, at least in the Netherlands, one out of four people dies from this 
disease (Centraal Bureau voor de Statistiek, 1980). 
Epidemiologists have estimated that at least 70% of human cancer 
would, in principle, be preventable if the main risk and antirisk factors could be 
identified (Doll & Peto, 1981). This is because the incidence of specific types of 
cancer differs markedly in different parts of the world where people have different 
lifestyles. Colon and breast cancer, which are among the major types of cancer in 
the United States, are quite rare among Japanese in Japan, but not among Japanese 
Americans. Epidemiologists are providing important clues about the specific 
causes of human cancer, in spite of inherent methodological difficulties. They 
have identified tobacco as an avoidable cause of about 30% of all U.S. cancer 
deaths. Less specifically, dietary factors, or the absence of certain dietary 
components, have been suggested in many studies to contribute to a substantial 
proportion of cancer deaths, though the intertwined risk and antirisk factors are 
being identified only slowly (Hopkins & Carroll, 1985; Bird et al., 1986). High fat 
intake may be a major contributor to colon cancer, though the evidence is not as 
definitive as that for the role of saturated fat in heart disease or of tobacco smoke 
in lung cancer. Alcoholic beverage consumption, particularly by smokers, has 
been estimated to contribute to about 3% of U.S. cancer deaths. 
Progress in prevention has been made for some occupational factors, 
such as asbestos, to which workers used to be heavily exposed. Prevention may 
also become possible for hormone-related cancers such as breast cancer 
(Henderson et al., 1982), or virus-related cancers such as liver cancer (hepatitis B) 
and cancer of the cervix (papilloma virus HPV 16) (Peto & zur Hausen, 1985). 
Further steps in prevention may prove to be difficult. According to Ames 
et al. (1987) we lack the knowledge to do low-dose risk assessment. We also are 
almost completely ignorant of the carcinogenic potential of the enormous 
background of natural chemicals in the world. 
Both genetic factors and the environment play a crucial role in the origin 
of cancer. In which part of the multi-stage process leading to cancer these genetic 
factors are expressed is not known. At least five steps can be distinguished in this 
process: 
1. The causative agent (usually a carcinogenic chemical) enters the body, mostly 
through surface epithelia. 
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2. It is converted enzymatically both to inactive products which can be eliminated, 
and to active carcinogenic forms. 
3. The latter can combine with cellular macromolecules and may -in the case of 
DNA- cause inheritable damage to the cell. This damage can possibly lead to 
escape of the commitment of cells to senescence leading to a capacity for infinite 
multiplication preceding malignant transformation. 
4. The transformed cell divides to form a tumor. 
5. The tumor can subsequently metastasize throughout the body. 
1.2 Biotransformation 
When consequences of environmental exposure to multiple agents are evaluated 
with respect to their health effects, metabolism of xenobiotics and metabolic 
interactions have to be considered. 
To facilitate the elimination of xenobiotics the organism uses several enzyme 
systems that alter the chemical structure of xenobiotics. This generally results in 
an enhanced water solubility of the products formed. This array of processes, 
called biotransformation, is indispensable for an organism to eliminate lipophilic 
compounds. 
Biotransformation of xenobiotics may be considered to occur in two 
phases. Phase I involves reactions like oxidation, reduction, hydrolysis which 
changes molecules in such a way that they become more hydrophilic and more 
readily excretable. The most important phase I enzymes are the cytochrome P450 
enzymes. Phase II metabolism (conjugation reactions) comprises reactions in 
which small endogenous molecules (water, glucuronic acid, glutathione, sulphate, 
glycine and other amino acids) are added to the functional groups of the 
xenobiotic or its phase I metabolite, making them even more polar. 
The so called P450 gene superfamily catalyzes a surprisingly large 
number of chemical reactions with an almost unlimited number of biologically 
occurring and xenobiotic compounds (Lu et al., 1980; Black & Coon, 1987; 
Schwab & Johnson, 1987; Ryan & Levin, 1990; Guengerich, 1991; Porter & 
Coon, 1991). The P450 gene superfamily encodes numerous enzymes, of which so 
far more than 150 have been characterized. These vary from about 10 to over 90% 
in sequence identity and occur in biological sources as diverse as microorganisms, 
plants, and animals. Almost all mammalian tissues contain one or more of these 
cytochromes in various organelles, predominantly in the endoplasmic reticulum 
and mitochondria. Some of the P450 isoforms are fairly specific in their choice of 
substrates (for example, the steroidogenic cytochromes), but many, and 
particularly those in the hepatic endoplasmic reticulum, catalyze a large number of 
reactions with an almost unlimited number of compounds. In the latter category 
are synthetic environmental chemicals, now estimated at about 250,000, most of 
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which are potential P450 substrates if not inducers or inhibitors of the individual 
cytochromes Examples of xenobiotìcs that serve as P450 substrates are drugs 
(including antibiotics), antioxidants, organic solvents, anesthetics, dyes, 
pesticides, alcohols, odorants, and flavorants, and a variety of unusual substances 
ш plants and microorganisms, which, despite their biological occurrence, are 
foreign to animals The physiologically important substrates include steroids, 
eicosanoids, fatty acids, lipid hydroperoxides, retinoids and acetone 
The P450 proteins from all sources with 40% or greater sequence 
identity are mcluded m the same family, as designated by an Arabic number, and 
those with greater than 55% identity are mcluded m the same subfamily, as 
designated by a capital letter The individual genes (and gene products) are 
arbitrarily numbered As an example, the major phénobarbital inducible 
cytochrome is called P4502B4 or CYP2B4 (enzyme) and the corresponding gene 
CYP2B4 (gene) 
ROH RH 
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H20 
HCO,H 
(R)(Fe-OH)3* 
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Figure 1 Overall scheme for mechanism of action of P450 Fe 
represents the heme iron atom ш the active site RH a substrate, 
and ROH the corresponding monooxygenation product R'LOOH 
represents a lipid hydroperoxide and R'H and LO represent the 
corresponding reduction products (alkane and oxoacid, 
respectively) XOOH represents a peroxy compound that serves 
as an alternate oxygen donor to molecular oxygen 
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The steps involved in the P450-catalyzed reduction of molecular oxygen 
with incorporation of one oxygen atom into a substrate, RH, to give the 
corresponding product, ROH, are shown in Figure 1. (Coon et ai, 1992). 
After exposure to various compounds increases in total liver P450 
content are observed. Generally, this process of induction leads to alterations in 
the distribution pattern of P450 enzymes and to modification of biotransformation 
activities. For a number of these enzymes fairly specific metabolic 
'marker-substrates' or 'marker-conversions' have been described. However, in 
control animals or in animals treated with other chemicals, additional P450 
isoenzymes may catalyze these reactions as well (Nakajima et al., 1990,1991; 
Nebert et al, 1991). 
Three of the P450 subfamilies are of special interest for the present study; they 
could play a part in the interaction between ethanol and PAHs. These are the P450 
1A, P4502C and P4502E subfamilies. 
The enzymes of the P4501A subfamily are induced by 3-Methyl-
cholanthrene (3-MC) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) among 
other (halogenated) aromatic hydrocarbons. Some evidence exists that the P4501A 
family can also be induced in humans. Many procarcinogens can be activated by 
these enzymes and P4501A induction is often considered to be associated with 
increased carcinogenicity (Guengerich, 1988; Ioannides & Parke, 1987,1990), but 
this is a matter of debate (McKillop & Case, 1991). P450 1A proteins are 
regulated via interaction of the inducing compound with a cytosolic protein, the 
Л/г-receptor (Nebert & Gonzalez, 1987; Nebert & Jones, 1989). 
After induction, P4501A1 and P4501A3 can be monitored in rat liver 
using the ethoxyresorufin O-deethylation (EROD) assay. Quantitatively, the 
P4501A enzymes are not very important in untreated rats (Sesardic et al, 
1990,1990a). In untreated male rats EROD activity is catalyzed to a high extent by 
other enzymes (P4502C6 and/or P4502C11) (Nakajima et al, 1990, 1991). In 
benzo(a)pyrene-treated C57B1 mice EROD is mainly catalyzed by P4501A2 
rather than P4501A1 (Tsyrlov & Duzchak, 1990). In human liver, P4501A2 can be 
found, induced by smoking. 
The largest P450-subfamily comprises the 2C enzymes. Among these are 
the P450s which are constitutively expressed to high levels. Of the total 
immunochemically detectable P450 in untreated adult male rat liver, the 
P4502C11 and P4502C6 enzymes make up for ca 50% and 30%, respectively 
(Steward et al, 1985). In female rats P4502C11 is hardly expressed but the 
functionally different P4502C12 form is expressed instead. These and some other 
forms are regulated by the fluctuation pattern of the plasma growth hormone 
concentration. (Waxman, 1988; Westin et al, 1990; Zaphiropoulos et al, 1990). 
P4502C11 can be monitored in rat liver using testosterone (TST) 2a- or 
16a-hydroxylation. For P4502C12 determination of 5a-androstene-3a,17ß-diol 
disulfate 15ß-hydroxylation might be a good indicator activity (Guengerich, 1987; 
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Waxman, 1988). P4502C8, P4502C9 and P4502C10 enzymes are abundant in 
human liver and are involved in mephenytoine-4-hydroxylation (Guengerich et al., 
1988). In part of the human population a phenotypic deficiency resulting in low 
mephenytoin metabolism is observed. This deficiency is probably attributable to 
defective P4502C enzymes (Guengerich, 1987). The human 2C8, 2C9 and 2C10 
P450-enzymes are closely related to rat P4502C11 and rabbit P4502C5 (Morel et 
ai, 1990a; Mennes, 1992; Wortelboer, 1992). 
An ethanol-inducible form of P450 was purified from rabbits (Koop et 
al, 1982) and has been characterized from many species, including rats, mice, 
hamsters, and humans, and it was demonstrated that the purified enzyme will 
catalyze bioactivation reactions (Lieber, 1984; Garro & Lieber, 1990; Koop & 
Coon, 1986). Additional observations support the involvement of P4502E1 in 
ethanol-potentiated hepatotoxicity: other compounds that induce P4502E1, such as 
acetone and other short-chain alcohols, also potentiate the same hepatotoxicity 
(Koop & Coon, 1986; Zimmerman, 1986). P4502E1 is located in the cell layers 
near the terminal hepatic vein and is induced in the same region by all inducers 
examined (Lieber, 1990). The centrilobular region of the liver is most susceptible 
to chemical toxins that are substrates for P4502E1. Many compounds have been 
identified as substrates for P450 2E1, as summarized in Table 1 (Koop, 1992). 
The substrates are, in general, small, relatively polar compounds. The list includes 
many solvents used extensively in industry such as benzene, chloroform, and 
trichloroethylene. As a result, the bioactivation of these types of protoxicants by 
P4502E1 places particular emphasis on this form of P450 in human health. The 
enzyme is readily inducible in humans (Umeno et al., 1988; Raucy et al., 1987; 
Guengerich et ai, 1991) and there can be significant exposure to its substrates in 
the workplace. Chronic ethanol ingestion is not required for induction of 
P4502E1; significant increases in the enzyme can be observed after a single dose 
of ethanol. All compounds that have been shown to be substrates in animal models 
are also substrates for the human ortholog. P4502E1 can be monitored in rat liver 
using hydroxylation of aniline, /j-nitrophenol and chlorzoxazone or demethylation 
of N, N-dimethy lnitrosamine. 
Concerning the possible interactions of ethanol and PAHs, the most 
interesting enzyme activities of the phase II biotransformation reactions are 
glutathione conjugation and epoxide hydrolase. Glutathione S-transferases (GSTs) 
exist in multiple forms which conjugate glutathione on the sulphur atom of 
cysteine to various electrophiles (Mannervik, 1985; Pickett & Lu, 1989; Coles & 
Ketterer, 1990; Boyer, 1989). In addition, GSTs bind a variety of hydrophobic 
compounds such as haem, bilirubin and polycyclic aromatic hydrocarbons (PAHs) 
with high affinity and have been suggested to act as intracellular transport proteins 
(Mannervik, 1987). The GSTs are cytosolic proteins, with the exception of a 
microsomal form identified in rodents. The enzymes are homodimers or 
heterodimers comprising at least seven subunits. Until now, evidence exists for the 
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occurrence of more than 11 subunits in the rat and 7 subunits in human (Coles & 
Ketterer, 1990). GSTs are classified into three different families, named alpha, 
mu, and pi. This classification is based on catalytic activity, isoelectric points and 
N-terminal sequences. Class alpha GST consists of rat 1-1, 1-2, 2-2, 8-8 and 
human a. Class mu consists of rat 3-3, 3-4, 4-4, 6-6 and human μ , class pi 
consists of rat 7-7 and human π (Mannervik et ai, 1987). GSTs are widespread in 
nature and have been found in almost every rat and human tissue examined. Their 
expression in different tissues is not uniform, however. In rat liver, subunits 1, 2, 3 
and 4 are predominant, whereas in the lung, small intestine and placenta, subunit 7 
is the major form. It has been suggested that expression of subunit 7 is a common 
phenotypic expression of malignant transformation of cells, including malignant 
liver cells. 
To determine the catalytic activity of GSTs the most commonly used 
substrate is l-chloro-2,4-dinitrobenzene (CDNB), since it is utilized well by most 
of the rat and human subunits. Although the products of GST-catalysed reactions 
are usually non-toxic, the formation of glutathione conjugates of some compounds 
may cause cell injury. The glutathione conjugate of 1,2-dibromoethane can react 
directly with DNA forming an adduci that is mutagenic in the Ames assay. 
Another type of enhanced toxicity is exerted via metabolism of glutathione 
conjugates of certain halogenated hydrocarbons within the kidney to cysteine 
conjugates. These may be further metabolized by a renal enzyme (ß-lyase) to a 
sulphur-containing reactive compound which can initiate injury in proximal renal 
tubular cells (Coles & Ketterer, 1990). 
Epoxide hydrolases (EH) are monomelic proteins important in the 
degradation of potentially reactive epoxides by the conjugation of water (Oesch, 
1980; Timms et al, 1987). Three different forms have been identified in the 
endoplasmic reticulum and one in the cytosol. The hydrolysis of the reactive and 
highly toxic ipoxides to dihydrodiols results, in many instances, in a 
detoxification, but can serve as a precursor of even more reactive dihydrodiol 
epoxides. For example, from benzo(o)pyrene [B(a)P] the reactive 
(+)-£w//-7,8-diol-9,10-epoxide (Gelboin, 1980) is formed (Section 3 of this 
Introduction refers to that process). In addition to hydrolysing epoxide metabolites 
of xenobiotics, epoxide hydrolases catalyse the hydration of endogenous epoxides, 
such as oestrogen and androgen epoxide, and cholesterol epoxides (Timms et al, 
1987). 
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Substrate 
Aromatic compounds 
pyridine 
3-hydroxypyndine 
p-mtrophenol 
benzene 
phenol 
acetaminophen 
pyrazole 
chlorzoxazone 
styrene 
aniline 
Halogenated alkanes and alkenes/alkanes 
chloroform 
pentane 
chloromethane 
dibromoethane 
dichloromethane 
1,2-dichloropropane 
ethyl carbamate 
1,1,1-tnchloroethane 
tnchloroethylene 
ethylene dibromide 
ethylene dichlonde 
vinyl chlonde 
vinyl bromide 
vinyl carbamate 
enñurane 
halothane 
1,1,1,2-tetrafluoro- ethane 
Alcohols/ketones/nitnles 
ethanol 
propanol 
isopropanol 
butanol 
pentanol 
glycerol 
acetol 
acetone 
acetonitnle (+catalase) 
acrylonitnle 
nitrosamines/azocompounds 
W.W-dimethylnitrosamine 
azoxymethane 
methylazoxymethanol 
W,W-diethylnrtrosamine 
W-nitrosopyrrolidine 
W-nitroso-2,6-dimethylmorpholme 
Ethers 
diethytether 
methyl r-butyt ether 
Reductive substrates 
carbon tetrachloride 
chromium ( C O 
13-hydroperoxy-9,11 -octadecadienoic acid 
15-hydroperoxy-5,8,11,13-eicosatetraenic 
acid 
cumyl hydroperoxide 
f-butylhydroperoxide 
oxygen 
Product measured 
pyridine N-oxide 
2,5-dihydroxypyndine 
4-nitrocatechol 
phenol 
hydroquinone, catechol 
glutathione conjugates 
4-hydroxypyrazole 
6-hydroxychlorzoxazone 
glutathione conjugate 
c-aminophenat 
glutathione conjugate 
product not measured 
formaldehyde 
glutathione conjugate 
glutathione conjugates 
glutathione conjugate 
1 ,/v*-ethenoadenosine 
1,1.1 -triehlorc-2-hydroxyethane 
chloral 
1 ,Ar*-ethenoadenosine 
1 ,nf*-ethenoadenosine 
1 ,Λ/'-ethenoadenoslne 
1 ,Λ/'-ethenoadenoslne 
1 ,Λ/'-ethenoadenoslne 
fluoride 
tnfluoroacetic acid 
fluoride 
acetaldehyde 
propionaldehyde 
acetone 
butyraldehyde 
valeraldehyde 
formaldehyde 
methylglyoxal 
acetol 
cyanide 
1 .W-ethenoadenosine 
formaldehyde/nitrite 
azoxymethand 
methanol/fofmic acid 
acetaldehyde 
4-hydroxybutyraldehyde 
A/-nrtroso-(2-hydroxypropyl)-(2-oxopropyl)amine 
acetaldehyde 
formaldehyde/(-butanol 
lipid peroxidation/ chloroform 
product not measured 
pentane 
pentane 
methane/acetophenone 
methane/acetone 
superoxide/peroxide/ water 
Table 1. Substrates metabolized by cytochrome P450 2E1 
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2. ETHANOL 
2.1 Human Exposure 
The word 'alcohol' stems from Arabic {al = the; kühl = 'spirit' or 'refined'). 
Originally it referred to a fine powder used to darken the area around the eyes, i.e. 
eyeblack, and is related to the Hebrew kahol, a substance outlining the eyes 
(Caenegem et ai, 1980; Keller et al, 1982). In Latin pharmacology the term was 
used to indicate fine powdery substances or concentrations of distilled liquids. 
Paracelsus (1493-1541) used the term for 'the best' or 'the spirit' of wine. 
The only alcohol suitable for consumption is ethyl alcohol, or ethanol. 
Ethanol is a clear, colourless liquid, generated by carbohydrate 
fermentation or by chemical synthesis. In its pure form ethanol may be used for 
several purposes, for example as a solvent, or -in a 70% solution- as a bactericide. 
When administered as a medicine, alcohol may have a stimulating as well as a 
sedative, anaesthetic or narcotic effect. Its effectiveness depends on the 
concentration in the organism (Majchrowitz, 1985). 
Ethanol is mostly consumed voluntarily as part of alcoholic beverages. 
Used in this way, the effects of alcohol may range from euphoria to intoxication. 
The predominant types of commercially produced alcoholic beverages are beer, 
wine (including fortified wine) and spirits (including liqueur-like beverages). In 
the Netherlands, standard glasses of wine, beer and spirits contain ca. lOg of 
ethanol each. Glasses of sherry, port and some less current beverages contain a 
little less alcohol. The ethanol concentration of a beverage is of importance in 
relation to the damage that can be caused to the gastrointestinal mucosa (Te 
Wierik, 1991). 
The main components of all alcoholic beverages are ethanol and water. 
Beers also contain substantial amounts of carbohydrates; sweet beverages contain 
sugar. Besides, alcoholic beverages may contain hundreds of other substances 
which together characterize the beverage in question. These substances can be 
classified into macronutrients (carbohydrates and proteins), vitamins, minerals and 
trace elements, congeners of ethanol, contaminants and additives. Small quantities 
of carbohydrates, proteins, vitamins and minerals may be present in alcoholic 
beverages, particularly in wine and beer. They do not contribute significantly to 
the daily nutritional intake. 
Congeners of ethanol can originate from the raw ingredients or be 
produced during fermentation (methanol, higher alcohols, phenols, acids). 
Pesticides, asbestos or mycotoxins may be present as contaminants. Additives can 
be head-retaining agents, flavouring agents and preservatives to prevent the 
activity of bacteria and moulds. Little is known about the physical effects of these 
compounds, caused by the mixture of minute quantities of these substances 
present in alcoholic beverages (Vrij-Standhardt, 1991). 
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In the seventeenth and eighteenth centuries, spirits shifted from a pharmaceutical 
status to an item of everyday consumption, as industrial production methods 
flooded the market. Technological innovations transformed beer production, 
starting in the latter part of the nineteenth century, from the craft producing 
beverages for local and immediate consumption to an integrated industry 
producing a beverage that could be transported worldwide and stored almost 
indefinitely (Anonymous, 1966). Improvements in agricultural methods and the 
development of disease-resistant vines have allowed greatly increased wine 
production and consumption. Thus, wine consumption in France quadrupled in the 
last decades of the nineteenth century (Johnson, 1985). In general, the advent of 
industrially produced alcoholic beverages with an indefinite shelf-life, 
improvements in transportation and development of a cash economy have erased 
constraints on availability of alcohol. Under these circumstances, constraints on 
consumption depend on state controls on availability and price and, for example, 
on religious and social habits (IARC, 1988). 
Even in Europe, the current level of availability of alcoholic beverages is 
a relatively recent historical phenomenon. By the middle of the nineteenth 
century, intake of alcoholic beverages was high in most countries in Europe and 
North America, but, at the turn of the century, there was a decline in consumption 
which continued until the period between the two world wars. Such patterns ('long 
waves') of consumption of alcoholic beverages are common across very different 
countries and are not associated with factors commonly proposed to explain these 
consumption habits, such as buying power, amount of leisure time, social misery 
or industrialization and urbanisation. The reform movements, including the 
international temperance movement may be a partial explanation of lower 
consumption in the first decades of the twentieth century in many industrialized 
countries (IARC, 1988). 
In contrast, the last few decades have been a period of increasing 
consumption in developed countries, with some countries approaching the peak 
levels of the nineteenth century. The largest growth rates have been recorded in 
countries with originally relatively low levels of average consumption. 
Consumption patterns tend to internationalise. The increase in consumption of 
alcoholic beverages slowed down or levelled off in many countries in the 1970s, 
and some decreases were recorded. This phenomenon has been explained partially 
by economic difficulties experienced in most industrialized countries and by 
changes in living conditions and life styles (Mäkelä et ai, 1981). In the developing 
countries, the variation in trends over the last 30 years has undoubtedly been 
greater. Most of the available information points toward increases in consumption, 
except in areas such as Muslim countries (Moser, 1985). 
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There are wide variations in the rates of consumption of alcoholic beverages 
between countries and between regions. In'Figure 2 the alcohol consumption 
around 1977 and trends in beer consumption for selected regions 1960-1981 is 
shown (Wld hlth statist annu, 1987). In 1960, as well as in 1981, commercially 
produced beer, wine and spirits contributed approximately equal amounts to the 
world ethanol consumption. 
In the Netherlands, the pure alcohol consumption per citizen increased 
from 2.6 1 per year in 1960 to 8.3 1 per year in 1988 (de Zwart, 1989). In general, 
8 to 10% of the Dutch population of 15 years of age and older has alcohol-related 
problems (Projectgroep Alcohol Voorlichtings Plan, 1990). There are 200,000 
alcoholics and half a million heavy drinkers who consume 8-12 drinks a day 
(Schoenmaker-Hol, 1988). Although moderate alcohol consumption is hard to 
define many scientists have tried to do so. McDonald defines two drinks per day 
for the average woman and three drinks per day for the average man as moderate. 
Up to 13 drinks per week by women and up to 20 drinks per week by men is 
regarded as healthy drinking in another study (Anderson, 1986). The Royal 
College of Physicians suggest 17 drinks per week for men and 11 drinks per week 
for women to be moderate (Anonymous, 1987). 
2.2 Pharmacokinetics 
2.2.1 Absorption 
Ethanol is absorbed over almost the entire length of the digestive tract. Absorption 
from the mouth and oesophagus is minimal, some more occurs in the large 
intestine. A significant proportion of ethanol is absorbed from the stomach (ca. 
20%) (Jones & Jones, 1984) and most from the duodenum and small intestine. The 
ethanol ingested is highly diluted by the admixture of saliva and digestive juices. 
The ethanol molecules are absorbed through the intestinal wall by a process of 
passive diffusion (Berggren & Goldberg, 1940); the quantity of ethanol absorbed 
per unit of time is directly proportional to the concentration gradient between 
intestinal lumen, epithelial cells, capillaries and the portal vein (Beck & Dinda, 
1981). Ethanol in the blood passes almost immediately into brain tissue (Harger et 
al, 1937). Ethanol absorption follows first-order kinetics. 
The presence of food (particularly food rich in fats and carbohydrates) in 
the stomach delays gastric emptying and consequently postpones the moment the 
ethanol is absorbed in the intestine. This results in a lower Blood Alcohol 
Concentration (ВАС) peak: the ethanol will be absorbed into the blood over a 
longer period of time while elimination has already set in. A light meal, taken just 
before the consumption of whisky or a martini-based cocktail (22-44g ethanol) 
lowered the ВАС peak by 50-80% (Haggard et al, 1941). Ethanol absorbtion may 
also be delayed by dilution, the presence of congeners, a drop in body 
Pharmacokinetics · 23 
temperature, deep mental concentration or physical exercise Aspinn, aminopynne 
and anticholinergic drugs also slow down absorption whereas cholinergic drugs, 
insulin-induced hypoglycaemis and a raise in body temperature increase the 
absorption rate slightly (Holford, 1987, Kalant, 1971) Variation m hormonal 
status (e g stage of the menstrual cycle) affects ethanol absorption (Jones & 
Jones, 1976) The absorption rate shows a diurnal rhythrrucity (Lotterie et al, 
1989) Ethanol absorption seems also to be under genetic control (Reed et al, 
1976) In normal circumstances the maximum blood alcohol concentration (ВАС) 
will be reached 45 minutes after the consumption of a smgle dose (Anonymous, 
1972) 
2 2 2 Distribution 
Absorption of ethanol from the gastrointestinal tract occurs by simple passive 
diffusion (Wallgren & Barry, 1970) Once ethanol has been absorbed into the 
bloodstream it is rapidly transported throughout the body and distributed over the 
body fluids The small, electncally-neutral ethanol molecules can diffuse easily 
through membranes During absorption the arterial ВАС tends to be higher than 
the venous ВАС, peaking at a higher level and requiring less time to reach the 
peak, until an arteno-venous concentration equilibrium is reached, whereafter the 
venous ВАС remains above the arterial ВАС (Martin et al, 1984) About 1-1V4 h 
after drinking an equilibrium is reached (Pawan, 1972) This will take place 
sooner m organs highly perfused with blood (brain, lungs, kidneys, liver) than m 
other organs (Wallgren, 1970) Once the equilibrium has been reached the amount 
of ethanol m the organs will be proportional to the organs' water content Body fat 
and skeletal mass hardly absorb any ethanol Therefore, an identical quantity of 
ethanol per kg body weight will induce a higher ВАС in women than m men 
Because women usually also have a lower body weight than men, the differences 
in ВАС between the 'reference woman' and the 'reference man' will be even 
greater after mgestion of an identical amount of ethanol The amount of body 
water of the reference women (58 kg) is only 69% ofthat of the reference man (70 
kg) Besides, a difference m 'first-pass metabolism' of ethanol in the stomach of 
males and females was found recently, man having a larger amount of ADH 
present (Frezza et al, 1990) 
2 2 3 Elimination 
During elimination, when the arteno-venous concentration equilibrium is reached, 
there is a close relationship between ethanol concentrations in breath, arterial 
blood and venous blood (Martin et al, 1984) so the blood alcohol concentration 
can be calculated from the breath value 
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Of the ethanol absorbed 90-98% is oxidized to C02 and H20, 1-5% is excreted in 
an unaltered state in urine, breath, sweat and tears and another 1-5% is expired via 
the lungs. 
At all times the excretion of ethanol is a function of the actual ВАС, so 
the total amount of excreted ethanol can be seen as a function of the area under the 
BAC-time curve (AUC). There is a non-linear relationship between oral ethanol 
dose and AUC (Wilkinson, 1980). An oral dose of 40 g alcohol for a person of 70 
kg results in an AUC of about 3 g.h/1. Assuming a breath/blood partition 
coefficient of 1:2100 and a lung ventilation rate (in rest) of 8 1/min, 720 mg of 
ethanol -2% of the dose- is expired. Alcohol is not concentrated in urine (Olson, 
1979). The blood/urine ethanol concentration ratio is around 1 (0.5-1.0 in the 
absorption phase, 1.2-2.0 in the elimination phase) (Schmidt, 1987). With an 
average urine production of 1.5 l/24h, 0.5% of a dose of 40 g ethanol is estimated 
to be excreted via the kidneys. 
The amount of ethanol excreted in sweat is negligible except in case of excessive 
perspiration, where it can reach 0.5% (Mallach, 1987). 
The height of a Blood Alcohol Curve (ВАС) at any given moment will 
depend on the amount of ethanol absorbed at that particular moment, its 
distribution over the body, and the amount of ethanol already converted and 
excreted (Wilkinson, 1980). The ВАС curve first shows a steep increase 
(absorption phase), followed by a slow decrease (elimination phase). Holford 
(1987) found a linear relationship between oral ethanol dose and ВАС peak; 
С
реак
(гп
ё
Л) = 20*dose (g/70kg). 
Two functions can be used to describe the elimination of ethanol from the blood: a 
straight line (zero-order kinetics according to Widmark), and the 
Michaelis-Menten equation (Lundquist & Wolthers, 1958; Wagner, 1976). 
Widmark equation: С = CQ-ßt 
С concentration at a given moment / 
C0 initial concentration 
β slope 
Michaelis-Menten equation: CQ-C + K^nCJC = Vmt 
K
u
 Michaelis-Menten constant 
V
m
 maximum velocity 
others symbols are the same as the Widmark equation 
The Michaelis-Menten equation expresses more adequately the experimentally 
obtained course of the curve than Widmark's straight line approach does. 
Particularly the tail of the curve fits the Michaelis-Menten equation. Yet it remains 
feasible to approach the elimination of ethanol from the blood by means of a 
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straight line, depending on the specific application required. The zero-order 
kinetics approach is simple, but less precise since it can be applied only to BACs 
exceeding 0.2 g/1. When applied to oral consumption of ethanol, absorption and 
distribution often being disturbing factors, this method usually is sufficiently 
accurate. The Michaelis-Menten equation covers the whole of the elimination 
phase, even when concentrations are low. Its application, however, requires more 
complicated calculations. 
The mean elimination rate from blood is 100 mg/kg bodyweight per hour 
with a range of 88-132 mg/kg per hour. Depending on individual elimination rate 
and body weight, an amount varying between 4.5 g and 12 g ethanol may be 
processed per hour. 
2.2.4 Metabolism 
The rate of ethanol metabolism varies among individuals, and studies of twins 
indicate that interindividual variability in the rate of ethanol metabolism is under 
genetic control (Vesell et ai., 1971; Kopun & Propping, 1977). 
Ethanol is eliminated from the body mainly by metabolism in the liver 
and only minimally by urinary excretion and pulmonary exhalation (Wallgren & 
Barry, 1970). Other tissues such as kidney (Lelair & Muñoz, 1938), and intestine 
oxidize ethanol to a small extent only. This was also thought of metabolism in the 
stomach, until it was recently discovered that indeed the stomach can attribute 
considerably to ethanol metabolism. This metabolizing capacity is much lower in 
women compared to men, and in alcoholics compared to normal drinkers. 
The hepatic metabolism of ethanol proceeds in three basic steps. First, 
ethanol is oxidized by alcohol dehydrogenase (ADH) within the cytosol of 
hepatocytes to acetaldehyde; second, acetaldehyde is converted by aldehyde 
dehydrogenases (A1DH) to acetate, mainly in the mitochondria; and third, acetate 
produced in the liver is released into the blood and is oxidized by peripheral 
tissues to carbon dioxide, fatty acids and water (citric acid cycle). The main 
pathway for ethanol metabolism proceeds via alcohol dehydrogenase (ADH). 
However, alternative pathways for ethanol oxidation have been described, which 
are situated in other subcellular compartments. 
ADH occurs in the soluble fraction of the liver and is also found in other 
tissues in the body, such as gastrointestinal mucosa, kidney, lung and possible 
brain (Mistilis & Garske, 1969; Hawkins & Kalant, 1972). It catalyses the 
oxidation of alcohols, including ethanol, to their corresponding aldehydes in the 
presence of NAD, according to the following scheme: 
RCH2OH + NAD+ —• RCHO + NADH + H+ 
(Hawkins & Kalant, 1972). The rate of elimination of ethanol in vivo correlates 
with the basal metabolic rate, indicating that the rate of mitochondrial NADH 
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oxidation is a major rate-limiting step in the ADH pathway. Although increased 
ADH activity is not associated with increased rates of ethanol oxidation, reduction 
in ADH activity does lead to a decrease in ethanol elimination (Lieber, 1983). 
In 1965, a NADPH-dependent ethanol oxidase was found in microsomes 
from pig's liver which catalyses the oxidation of methanol to formaldehyde and 
thaf*of ethanol to acetaldehyde (Orme-Johnson & Ziegler, 1965). This system, 
which was subsequently designated the microsomal ethanol-oxidizing system 
(MEOS; Lieber & DeCarli, 1968), carries out the following reaction: 
CH3CH2OH + NADPH + 0 2 + Ы —* CH3CHO +NADP
+
 + 2H20 (Lieber, 
1970) 
Human ADH is coded by three structural gene loci, the corresponding products 
α-, ß- and γ-polypeptides combine to form active dimeric isozymes. The ADH 
molecule may appear in at least nine electrophoretically different isozyme forms 
(Smith et al, 1971, 1973). An 'atypical' ADH has been described which differs 
from the usual enzyme in its catalytic activity, pH optimum, kinetic parameters 
and molecular structure (Yoshida et al, 1981). In European countries the incidence 
of atypical ADH ranges from 4 to 20% (von Wartburg & Schiirch, 1968). In 
Japan, however, 85-98% of the population carries the atypical ADH (Agarwal & 
Goedde, 1986). In spite of the presence of highly active atypical ADH, however, 
the rate of ethanol metabolism in normal and atypical ADH phenotype carriers is 
not significantly different. Other isozyme forms found in human liver include 
π-ADH (Li et al, 1977) and ADH-Indianapolis (Bosron et al., 1980). 
Ethanol binds to hepatic cytochrome P450 and gives a modified type-II 
binding spectrum (Rubin et al, 1971). The K
m
 of cytochrome P450 for ethanol 
(about 8 mM) is greater than that of ADH (Lieber & DeCarli, 1970; Lindros et al., 
1974). An isozyme of cytochrome P450 that is induced by ethanol, ΠΕΙ 
(previously described as P4503l, P450ALCor P450j; Nebert et al, 1987) has been 
purified from the liver of rabbits (Koop et al, 1982), rats (Peng et al, 1982), 
hamsters, deermice and baboons (Lasker et al, 1986a). Its presence has been 
demonstrated in rabbit kidney and nasal mucosa (Ding et al, 1986; Ueng et al, 
1987) and in rat kidney (Thomas et al, 1987), but not in microsomes from a 
variety of other tissues (Ding et al, 1986). Cytochrome P450-dependent ethanol 
oxidizing capacity has also been demonstrated in mucosal cells from the upper 
gastrointestinal tract and colon of rats (Seitz et al, 1979, 1982) and in 
macrophages from a variety of tissues in mice (Wickramasinghe et al, 1987). 
Catalase is a haemoprotein located in the peroxisomes of many tissues 
(de Duve & Baudhuin, 1966). An early suggestion that catalase might play a role 
in the metabolism of ethanol (Keilin & Hartree, 1936) was later confirmed by 
Laser (1955), who showed that ethanol could be oxidized effectively in the 
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presence of hydrogen peroxide and catalase. Catalase can oxidize ethanol in vitro 
only in the presence of a hydrogen peroxide generating system. 
During the second step in the oxidation process the acetaldehyde 
generated is converted into acetate by aldehyde dehydrogenase (A1DH). A 
NAD-dependent A1DH with a broad substrate specificty for aldehydes was 
described in 1949 (Racker). The enzyme has a very low Km value and a high 
reaction rate (Grunnet, 1973), therefore, normally, only low concentrations of 
acetaldehyde are found outside the liver (Jacobsen, 1952; Kiessling, 1962; 
Review; IARC, 1985). At low concentrations of acetaldehyde (<50 M) during 
ethanol oxidation, acetaldehyde oxidation is predominantly a mitochondrial 
process (Grunnet, 1973; Marjanen, 1973; Lindros et a!., 1974; Parrilla et ai, 
1974). Several isozymes of A1DH have been identified (reviews Lindros, 1978; 
Salaspuro & Lindros, 1985). Human A1DH is a tetrameric enzyme with a 
molecular weight of ca. 2,300,000. In the liver at least four different isozymes 
exist, which differ in structural and functional properties such as primary 
structure, molecular weight, electrophoretic migration, isoelectric point, catalytic 
constants and subcellular distribution. A1DH2 has the highest affinity to alcohol. 
A1DH2 is located in the mitochondria, the other A1DH isozymes in the cytosol. 
Cytosolic A1DH is more susceptible to inhibition by disulfiram (Alderman et al., 
1982). 
Whites have two predominant A1DH isozymes: A1DH, and A1DH2. 
Many Asians do not have the active A1DH2 isozyme, but an inactive form (Goedde 
& Agarwas, 1987). This variant is found in about 50% of Japanese, 35% of 
Chinese and 40% of Vietnamese and Indonesians. The lack of the active form of 
this A1DH isozyme, causing an increased acetaldehyde level upon alcohol 
consumption, is considered the main cause of the flushing syndrome (Harada et 
al., 1981; Yoshida, 1983). This is a hypersensitivity to alcohol frequently seen in 
people belonging to the mongoloid race, manifesting itself in cardiac arrhytmia 
and flushing. These phenomena are comparable with the disulfiram reaction. They 
are considered to result from acute acetaldehyde intoxication. The atypical ADH 
isozyme demonstrable in ca. 90% of all orientals is now considered of little 
importance as a cause of flushing (Lindros, 1982; Ricciardi, 1983). Alcohol 
ingestion by Orientals resulted in marked elevations of blood acetaldehyde levels, 
with concentrations ranging from 0.4 to 3 mg/1 (Ijiri, 1974); and individuals 
developed facial flushing and tachycardia as a direct consequence of elevated 
blood acetaldehyde levels. Tissues other than the liver may also produce 
acetaldehyde after ethanol administration (Baraona et al, 1985), and intestinal 
bacteria have been shown to produce small amounts (Baraona et ai, 1986). 
It is not clear whether, in the liver, free acetate or acetyl-CoA is 
generated from ethanol (Wallgren & Berry, 1970). The acetate (or acetyl-CoA) 
formed in the liver is hardly oxidized during the citric acid cycle because of an 
NAD* shortage in the liver caused by previous oxidation of ethanol and 
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acetaldehyde (von Wartburg, 1976). Most of the acetate is released into the 
circulation and oxidized extrahepatically to C02 and H20 through acetyl-CoA in 
the citric acid cycle. 
Extrahepatic dissimilation of acetate yields about two thirds of the total 
combustion energy produced by ethanol. The remaining energy is released during 
the generation of acetate in the liver. If completely converted via the ADH 
pathway, ethanol yields 30 kJ/g energy. In case of habituation to large quantifties 
of ethanol, it yields less energy owing to a different metabolic mechanisms. In 
comparison, the energy yield of both carbohydrates and proteins is 17 kJ/g, and of 
fats 38 kJ/g. Alcoholic beverages may be considered as food-stuffs which are 
neither useful nor indispensable to the anabolism of the human body, however. 
2.3 Health Effects 
Alcohol consumption is associated with many health problems, which can be 
divided into three main types: chronic physical problems, casualty and disability 
problems, and mental problems. 
Physical health problems include malfunction and cirrhosis of the liver, 
cancers at various sites, effects on the developing embryo and fetus, and other 
diseases affecting the gastrointestinal, cardiovascular, respiratory, nervous, 
inumino and reproductive systems (World Health Organization, 1980). Of all 
patients in a regular hospital, 25-40% are dependent on alcohol. However, in 
general, physical health problems only occur if the alcohol consumption is 
relatively high. Among moderate drinkers (maximal 2-3 drinks a day) a lower total 
mortality has often been found in relation to alcohol intake (Shaper et ai, 1988). 
This is due to the reduced incidence of coronary heart disease in this group. 
Acute symptom associated with diverse alcohol promillages are given in Table 2. 
2.3.1 Effects of ethanol on the liver 
The organ most frequently affected by excessive ethanol consumption is the liver. 
Alcoholic liver disease ranges from fatty liver, alcoholic hepatitis and fibrosis to 
irreversible cirrhosis. Fatty liver, also called steatosis, is a reversible disorder, in 
which fat accumulates in the liver cells. In the case of hepatitis much of the liver 
tissue is destroyed (necrosis) causing subsequent inflammation. Alcoholic 
cirrhosis is characterized by hepatic fibrosis. The normal structure of the liver and 
liver functions are irreversibly disturbed. 
Chronic alcohol abuse results in functional and structural changes 
in liver cell mitochondria (Lieber, 1973). This in turn leads to a decrease in fatty 
acid oxidation and thus promotes accumulation of fat. A decreased production or 
decreased release of lipoproteins also adds to fat accumulation (Koga & 
Health effects · 29 
Hirayama, 1968; Lieber, 1975). In Figure 3, possible mechanisms of fatty liver 
production through either increase (—>) or decrease (-ll->) of lipid transport and 
metabolism are shown (Lieber, 1990). 
Promillage mg/l 
500-1500 
1500-3000 
3000-5000 
»5000 
clinical features 
mild intoxication emotional lability, slight impairment of visual acuity, muscular 
coordination and reaction time 
moderate intoxication visual Impairment, sensory loss, muscular incoordination, slowed 
reaction time and slurred speech 
severe intoxication muscular incoordination, blurred or double vision, sometimes stupor 
and hypothermia, occasionally hypoglycaemia and convulsions 
coma depressed reflexes, respiratory depression, hypotension and hypothermia Death 
may occur from respiratory or circulatory failure or as the result of aspiration of stomach 
contents in the absence of the gag reflex 
Table 2 Clinical features of ethanol intoxication (Weatherall et 
al, 1983) 
Hepatitis and cirrhosis seem to have multiple causes: 
-hypoxia (French, 1989; Gavaler, 1982; Israel, 1979) 
-increased peroxidation (Aaseth et al, 1986; Dicker & Cederbaum, 1988; 
Ingelman-Sundberg et ai, 1987) 
-abnormal cellular immunological activity and disturbed lymphocyte activity 
(Anonymous, 1983; Barry, 1988; Eddleston & Vento, 1988) 
-changes in collagen production (Gavaler, 1982; Horrobin, 1980,1987) 
-mitochondrial injury caused by ethanol itself or by acetaldehyde (Lieber, 1980) 
-interference with essential fatty acid and prostaglandin metabolism (Glen et ai, 
1987) 
-an antitubular effect of alcohol or acetaldehyde, causing the formation of Mallory 
bodies (Isselbacher, 1977). 
As opposed to some thirty years ago, nutritional deficiencies are now not 
regarded as the primary cause. Alcohol consumption itself, rather than the 
attendant malnutrition in alcoholics, plays a key aetiological role in the 
development of liver injury (Achord, 1988; Lieber, 1982). 
Hypoxia seems to be an important factor in hepatic damage, because 
necrosis and later fibrosis will first be observed in the perivenular zones of the 
cells. Israel et al. (1979a, 1979b) consider necrosis in these zones as caused by a 
disturbance of the equilibrium between the availability of oxygen and the liver's 
oxygen requirement. It has been demonstrated that liver cells have an increased 
oxygen demand during ethanol metabolism, but this can be fully offset by a 
parallel increase in bloodfiow. According to French (1989) chronic ethanol 
ingestion leads to hepatocellular injury only if multiple factors are operative in 
combination to induce centrilobular hypoxia. Possible factors are a shift in redox 
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state, MEOS (Microsomal Ethanol Oxidizing System) induction, a high blood 
alcohol concentration (BAC), a diet rich in polyunsaturated fatty acids (PUFA), 
and episodic decreased oxygen supply to the liver. 
Figure 3. Possible mechanisms of fatty liver production through 
either increase (—>) or decrease (-II->) of lipid transport and 
metabolism (from Lieber, 1982) 
In 1957 the first report was published about a NADPH-dependent 
production of hydrogen peroxide in liver microsomes (Gillette et al, 1957). 
Twenty years later it was shown that a catalytically active rabit liver microsomal 
P450 system produces hydrogen peroxide. In the presence of substrate, as much as 
55% of the consumed oxygen can result in hydrogen peroxide formation, whereas 
in the absence of substrate, up to 100% of oxygen can be transformed to hydrogen 
peroxide (Nordblom & Coon, 1977). Nordblom & Coon also found that the nature 
of the substrate alters the coupling efficiency of the enzyme. The rate of hydrogen 
peroxide production in isolated perfused rat liver has been determined by spectral 
intermediates of catalase and the value obtained was 82 nmol HjO^min per g 
liver. This would give an estimated steady state concentration of 10'9-10'7M 
hydrogen peroxide in the liver (Oshino et al, 1973). Premereur et al (1986) have 
found evidence for the existence of a basal P450-dependent hydrogen peroxide 
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production m vivo in guinea pig. Hydrogen peroxide can be produced by 
dismutation of superoxide anions. 
2 02- + 2 H+ - * · 2 H202 + 0 2 
This reaction is catalyzed by superoxide dismutase but can also occur 
spontaneously at a slower rate. 
The oxycytochrome P450 complex can be autooxidized by loss of the 
superoxide anion (Figure 1, par 1.2) and the microsomal hydrogen peroxide 
production appears to result from dismutation of the liberated superoxide anions. 
In a hon-heme iron catalyzed Haber-Weiss reaction hydroxyl radical formation in 
biochemical systems could be realized. 
Free radicals are believed to play a role in the pathogenesis of ethanol-induced 
liver damage. In figure 4 reactions of reactive free radicals are given. 
DNA damage 1—> cell injury 
1—> mutations 
destruction of nucleotide coenzyme activities 
change in redox status of NAD(P)H 
disturbance to SH-dependent enzymes 
change in SH/S-S status 
covalent binding to protein and lipid 
changes in enzyme activities and lipid metabolism 
damage to proteins, increased protein turnover 
lipid peroxidation, changes in membrane 
structure and function 
secondary products causing disturbances 
at a distance, such as to the functions of 
other mem branes 
membrane damage to proteins, transport 
disturbances 
Figure 4. Reactions of reactive free radicals (from Slater, 1987) 
The vulnerability of a tissue to peroxidation is a function of the balance between 
pro-oxidant and antioxidant systems. Glutathione (GSH), ascorbic acid, selenium 
REACTIVE FREE RADICALS -
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and α-tocopherol have antioxidant properties. Ethanol seems to influence both 
systems at various sites. Recently, the in vivo formation of a free radical 
metabolite of ethanol (α-hydroxyethyl radical) has been demonstrated (Knecht et 
al, 1990). Johansson et al. (1988) suggest that an enzymatic Haber-Weiss reaction 
in the active site of the ethanol inducible P450 enzyme. Proposed schemes for 
possible mechanisms of P450 dependent ethanol oxidation are presented in figure 
5. 
P450
 e
- P450 Q, P450 °2 P450 
Fe+ F> ¿ e 3 + 0 - F'e3+ 
2 0"2+ 2 H + ^ Ht¡02 
P450 P450 P450 
i 3 + - ^ i2+ — r \ * із+ 
Fe F e F e 
" 2 ° 2 *OH 
CbijC^OH CKfHOU 
Figure 5. Proposed mechanism for ethanol oxidation catalyzed by 
the etanol-inducible cytochrome P450. From Johansson (1988). 
Acetaldehyde is also a substrate of free radical production (Reinke et ai, 1988). In 
this way, both acute ethanol consumption (direct and via acetaldehyde) and 
chronic ethanol consumption (by inducing MEOS) promote free radical 
production, which may contribute to the hepatotoxic effects of ethanol. 
2.3.2 Cancer Epidemiology 
In France, in 1910, it was observed that about 80% of patients with cancer of the 
oesophagus and cardiac region of the stomach were alcoholics, who drank mainly 
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absinthe (Lamy, 1910). In the first half of the century it was noted from mortality 
statistics in various countries that high risks for cancers of the oral cavity, 
pharynx, oesophagus and larynx occurred among persons employed in the 
production and distribution of alcoholic beverages (Young & Russell, 1926; 
Clemmesen, 1941; Kennaway & Kennaway, 1947; Versluys, 1949). Cancers at 
these sites occur at lower rates in people who take no alcohol, such as Seventh-day 
Adventists (Wynder et al, 1959; Lemon et al, 1964; Phillips et al, 1980). 
Subsequent to historical observations and studies of religious groups, analytical 
studies of the cohort and case-control type have been carried out. 
In descriptive studies, a very crude level of alcohol intake is typically 
inferred for a group of individuals, on the basis of characteristics such as treatment 
for alcoholism. Frequently, even measurements of average alcohol intake in these 
groups and in the groups with which they are compared are lacking. 
In case-control and cohort studies involving individual subjects, 
measurements of alcohol intake are usually obtained by structured interviews or 
questionnaires. The questions asked vary widely among studies, providing 
markedly different levels of details about alcohol intake (Room, 1979). In some 
studies, a single question was asked that provided only a few categories of alcohol 
consumption. In many studies, separate questions were asked regarding the 
average frequency (usually in terms of standard units) of drinking beer, wine, 
spirits and other specific beverages. This information allows a calculation of usual 
total ethanol intake as well as an estimation of that from the specific beverages. In 
general, details about mtraindividual variations, such as 'binge drinking', have not 
been incorporated in studies. The validity of self-reported alcohol consumption 
has been reviewed by Midanik (1982). In some populations (Pernanen, 1974), self 
reporting of alcohol intake results in a lower total than that for alcohol sales. 
However, even if a population as a whole tends to underestimate its intake, this 
may not necessarily be true of participants in epidemiological studies, such as 
those who volunteer to enrol in a cohort study. Moreover, there is some evidence 
that underestimation tends to be proportional to consumption, so that at least the 
broad ordering of respondents is correct (Boland, 1973). 
Descriptive studies of the relationship between alcohol consumption and 
cancer risk entail analysis of the covariation of population-based measures of 
those two variables. Variations (known or inferred) in alcohol consumption by 
time, geographic location and category of person are examined in relation to 
variations in cancer incidence or mortality rates. Since alcohol consumption tends 
to be associated with other forms of behaviour that might also influence the risk of 
developing cancer (especially cigarette smoking and aspects of diet), and for 
which equivalent measures of exposure are frequently not available, it is not 
possible in descriptive studies to infer a causal relationship between alcohol 
consumption and cancer risk. Descriptive studies have been used most frequently 
to study alcohol consumption in relation to specific cancers of the upper 
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alimentary tract and larynx. Oesophageal cancers, in particular, have been studied 
in this way in both developed and developing countries. Many geographic 
correlation studies have been carried out to examine mortality from alimentary 
tract cancer in relation to mortality from liver cirrhosis and alcoholism within the 
departments of France (Lasserre, 1967). These studies have consistently shown a 
strong correlation of oesophageal cancer with the index of alcohol consumption; 
less strong correlations have been seen for cancers of the mouth, pharynx and 
stomach. 
The relationship between alcohol intake and cancer at a variety of sites 
has been assessed in many large cohort studies. With few exceptions, detailed 
information on type of beverage, amount drunk and on smoking was not available. 
Tobacco smoking and alcohol drinking are often correlated at the individual level, 
and tobacco smoke is a cause of cancer at many sites that may also be related to 
alcohol consumption (IARC, 1986). However, a major methodological advantage 
of cohort studies over case-control studies is the lesser probability of selection 
bias and bias with regard to information on exposure. The most detailed evidence 
about the relationship between alcohol and cancer at individual sites has come 
from case-control studies. 
From the human carcinogenicity data it can be concluded that the 
occurrence of malignant tumours of the oral cavity, pharynx, larynx, oesophagus 
and liver is causally related to the consumption of alcoholic beverages. Overall, 
studies on cancers of the urinary bladder, kidney, ovary, prostate and lymphatic 
and haematopoietic system show no association with consumption of alcoholic 
beverages. The sparsity of the observations on cancers of the skin, corpus and 
cervix uteri, vulva, testis, brain, thyroid and soft tissues precludes an evaluation 
(IARC, 1988). 
2.3.3 Ethanol Related Mechanism of Carcinogenesis 
It is not clear how the influence of alcoholic beverages on the pathogenesis of 
cancer of the mouth, pharynx, larynx, oesophagus and liver can be explained; the 
beverages may be carcinogenic in themselves, or be active as a cocarcinogen; 
either ethanol or other additives may cause those effects. Indirect effects of 
alcohol use may also play a part. There is no evidence from animal studies that 
ethanol per se is carcinogenic. However, ethanol may increase the susceptibility of 
various tissues to chemical carcinogens by a variety of mechanisms (Swann, 
1984). Among these are alteration of the metabolism and/or distribution of 
carcinogens, interfering with the repair of carcinogen-mediated DNA alkylation 
and the immune response, and stimulation of cellular regeneration. Regarding 
carcinogenesis in sites that are directly exposed to alcoholic beverages, a local 
effect has been suggested. Figure 6 shows the possible sites for application in 
carcinogenesis. 
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Ethanol itself is unlikely to be carcinogenic. Experiments performed to induce 
cancer with ethanol in well-fed laboratory animals without liver injury have failed 
so far (Keller, 1980). Fusel alcohols, i.e. the higher alcohols present in all 
alcoholic beverages in varying quantities, contribute to the specific taste and 
flavour of these beverages. Several animal experiments have shown that fusel 
alcohols (in far greater quantities than usual) are carcinogenic (Gibel, 1975; Obe, 
1979). Small quantities of nitrosamines, known to be carcinogenic, have been 
found in African maize beer, German beer and distilled maize beverages 
(McGlashan, 1969) while in the areas where these beverages are consumed, the 
incidence of cancer of the oesophagus is high (Cook, 1971). In cider distillates, 
small quantities of nitrosamines have also been found. 
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Figure 6. Scheme of two-step carcinogenesis and possible sites of 
action of ethanol (after Seitz, 1988) 
Some suggest this as a possible explanation of the fact that mortality from cancer 
of the oesophagus in France is highest in Normandy and Brittany, where 
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consumption of this kind of alcoholic beverages is highest. Whisky and some 
types of beer (especially the dark types), contain traces of nitrosamines (Keller, 
1980) which are formed when the malt is roasted. Furthermore, the presence of 
ethanol seems to catalyse the production of nitrosamines from their constituent 
compounds, namely nitrites and secondary amines, under the conditions 
encountered in the upper gastrointestinal tract (Pignatelli et al, 1976). Alcoholic 
beverages are extremely complex mixtures in which hundreds of substances may 
be present. One or more of these can contribute to carcinogenesis. Mutagenesis 
investigations have revealed mutagenic activity in several commercially produced 
and home-made apple brandies as well as in red wine and in red grape juice. A 
variety of carcinogens such as polycyclic hydrocarbons (Matsuda et al., 1966) and 
asbestos fibres (Wehman, 1974) have been detected in alcoholic beverages. 
Acetaldehyde, the major intermediary metabolite of ethanol, was tested 
for carcinogenicity in rats by inhalation and in hamsters by inhalation and by 
intratracheal instillation. It produced tumours of the respiratory tract following 
inhalation, particularly adenocarcinomas and squamous-cell carcinomas of the 
nasal mucosa in rats and laryngeal carcinomas in hamsters. In hamsters, it did not 
result in an increased incidence of tumours following intratracheal instillation. 
Inhalation of acetaldehyde enhanced the incidence of respiratory-tract tumours 
induced by intratracheal instillation of benzo(a)pyrene in hamsters (IARC, 1987). 
Nutritional deficiencies are very common in alcoholics. A poor 
nutritional status seems to be a risk factor for oesophageal cancer (Ziegler, 1981). 
Chronic alcohol consumption has striking effects on tissue vitamin A levels. 
Considering the enhancing effects of vitamin A deficiency on carcinogenesis, it is 
conceivable that part of the interaction between alcohol and cancer may be caused 
at least indirectly by the alteration of the vitamin A status induced by chronic 
alcohol abuse (Leo et al, 1986). Deficiencies of some other vitamins (riboflavin, 
vitamin B6, vitamin E) have also been implicated in the pathogenesis of cancer 
(Lieber et al, 1986). 
Hepatitis В virus (HBV) is associated with an increased risk of 
hepatocellular carcinoma (Liaw et al, 1986), and alcoholics have an increased risk 
of HBV infection (Mills et al, 1979). An association between cirrhosis and 
hepatocellular carcinoma has also been observed (Johnson et al, 1978). 
Chronic ethanol consumption can lead to a reduced salivary secretion 
rate (Dutta, 1989). Since saliva seems to be able to protect the mucosa against the 
local actions of chemical carcinogens, reduction of the salivary gland function 
might play a role in carcinogenesis of the upper digestive tract. 
Ethanol causes changes in the permeability of membranes (McGoy & 
Wynder, 1979; Obe & Ristow, 1979) which may increase the diffusion of 
carcinogenic substances from tobacco smoke and other sources into the cells.By 
acting as a solvent for carcinogens ethanol may increase its activity. 
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As a another possible mechanism MEOS induction has been suggested. Regular 
alcohol consumption induces the microsomal ethanol-oxidizing system (MEOS) in 
the liver and in the intestine which is associated with an increase in various 
constituents of the microsomal system, namely phospholipids, cytochrome P450 
reductase and cytochrome P450. The bioactivation of procarcinogens into their 
reactive intermediates in the intestine and/or liver can also be stimulated via this 
induction (Liebere/ al, 1979; Obe & Ristow, 1979; Seitz et al, 1978). 
There are two effects of ethanol on DNA that might be associated with 
cocarcinogenic activity, namely its effect on sister chromatid exchanges (SCEs) 
and on DNA repair. Obe and Ristow (1979) found an elevation of chromosomal 
aberrations in the lymphocytes of alcoholics. Results of animal studies indicate 
that chronic alcohol consumption inhibits the activity of the DNA repair enzyme 
06-methylguanine transferase. However, it remains to be determined whether 
ethanol also inhibits human 06-methylguanine transferase (Garro et ai., 1986). 
DNA demethylation might be related to tumour development by 
enhancing gene expression or inhibiting chromatin condensation. Inoue et al. 
(1988) noted that demethylation of exon 2 of the c-myc gene of the hepatocellular 
carcinoma is more (albeit not significantly more) frequently encountered in groups 
of heavy drinkers. 
Several studies have shown an association between heavy drinking and 
decreased immune response (Mufti et al, 1989). Ethanol-associated 
immunosuppression has been considered a possible factor contributing to an 
increased risk of cancer (Daynes et al, 1979). For the most part, however, studies 
in which decreased immune response has been associated with alcohol abuse 
involved patients who already had alcoholic liver disease. Therefore, it is difficult 
to assess whether the immunological defects observed were due directly to alcohol 
or reflected other aspects of the ongoing disease process. There is reason to 
question the significance of immunosuppression in general carcinogenesis. 
Although cancer incidence is higher among immunosuppressed patients and 
animals, the cancers observed are mostly cancers of the immune system itself 
(Baird et al, 1982). Nevertheless, the immune system may play a vital role in the 
defence against virally induced tumours, particularly in HBV-associated 
hepatocellular carcinoma (Garro & Lieber, 1990). 
2.4 Exposure Models for Rats 
Historically, the primary reason for doing research on alcohol is that it causes a 
multitude of problems in humans. The research was mainly concerned with 
alcoholism and its pathological consequences. The goal of the research was the 
development of a better understanding of the mechanisms and underlying causes 
of these problems and ultimately the discovery of ways to prevent or cure the 
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problems (Eriksson, 1980). The first animal model on alcohol research was used 
by Richter in 1926, who caried out studies on rats' voluntary choice between an 
alcohol solution and water. 
Much of the research of relevance for humans cannot be conducted on 
human beings for ethical or technical reasons. Especially for ethanol, it is of 
importance that using an animal model, it is theoretically possible to examine the 
effects of alcohol per se, without interference from such confounding variables as 
poor nutritional status, multidrug abuse, prior exposure to alcohol or other drugs, 
and organ damage. Animal models have been developed in many areas of alcohol 
research. Selective rodent strains have been bred with either low or high 
preference for alcohol (Eriksson, 1968; Elmer et ai, 1988) in order to identify 
biochemical, physiological and behavioural differences between those strains. The 
strains best studied are the AA and ANA rats bred at the research laboratories of 
ALKO in Finland and the P- and NP-rats from the laboratory in Indianapolis, 
USA. AA- and P-rats consume large and ANA- and NP-rats very small amounts of 
alcohol (Lumeng et al., 1982; Waller et al., 1984). The existence of these strains 
suggests that genetic components exist in the degree and nature of alcohol 
drinking behaviour of rodents, although it is unlikely that a complex disorder like 
alcohol addiction could ever be fully explained in terms of the action of a single 
gene (Holden, 1991). Random bred rats are used to study all kinds of 
physiological changes coupled with (prolonged) ethanol consumption. 
The classical and, at one point, only model of experimental alcohol 
administration is the incorporation of ethanol in the drinking water of the animals. 
This technique has the advantage of simplicity, but it has two drawbacks, namely: 
the nutritional effects associated with the consumption of alcohol are difficult to 
assess and to control; the alcohol intake is low, as a result of the natural aversion 
of most animals for ethanol. When the diet is adequate, no significant liver 
damage is caused (Best et al, 1949). 
Today, three categories of animal models can be recognized, each 
concerned with a different aspect of ethanol consumption. To study alcohol 
addiction an important criterion for experimental models is that animals have to 
self-administer alcohol, they must have a wish to consume alcohol (Stewart & 
Grupp, 1989). This forces the use of self-administration models like 
schedule-induced polydipsia (rats maintained on a fixed interval schedule of 
reinforcement for food consumed copious amounts of alcohol during the intertrial 
intervals), preference studies or operant studies (Komet, 1991). 
Physiological complications observed in alcoholics can be reproduced 
with the liquid diet technique (DeCarli & Lieber, 1967; Lieber & DeCarli, 1982). 
This diet induces fatty liver, hyperlipemia, various metabolic and endocrine 
disorders, tolerance to ethanol and other drugs, physical dependence and 
withdrawal and, in the baboon, liver fibrosis and cirrhosis. Main disadvantage is 
that control and experimental animals have different feeding patterns. One day the 
Polycyclic aromatic hydrocarbons · 39 
total caloric intake of the ethanol consuming rats is measured. The other day the 
control rats get the same amount of calories without ethanol. Control animals 
consume the major portion of their food on initial feeding and effectively starve 
themselves for the remainder of the 24-hr period (Keane & Leonard, 1989). 
Alternatively the alcohol-drinking water techniques is used. This is more 
appropriate if one is interested primarily in more specific effects of ethanol, and if 
the effect is observed with lower levels of ethanol consumption. The 
ethanol-drinking water technique provides a simple and useful tool, as illustrated 
by the induction of a specific microsomal cytochrome P450 in the liver (Lieber et 
al., 1989). Both the Lieber diet and the ethanol-drinking water technique are 
isocaloric, not isonutrient. 
3. POLYCYCLIC AROMATIC HYDROCARBONS 
3.1 Human exposure 
The history of the toxicology of polycyclic aromatic hydrocarbons (PAHs)1 is 
closely related to the establishment of the carcinogenicity of coal tar (Phillips, 
1983). As early as 1775, the British surgeon Sir Percivall Pott published studies 
which indicated increased incidences of scrotal cancer among chimney sweeps in 
England, resulting from prolonged contact of the skin with coal soot (Pott, 1775). 
In the nineteenth century, high incidences of skin cancer were reported 
among workers in the paraffin refining (von Volkmann, 1875), shale oil (Bell, 
1876) and coal tar industries (Butlin, 1892). Early attempts to produce cancer in 
experimental animals with the raw materials of these industries were unsuccessful 
and it was only in 1915 that investigators succeeded in inducing tumors with coal 
tar. Yamagiwa and Ichikawa showed that if coal tar was repeatedly painted inside 
the ears of rabbits (two to three times a week), malignant tumors developed at the 
site of the skin painting after 3 months, and these later grew over the whole ear 
(Yamagiwa et al, 1915). Soon afterwards Tsutsui obtained malignant skin 
tumours in mice by painting them with coal tar (Tsutsui, 1918). Attempts were 
started to characterize the carcinogens in coal tar. It was found that the 
carcinogenic factor was concentrated in the high-boiling fractions and was free of 
arsenic, nitrogen and sulphur (Bloch et al, 1921). 
In 1922, Kennaway and his group at the Research Institute of the Cancer 
Hospital in London started a series of chemical and physical studies of coal tar. It 
was found that the fluorescence spectrum of benzanthracene was very similar to 
those of the carcinogenic tars, although shifted to longer wavelengths (Hieger et 
al, 1930; Kennaway & Hieger, 1930). After the synthesis of 
dibenz(a,h)anthracene and its 3-methyl-derivative these compounds were tested by 
' PAH in this context means homocydic, non-substituted PAH 
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skin painting of mice and found to produce tumors. This was the first recognition 
of the carcinogenic activity of a chemical of defined structure. Hieger and 
co-workers (1933) initiated a large-scale isolation of the carcinogens(s) in coal tar. 
Starting with two tons of pitch, they performed a series of fractional distillations, 
differential extractions, and crystallizations. The various fractions were 
characterized by their fluorescence spectra and their carcinogenic activity by skin 
painting on mice. In two years they had isolated about 7 g of a yellow crystalline 
material which had the correct fluorescence spectrum and exhibited high 
carcinogenic activity. This material was found to consist of two isomeric 
compounds, benzo(ajpyrene [B(a)P] and benzo(e)pyrene [B(e)P]. Both the 
synthetic and the isolated samples of B(a)P were highly carcinogenic. 
In the following years, a large number of PAH compounds were isolated 
and synthesized, and were tested for carcinogenic effects by skin painting. These 
studies were the first of a large number of studies of the carcinogenic properties of 
PAHs. By 1976, more than 30 parent PAH compounds and several hundred alkyl 
dérivâtes of PAHs were reported to have some carcinogenic effects (Committee on 
Biologic Effects of Atmospheric Pollutants, 1972; Dipple, 1976). This makes 
PAHs and their derivatives the largest class of chemical carcinogens known today. 
Recently, the International Agency for Research on Cancer (IARC) made a critical 
evaluation of all available data on the carcinogenic effect of 32 PAHs. It was 
concluded that 11 PAHs were found to be proven carcinogens in experimental 
animals, 6 were found likely to be carcinogens, 12 had inconclusive evidence, and 
3 were proven noncarcinogens (IARC, 1983). 
PAHs can be formed by decomposition of any organic materials 
containing carbon and hydrogen. The formation is based on two major 
mechanisms: (1) pyrolysis and pyrosynthesis or incomplete combustion, and (2) 
low temperature carbonization processes. In addition, some investigators suggest a 
biological formation of PAHs (Bjorseth et al., 1986). 
Although the mechanism of PAH formation in combustion processes is 
complex and variable, Badger and coworkers (1962) suggested the stepwise 
synthesis of PAHs from C2 species during hydrocarbon pyrolysis. Once formed, 
PAHs might undergo further pyrosynthesis reactions to form larger PAHs by 
intermolecular condensation and cyclization (Lang et al., 1963). 
Only a limited number of PAHs enter the environment. Irrespective of 
the type of material to be burned, surprisingly similar ratios of PAHs are formed at 
a defined temperature. For example, thermal decomposition of pit coal, cellulose, 
tobacco, and also of polyethylene and Polyvinylchloride carried out at 100 °C 
yields very similar PAH profiles (Grimmer, 1983). The absolute amount of PAHs 
formed under defined pyrolysis conditions depends, however, on the temperature 
as well as the material. 
PAHs in fossil fuels have been formed at low temperatures by a 
carbonization process over millions of years. The PAH profile contained within 
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fossile fuels is clearly different from that obtained by pyrolysis. In petroleum, the 
alkylated PAHs outnumber the parent PAHs. 
The amount of PAH possibly formed by biosynthesis in microorganisms 
or plants is negligible in comparison with the quantities formed by abiotic 
processes (Grimmer, 1976). 
Figure 7 lists the names and structures of parent PAHs (with 3 or more rings) most 
frequently found in environmental samples. 
Figure 7. Structures of carcinogenic and non-carcinogenic 
unsubstituted polycyclic aromatic hydrocarbons (PAHs). These 
compounds show tumor-initiating activity. From Dipple et al. 
1984 
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3.1.1 Environmental exposure 
The routes of exposure to PAHs for the general population are through inhalation 
of air, drinking of water and intake of food. Emissions of PAHs in the air began 
with forest fires and volcanic eruptions and have greatly increased as consequence 
of industrialization. In the Netherlands, about 1350 tons of B(a)P is produced 
and/or imported yearly (Verhoeve et al., 1980). The emission is about 10 
tons/year. The largest quantity of B(a)P comes from the production and import of 
coal-tar (1250 tons). Of this amount about 75% is transformed into coal-tar pitch 
(920 tons B(a)P) and heavy oil (30 tons B(a)P). The largest part of the coal-tar 
pitch is used by the graphic and electrode-manufacturing industry, a smaller part 
in the production of active coal. Coal tar pitch is also used in various (industrial) 
products such as binding agents, roofing products and coatings. Heavy oil is used 
for the production of soot. 
The total PAH emission into the air is several thousands of tons/year. 
These consist for over 90% of lower PAHs (molecular weight < 200-230) and 
80% of these emissions come from industrial sources. PAH emissions into water 
amount to about 150 tons/year. These also consist mainly of lower PAHs (for over 
90%). Diffuse sources are responsible for more than 90% of these emissions (van 
der Naald et al., 1988).Β(α)Ρ emissions are mainly produced in industry (65%). 
Large diffuse sources are the use of coal burning as heating source and waste oil 
(14% and 18%, respectively). 
Almost all PAHs with 4 or more rings present in the air are adsorbed 
onto particles which are deposited on the ground and in the water and thus 
contribute to exposure through drinking water and food. The major portion of 
PAHs in ambient air is found adsorbed on particles smaller than 0.5 μπι. About 
500 PAHs have been detected in the air but most measurements concern B(a)P. 
B(a)P levels in clean air are < 1 ng/m3 but heavely polluted air can contain levels 
up to 100 ng/m3 (Hemminki, 1990). In the Netherlands, the amount of B(a)P in the 
air is usually about 10% of the total amount of all PAHs. The concentration of 
B(a)P in the air, averaged over one year, amounts to 1 ng/m3 for the past few 
years; higher concentrations have been found in the IJmuiden-area (Hoogovens): 
up to 4 ng/m3. Up to the nineteen sixties these concentrations were much higher: 
often higher than 20 ng/m3. Since then the concentrations of B(a)P -and 
presumably all PAHs- have decreased strongly, probably as a result of the large 
scale use of natural gas as an energy source, instead of coal. Adult humans inhale 
about 20 m3 air per day and the PAH deposition rate in lungs amounts to about 
50%. This results in intakes between 10 and 1000 ng B(a)P per day for clean air. 
For comparison, the average total B(o)P content of the mainstream smoke of one 
cigarette can vary between 20 and 40 ng. 
Smoking and the use of wood in fireplaces cause a considerable increase 
in the background concentration of PAHs in interior air (Slooff et ai, 1989). Data 
on PAHs in food were reviewed recently (Grasso, 1984; Grimmer, 1983; Vaessen, 
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1988). PAHs are found in substantial quantities in some foods, depending on the 
method of cooking, preservation and storage; the B(a)P content in 
charcoal-broiled and smoked foods was reported to be as high as 50 μg/kg. PAHs 
are detected in a wide range of fresh meat, fish, vegetables and fruits; high levels 
were found in leafy green vegetables. The latter levels paralleled with the 
atmospheric burden, indicating that PAHs are deposited from the atmosphere 
(Grimmer, 1983). It is assumed that 99% of the environmental exposure to PAHs 
can be attributed to food, 0.9% to inhalation and 0.1-0.3% to the drinking of water 
(WHO, 1984). A recent study of Dutch total diet showed that the major daily PAH 
intake comes from sugar and sweets, cereals, oils, fats and nuts and ranged up to 
1.4 μg/kg (de Vos et al., 1990). 
3. J. 2 Occupational exposure 
PAHs in the workplace atmosphere may originate from two major processes: (1) 
evaporation during heating of РАН-containing matter, and (2) formation by 
pyrolysis and pyrosynthesis or incomplete combustion. Coal tar products, derived 
from the carbonization of coal, are the most important sources of PAH emissions 
in the work environment (NIOSH, 1977; Kipling, 1976). Coal tar products are 
used at elevated temperatures in many industrial processes, such as aluminium 
melting, iron and steel production, and foundry and asphalt production thereby 
emitting PAHs into the work atmosphere. In some studies, average daily inhaled 
doses of 50 μg B(a)P have been observed (Hammond et al., 1976). 
The main Dutch industries associated with considerable occupational 
(and environmental) pollution of PAHs are: carbon electrode plants, coke works, a 
needle coke ρΐαηζ aluminum producings plants, a coal tar distillation plant, 
phosphor plant, silicium carbide plant, and an iron and steel works. More 
peripheral industries are wood preserving industries, soil decontamination of 
tar-contaminated soil, asphalt handling (re-use of coal tar asphalt), glassworks, 
foundries. Peripheral exposures are associated with the production, handling and 
application of: hot tar derived products, tar derived coatings, waste oil, exposure 
to exhaust gases (industrial + vehicle), carbon black or carbon-black derived 
materials (Jongeneelen, 1987). 
Pathways for exposure of workers to PAHs are the inhalation of vapors 
or particles, contamination of the skin, and ingestion. The relative importance of 
each exposure route varies according to the particular technology used or the 
particular type of work in which the worker is engaged. Exposure to PAH vapors 
may not pose a direct carcinogenic risk, because only high-boiling PAHs with 
correspondingly low vapor pressures have been demonstrated to be carcinogenic. 
However, some of the vapors could exert promotional or co-carcinogenic 
responses when inhaled together with other vapors or particulate PAHs. 
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PAHs with four or more rings are primarily associated with particles when they 
occur in the atmosphere. The particles may be deposited in various compartments 
of the respiratory tract depending on the physical properties of the particles, the air 
velocity in the respiratory tract, and the branching of the respiratory tract (Pott & 
Oberdörfer, 1983). Particles exceeding 10 μηι in aerodynamic diameter usually 
remain in the upper respiratory tract and do not penetrate into the lungs. 
In other industries, skin contact with РАН-containing material may be 
the major route of human exposure to PAHs. As PAHs are highly lipophilic, they 
readily penetrate the skin and may cause systemic effects. 
Direct ingestion of particles will be prohibited by good occupational 
hygiene and will seldom occur. However, the inhalation and swallowing of coarse 
particles may represent an indirect route of ingestion. The inhaled larger particles 
will be trapped in the mucous fluids of the upper and middle respiratory system. 
After transport to the throat, they will be swallowed. 
3.2 Fate in the body 
3.2.1 Absorption, distribution and elimination 
Mitchell (1982, 1983) showed that 1 to 2 μπι aerosol particles of B(a)P inhaled by 
rats were deposited mainly in the upper respiratory tract. B(o)P was cleared from 
the lungs and transported to the internal organs in two phases: an initial rapid 
phase where 50% of the B(a)P was cleared in approximately 2 hr and a second 
slower phase that continued for about 2 days after exposure. Metabolites of B(a)P 
were found in the lung, liver, and kidney shortly after the inhalation exposure. The 
amount of unmetabolized B(o)P in lung tissue was not greater than 20%. The 
results indicated that a large portion of inhaled B(a)P was metabolized by the lung 
tissue prior to clearance from the lung. Furthermore, it was found that a significant 
amount of B(o)P was covalently bound to the lung tissue and retained for a much 
longer time than the soluble metabolites. 
Sun et al. (1982) found that about 10 % of pure B(a)P aerosol 
(approximately 0.1 μπι in diameter) was deposited in the lung of rats. During the 
exposure, and within the first 30 min after exposure, about 90% of the amount of 
B(a)P was cleared from the lung by absorption into blood followed by excretion 
from the body through the feces. The retention of B(a)P, however, was much 
longer when B(a)P coated on insoluble particles was inhaled. Furthermore, both 
studies indicated that a substantial amount of inhaled B(a)P particles were 
removed from the lung by mucociliary clearance and subsequent swallowing of 
the material. This mechanism can result in high PAH levels in the GI tract from 
which they may be absorbed. This may be a second important route of exposure to 
PAHs. The lung retention.of particle-bound PAHs depends on particle-size, but 
will always be higher than gaseous PAHs. Small particles penetrate the deeper 
Fate in the body · 45 
parts of the lungs and are retained there for a long time; a relatively large 
proportion of PAHs will therefore elute at that location. Larger particles stay in the 
upper respiratory tract, where clearance is more rapid and therefore less PAH 
elution from the particles occurs. It was estimated that, in man, approximately 
20% of the inhaled higher PAHs as occurring in outdoor air will come into contact 
with lung tissue after retention in the lungs and elution (Van Vaeck & 
Cauwenberge, 1983). 
In a study by Heidelberger and Weiss (1951), topical application of a 
B(a)P solution to shaved backs of mice was followed by a diphasic disappearance 
of radioactivity, with half-lives of 40 and 104 hr for the initial rapid phase and the 
subsequent slow phase, respectively. Since essentially all of the radioactivity was 
recovered in the feces within 16 days, quantitative percutaneous absorption of 
B(a)P is apparent. 
PAHs, once absorbed, become localized in a wide variety of body 
tissues. The distribution of radioactivity derived from 14C-B(a)P in the rat and 
mouse was determined following subcutaneous, intravenous, and intratracheal 
administration (Kotin et ai, 1959). The pattern of distribution was found to be 
similar in all cases, except for high local pulmonary concentrations following 
intratracheal instillation. Concentrations of B(a)P-derived radioactivity in the liver 
reached a maximum within only 10 min after injection and represented 12% of the 
total dose. Radioactivity in the liver was reduced to 1 to 3% of the administered 
dose within 24 hr. Similarly, maximum blood levels of B(a)P following intra 
venous injection were reached very quickly, and radioactivity became barely 
detectable after 10 min. Minimal tissue localization of radioactivity (B(a)P and/or 
its metabolites) occurred in the spleen, kidney, lung, and stomach; maximum 
radioactivity derived from labeled B(a)P was recovered in the bile and feces. 
Levels of radioactivity in fat, skin, and muscle were not determined, nor was the 
amount of unchanged B(a)P in any tissue. Bock & Dao (1961) later showed that, 
relative to other tissues, unmetabolized B(a)P was located extensively in the 
mammary gland and general body fat after a single feeding of the carcinogen (10 
to 30 mg). According to Bjorseth and Becher (1986), the results of the studies 
indicate the following: 1. Detectable levels of PAHs and/or PAH metabolites can 
be observed in most internal organs from minutes to hours after administration. 2. 
Mammary and other fat tissues are significant storage depots where PAHs may 
accumulate and be slowly released. 3. The gut contains relatively high levels of 
PAHs and/or PAH metabolites as a result of hepatobiliary excretion or of the 
ingestion of particulate PAHs following mucociliary clearance after inhalation. 
Hepatobiliary excretion and elimination through the feces is the major 
route by which PAHs are removed from the body. Kotin et al. observed that 4 to 
12% of the subcutaneously injected dose of B(a)P was eliminated in the urine of 
mice within 6 days after injection, while 70 to 75% of the dose was recovered in 
the feces. Camus et ai, 1984) determined fecal excretion rates of B(a)P in two 
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different strains of mice following i.p. injection of B(a)P. The cumulative 
excretion of B(a)P in the feces followed an exponential curve with half-lives of 
1.2 and 0.6 days for the two different strains. The majority of metabolites in the 
urine appeared as highly water-soluble conjugates. After enzymatic deconjugation, 
various oxidated B(a)P metabolites could be identified. 
Fecal excretion is the major pathway for the elimination of B(a)P and 
metabolites from the body. Depending upon the dose given, a nonabsorbed portion 
of the xenobiotic contributes to fecal excretion. The part of the dose that is 
absorbed from the gastrointestinal tract in the blood passes through the liver 
before reaching the general circulation. The liver is the main site of 
biotransformation of B(a)P and the metabolites thus formed may be excreted 
directly into bile. B(a)P and/or metabolites entering the intestine with bile may be 
excreted with feces, or when the physicochemical properties are favorable for 
reabsorption, an enterohepatic circulation may ensue. Once a compound is 
excreted into bile and enters the intestine, it can either be reabsorbed or eliminated 
with feces. Conjugated polar metabolites are not sufficiently lipid soluble to be 
reabsorbed. However, intestinal microflora may hydrolyze glucuronide and sulfate 
conjugates. Reabsorption of a xenobiotic completes an enterohepatic cycle. An 
increase in hepatic excretory function has been observed after pretreatment with 
some drugs but B(a)P is relatively ineffective (Klaassen & Rozman, 1991). 
3.2.2 Metabolism ofPAHs 
PAHs themselves are not chemically reactive, but they exert their carcinogenic 
activity through metabolites which are sufficiently reactive to modify cellular 
macromolecules such as nucleic acids (DNA, RNA) and proteins (Miller & Miller, 
1973). Metabolism is dominated by oxidation through the microsomal cytochrome 
P450 dependent mixed-function oxidase (MFO) system, also termed aryl 
hydrocarbon hydroxylase (АНН) (Nebert & Gonzalez, 1987). The initial step in 
the metabolism of unsubstituted PAHs is the formation of epoxides involving the 
addition of oxygen across a double bond. Further metabolism of epoxides results 
in hydration to dihydrodiols by epoxide hydrolase, isomerization to phenols, or 
conjugation with glutathione by glutathione S-transferase. Glutathione conjugates 
can be easily excreted as mercapturic acids in urine but the phenols and 
dihydrodiols are often not sufficiently polar to be excreted as such. These 
hydroxylated metabolites are conjugated with glucuronic acid or sulphuric acid to 
facilitate excretion. The enzymes that catalyze these conjugations are 
glucuronyl-transferases, located in the endoplasmic reticulum, and 
sulphotransferases which are cytosolic enzymes (figure 8). 
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Figure 8 Enzymatic pathways involved in the activation and 
detoxification of PAHs 
The metabolism of PAHs results mainly in the formation of more water 
soluble derivatives which can be excreted. Sometimes, however, the enzyme 
system will activate the parent compound into biologically reactive forms. 
Certain 'bay region diol epoxides' are the main DNA binding metabolites 
of B(a)P (Sims et al, 1974; Grover et al, 1967). Fluorescence spectral evidence 
was found that benzo(a)pyrene-DNA products in mouse skin arise from 
diol-epoxides (Daudel et al, 1975). Both B(o)P-7,8-epoxide and 
B(ûf)P-7,8-dihydrodiol exist as pairs of enantiomers. Consequently, two 
diastereoisomeric vicinal B(a)P-7,8-dihydrodiol 9,10 epoxides (BPDE's) exist as 
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either the syn- or anti-îorm. [the epoxide oxygen on either the same (syn) or the 
opposite (anti) face of the ring as the hydroxyl group in the 7-position], each 
comprising two enantiomers. In fact, the monooxygenases involved are highly 
stereoselective and the addition of oxygen across the 7,8 double bound results 
predominate (>90%) in the (+)-7R,8S-epoxide and the (-)-7R,8R-dihydrodiol, 
whilst further oxidation of the dihydrodiol yields mainly (+)-anti-
7,8-dihydrodiol-9,10-epoxide from the R,R enantiomer and mainly (+)-syn-
7,8-dihydrodiol-9,10-epoxide from the S,S enantiomer (Dipple et ai, 1984; Yang 
et al, 1984) (Figure 9). 
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Figure 9 Stereochemistry of the metabolic activation of 
benzo(a)pyrene [B(a)P]. 
The four resulting stereoisomers differ markedly in their biological reactivity, and 
in most test systems (+)-an/;-B(a)P-7,8-dihydrodiol-9,10-epoxide has been found 
to possess greater activity than the other three metabolites (Dipple et ai, 1984). 
DNA adducts formed in tissues or cells treated with B(a)P are derived 
predominantly from the (+)-a«/;'-dihydrodiol-epoxide, with minor involvement of 
the (+)-syw-dihydrodiolepoxide in some cases (Weston et ai, 1983). In DNA and 
polyribonucleotides, B(a)P dihydrodiol-epoxides react principally with guanine. 
The major adduct is (+)-a/i//'-BPDE-dG and the linkage is between the 2-amino 
group of guanine and the C-10 position of B(a)P (Weinstein et ai, 1976). The 
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dihydrodiol epoxides can also bind to the N-7 of guanine, the exocyclic amino 
groups of adenine and cytidine and to phosphate residues. It should be mentioned 
that other metabolites of B(a)P, for example B(a)P-4,5-oxide, can also bind to 
DNA, especially under m vitro conditions (Baird et ai, 1975). 
3.3 Health effects of PAHs 
3.3.1 Cancer 
Excess of lung cancers was found in the British and Japanese gas works (Doll et 
ai, 1972; Kawai et ai, 1967), in the American, Japanese and British coke works 
(Lloyd, 1971; Redmond et ai, 1976; Sakabe et ai, 1975; Mazumdar et ai, 1975) 
and in the Russian, Canadian and American aluminium industry (Konstantinov et 
ai, 1979a,1979b; Gibbs, 1979,1985; Aluminium Ass, 1977). An investigation of 
2071 chimney sweeps also showed an excess of lung cancer (Hogstedt et ai, 
1982). Metal workers exposed to coal tar pitch volatiles showed a two-fold 
increase of lung cancer (Silverstein et ai, 1985). 
In the past, scrotum cancer cases have been reported from chimney 
sweeps (Pott, 1775; Paget, 1850). An excess of skin cancer was found in the 
Russian aluminium industry (Konstantinov et ai, 1979a) and among workers 
handling hot pitch and asphalt (Hammond et ai, 1976). 
Many authors have found an increased incidence of bladder cancer 
among coke oven workers. Generally, it is the presence of certain amines that is 
held responsible for this particular type of cancer (Zorn, 1966). An increase of 
cancer of the gastro-intestinal tract was found in American coke works and among 
workers handling pitch and asphalt (Redmond et ai, 1976; Hammond et ai, 
1976). Excess malignant neoplasms of the stomach and oesophagus were found 
among aluminium reduction plant workers (Gibbs, 1985). Metal workers exposed 
to coal tar pitch volatiles (CTPV) showed a two-fold excess of cancer of the 
digestive organs (Silverstein et ai, 1985). Workers handling pitch and asphalt 
showed an increase of leukaemia (Hammond et ai, 1976). A slight and non 
significant increased frequency of leukaemia was observed among aluminium 
industry workers (Aluminium Ass, 1977). Metal workers exposed to CTPV 
showed a four-fold excess of leukaemia (Silverstein et ai, 1985). 
Non-carcinogenic effects of PAHs-containing coal tars and creosote on 
humans have also been studied. The majority of toxic effects concern the skin and 
eyes; skin effects include dermatitis, chronic tar dermatosis, tar or pitch warts, 
cutaneous phototoxicity and chronic melanosis, folliculitis and pitch acne (IARC, 
1986). Naphthalene and anthracene are both primary (mild) irritants. High 
naphthalene concentrations causes cataract, whereas anthracene and phenanthrene 
have photo-sensitizing properties. Only little information is available about the 
effects on reproduction and foetal/embryonal development. 
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Epidemiological evidence suggests that smoking of tobacco is causally related to 
cancer of the respiratory tract, the upper digestive tract, pancreas, renal pelvis, 
bladder, and cervix (IARC, 1986). It has been estimated that more than 80% of 
deaths from lung cancer and 30-40% of deaths from all cancers can be attributed 
to smoking (Loeb et al., 1984; IARC, 1986). In addition to active smoking, passive 
smoking i.e. exposure to side stream tobacco smoke or environmental tobacco 
smoke, has been incriminated as a risk factor for cancer of the lung in nonsmokers 
(IARC, 1986; Saracci & Riboli, 1988). 
More than 3800 chemicals have been identified in tobacco smoke 
comprising at least 40 known carcinogens including tobacco-specific nitrosamines, 
aromatic amines and PAHs (reviewed in IARC, 1986; Hoffman & Hecht, 1990). 
Bos & Henderson (1984) identified 70 genotoxic agents in mam stream cigarette 
smoke, among which 23 PAHs. Animal studies showed the major tumorigenic 
activity of tobacco smoke to be concentrated in the particulate matter (tar), 
whereas for the gas phase no tumorigenic acitivity has been established, although 
it contains traces of carcinogens. The contribution of tar to the carcinogenic action 
of cigarette smoke was also shown in epidemiological studies which found 
cigarettes with low tar yields to be less hazardous than high tar cigarettes (Wynder 
& Hoffmann, 1982). Although the molecular events associated with cigarette 
smoking-induced carcinogenesis are not definitively identified, it is thought that 
they are related in part to the genotoxic activities of the chemicals associated with 
cigarette smoking (De Marini, 1983). In addition, there is evidence for the 
presence of compounds in cigarette smoke that can act as tumor promoters or 
cocarcinogens (Willey et al, 1987). 
Studies with laboratory animals have demonstrated a possible role for 
PAHs as tumor initiators in tobacco-related carcinogenesis. For instance, several 
studies showed the occurrence of respiratory tract tumors in Syrian golden 
hamsters after inhalation of B(a)P (Thyssen et ai, 1981), intratracheal instillation 
of PAHs (Saffioti et ai, 1985), and intratracheal instillation of 
7,12-dimethylbenzanthracene, followed by exposure to tobacco smoke (Kobayashi 
et al, 1974). Additional evidence for a role of PAHs in tobacco-related 
carcinogenesis came from bioassays on mouse skin using subfractions of the 
particulate matter containing PAHs (Hoffman et ai, 1978). PAHs also induced 
lung tumors in rats upon implantation of PAHs in the lung (Deursch-Wenzel et al, 
1983). 
3.3.2 Mechanisms of carcinogenic effects ofB(a)P 
The International Agency for Research on Cancer (IARC, 1983) has stated that 
there is sufficient evidence that 11 PAHs are carcinogenic to experimental 
animals. However, human carcinogenicity data are only available for PAH 
mixtures, mostly including other substances as well. 
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The formation of DNA adducts is believed to be a necessary step in the process by 
which these carcinogens exert their biological effects. Alteration of DNA, if not 
recognized and removed by DNA repair processes, may result in changes of the 
genome through point mutations, deletions, gene amplifications or rearrangements 
(Singer & Gmnberger, 1983). Point mutations but also other events may lead to 
the activation of proto-oncogenes (Stowers et al, 1987). At present, it is known 
that several types of tumors induced in rodents by chemical carcinogens and 
certain tumors in humans are associated with base substitutions at specific sites in 
the ras oncogene family (Bos, 1989). The activation of proto-oncogenes to 
oncogenes results in altered levels of expression of normal proteins, or in 
expression of abnormal proteins (Weinstein, 1988). The number of 
proto-oncogenes that must be activated in order to convert a normal cell into a 
malignant one is currently known for certain tumors and both activation of 
proto-oncogenes and inactivation of tumor suppressor genes are involved. 
3.3.3 Human risk assessment 
In 1984 the Health Council of the Netherlands stated that no toxicological limit 
values could be given for ambient air because the concentration range of human 
exposure was too small compared to the doses used in experimental animals 
(Gezondheidsraad, 1984). In 1989 an integrated criteria document about PAHs 
was produced by the National Institute of Public Health and Environmental 
Protection in which toxicological limit values were given. 
Attempts for risk extrapolations for the general population were made by 
Kramers and van der Heijden (1988). For the oral route the authors relied on 
animal data. Chronic studies with B(a)P were available, although none of these 
met the criteria currently applied to this type of study (Rigdon & Neal, 1966; Neal 
& Rigdon, 1967; Horie et al., 1965; Chouroulinkov et al., 1967). Based on the 
studies of Horie and of Chouroulinkov, Gold et al. (1984) calculated a TD50 value 
for B(cr)P of 1.86-12.4 mg/kg body weight/day; i.e. this daily dose given lifetime 
would produce tumours in 50% of the animals. Estimates of daily uptake of B(a)P 
via food consumption amount to 0.16-1.6 μg in the US (Santodonato et al., 1981), 
whereas the levels as measured by Vaessen et al. (1987,1988) in duplicate diets in 
the Netherlands average 0.08 μg per person per day. Kramers and van der Heijden 
(1988) carried out a linear non-treshold extrapolation from the TD50 value. They 
calculated that the daily intake of 0.08 μg B(a)P would represent an extra lifetime 
tumour risk of 0.06-0.4 per million for only B(a)P. This might be multiplied by а 
factor of 25 to account for all carcinogenic PAHs, yielding a PAH risk of 1.5-10 
per million. According to the authors, this range is insufficient considering the 
insecurity of this kind of operation. The studies by Rigdon and Neal (1966) and 
Neal and Rigdon ( 1967) produced data suggestive of a concave exposure-response 
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relationship. Besides, more than half of the tumours on which the calculated TD50 
value was based were in fact non-malignant papillomas of the forestomach. 
Concerning exposure via air, the WHO working group on Air Quality 
Guidelines (1986) has recently provided a risk estimate for PAHs in ambient air, 
on the basis of epidemiological data collected from cohorts of coke-oven workers 
by Redmond et al. (1976) and a calculation made by EPA (1984) using these data. 
With a linearized multi-stage model, EPA has calculated an excess risk of 
6.2ХІ0"4 at lifetime exposure to 1 μg/m3 of the fraction of coke-oven emission 
which is defined by its solubility in benzene. Taking a B(a)P content of 0.71% of 
this fraction (WHO, 1986), this would convert to a risk of 8.7x10s after lifetime 
exposure to 1 ng/m3 B(a)P plus other carcinogens present in coke-oven emissions. 
This is the same value as presented in the dutch Integrated Criteria Document on 
PAHs. Average B(a)P concentrations in dutch ambient air range from 0.3 to 0.7 
ng/m3, depending on the location (Thijsse & Huygen, 1985) but in certain areas 
and/or periods the level often exceeds 1 ng/m3. The upper limit B(a)P levels (plus 
other PAHs) would present an individual lifetime risk of 15-60 per 106. 
Risks due to food versus ambient air have been compared. The maximum 
B(a)P uptake (assuming 100% uptake of PAHs from inhaled air and 15 m3 of air 
inhaled per 24 h (Spector, 1956) for the average levels of 0.3-0.7 ng/m3 B(a)P 
would amount to 4.5-10.5 ng/day, being in the order of 10-fold less than the 
estimated uptake via food (0.08 μg B(a)P/day). Therefore, we may consider food 
as the main source of the human PAH burden. However, the risks as calculated 
above, in connection with the exposure levels, rather suggest the opposite, the 
inhalation risk exceeding the one for food uptake. This is due to the difference in 
the effective dose of the reactive metabolites at the target level (DNA), caused, for 
instance, by differences in metabolism and repair capacity in the affected tissues. 
3.4 Biomarkers of PAH exposure 
In the past, most knowledge on PAH toxicokinetics has been obtained by using 
radiolabeled compounds in experimental animals. Nowadays, reversed-phase 
HPLC on chemically bonded nonpolar phases (such as C lg) is the most popular LC 
method for the separation of PAHs (metabolites). A major advantage of HPLC for 
the determination of PAHs is the availability of sensitive and selective detectors. 
When a HPLC system is connected to a fluorescence spectrofotometer, several 
metabolites can be detected without the use of radioactive labelled B(a)P. The UV 
detector operated at 254 nm is universal for PAHs, as all PAHs exhibit some 
absorption at this wavelength. Fluorescence detection of PAHs provides much 
greater sensitivity and selectivity than UV detection. The selectivity for individual 
PAHs (metabolites) is optimized by changing the fluorescence excitation and 
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emission wavelengths during the reverse-phase chromatographic separation 
(Bjorseth & Becher, 1986). 
To evaluate exposure and health risks in humans, methods for biological 
monitoring (BM) and biological effect monitoring (BEM) have been implemented 
besides environmental monitoring (EM) approaches. 
Environmental monitoring agents at the workplace or in the natural 
environment are measured to evaluate the ambient exposure and to assess the 
health risk. The most widely used method for air pollutants containing PAHs is the 
measurement of the benzene or cyclohexane soluble fraction of suspended 
particulate matter (NIOSH, 1977). A second method is the determination of a 
single PAH, for instance B(a)P, in airborne particulate matter. A third method is 
the measurement of a group of PAHs, for example the 6 Bomeff components 
(Bomeff & Kunte, 1969) or the 16 EPA-components (EPA, 1979) or a complete 
analysis. In several countries treshold limit values are based on one of these 
measurement methods. 
Biological monitoring is primarily an activity during which repetitive 
measurements of toxic chemicals in biological specimens are applied to assess the 
exposure levels of individual workers and of groups of workers. Four ways of 
biological monitoring of PAHs have been proposed: the urinary mutagenicity 
assay, reduction of urinary РАН-metabolites to their parent compounds, 
determination of the unmetabolized B(a)P in body fluids and determination of a 
representative metabolite for exposure to complex PAH mixtures. 
The prevalence of different biological effects in РАН-exposed people 
was reported and can be considered as possibilities for monitoring; the 
determination of B(a)P-DNA-adducts in peripheral blood lymphocytes, sister 
chromatid exchanges in blood lymphocytes, chromosomal aberrations in cultured 
lymphocytes from blood samples and semen abnormalites (Jongeneelen, 1987). 
Since the formation of specific DNA modifications appeared to be a critical event 
in carcinogenesis, measurement of carcinogen-DNA adducts should provide 
biologically relevant information on the net result of exposure, absorption, 
metabolism, DNA adduct formation and DNA repair in man and experimental 
animals. 
32P-postlabelling analysis is currently the most sensitive technique 
available for the detection of aromatic adducts. Only small quantities (1-5 μg) of 
DNA are required to perform the analysis. The covalent binding of a number of 
PAHs to DNA in vivo has been analyzed by 32P-postlabelling (Phillips, 1990a). 
Each PAH that binds to DNA produces a characteristic partem of spots on 
PEI-cellulose TLC (Reddy et al., 1984). A major advantage of the postlabelling 
assay is the detection of unidentified adducts. In most cases in which standards 
were available, such as BPDE-DNA adducts, it has been found that nearly 
quantitative labelling of adducts can be achieved (van Schooten, 1991). The value 
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of this approach to estimate intake levels and consequent damage of health has not 
been proven yet. 
4. TOXICOLOGICAL INTERACTIONS 
Chemical mixtures and combined exposures are aspects of human risk assessment 
which need to be considered. Man can be exposed to various combinations of 
chemicals including drugs, ethanol, cigarette smoke, dietary constituents, and 
environmental pollutants. Interactions between these chemicals have to be taken 
ino account while evaluating the safety of the individual xenobiotics. Interactions 
between chemicals can result in toxic effects quite different from the simple sum 
of the effects of the individual compounds. Joint exposure can give rise to 
additive, synergistic (more than additive) or antagonistic (less than additive) 
effects. Interaction can take place in the exposition phase, in the pharmacokinetic 
(absorption, distribution, metabolism, excretion) phase and in the toxicodynamic 
phase (toxic effect at target organ). 
4.1 Pharmacokinetic interactions between alcohol and drugs 
The effect of ethanol on the metabolism of drugs, and vice versa, can be partly 
explained by their common oxidative pathway through the cytochrome P450 
system. Other interactions can be mediated by alteration of ADH, A1DH, gastric 
emptying, plasma binding of proteins and acetylation (Vrij-Standhardt, 1991). 
Long-term ethanol consumption results in proliferation of smooth hepatic 
endoplasmic reticulum and an increase in the level of cytochrome P450 (Iseri et 
al., 1966; Rubin & Lieber, 1968; Joly et ai, 1973). In alcohol consumers, the 
microsomal ethanol oxidizing system (MEOS) or more specifically P450 2E1 is 
induced and thus capable of metabolizing larger quantities of its substrates. When 
alcohol users are sober, this enhanced capacity is used to convert drugs and other 
xenobiotics more rapidly. If these substances themself are bio-active, they are 
consequently less effective, but the concentration of metabolites, which are quite 
often hepatotoxic, increases (Lieber, 1983; Tsutsumi et al., 1990). If a person is 
not sober the MEOS is blocked by ethanol, the 'preferred' substrate, which causes 
a delay in elimination and an increased activity of parent drugs as shown in figure 
10 (Hasamura & Takeuchi, 1978; Lieber, 1973; Rubin & Hutterer, 1968; Lieber, 
1990). 
Induction of P4502E1 may also result from the use of certain types of 
drugs such as barbiturates. Pretreatment with these drugs may activate ethanol 
metabolism whereas the presence of drugs may have an inhibitory effect. 
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Although acute and chronic forms of alcohol consumption have a strong effect on 
drug metabolism, the reverse effect is much smaller (Lieber, 1983). 
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Figure 10. Alcohol is metabolized by alcohol dehydrogenase, and 
drugs by microsomes. Microsomal drug metabolism is inhibited in 
the presence of high concentrations of ethanol, in part through 
competition for a common microsomal detoxification process (B). 
Microsomal induction after long-term alcohol consumption 
contributes to accelerated ethanol metabolism at high blood 
ethanol levels (C). Increased drug metabolism and activation of 
xenobiotics (due to microsomal induction) persists after cessation 
of long-term alcoholconsumption contributes to accelerated 
ethanol metabolism at high blood ethanol levels (C). Increased 
drug metabolism and activation of xenobiotics (due to microsomal 
induction) persists after cessation of long-term alcohol 
consumption (D). Hatching indicates high blood alcohol levels 
(from Lieber, 1988). 
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The interaction between ethanol and drugs does not take place via the P450 
pathway only (Lieber, 1990). Some antimicrobial drugs inhibit A1DH, resulting in 
disulfiram-like reactions when combined with ethanol. The effect of drugs 
converted by ADH can be influenced by ethanol through direct competition. 
Gastric ADH is inhibited by H2-receptor antagonists such as Cimetidine, resulting 
in higher blood alcohol levels (Caballería et al, 1989). Alcohol consumption 
might alter drug absorption by increasing solubility (Linnoila et al, 1979) or by 
interfering with gastric emptying. Liver injury is usually accompanied with a 
diminished capacity for and a consequent delay in biotransformation (Klinger, 
1981). Alcoholic cirrhosis causes reduced plasma binding of some drugs, resulting 
in toxic effects, even at therapeutic plasma concentrations. The metabolic rate of 
drugs metabolized through acetylation is increased by ethanol (Olsen & Morland, 
1978) due to enhanced acetyl-CoA production during alcohol metabolism. 
There are few data about effects of ethanol exposure on PAH 
toxicokinetics in man. Considerable PAH intake is seen at occupational sites. A 
study with coke oven workers (Jongeneelen et al, 1990) showed the effect of the 
job category at the coke oven, of smoking habits, and of using protective devices 
on the bodyburden of coke oven workers. A modifying effect of alcohol 
consumption and the use of medication on the toxicokinetics of pyrene was not 
established. In this study 1-hydroxypyrene has been suggested as a suitable 
biological indicator of the internal dose of PAHs (Jongeneelen et al, 1990). 
4.2 Cancer risk from joint consumption of alcohol and tobacco 
The perhaps most common joint exposure in the daily environment is that of 
alcohol consumption and tobacco smoking. Rothman and Keller (1972) and 
Rothman (1976) reanalysed the information on consumption of alcohol and 
tobacco obtained by Keller and Terris (1965) in their study on US veterans. The 
analysis showed a synergistic effect between alcohol and tobacco in the 
development of oral cavity and pharyngeal cancer. Heavy drinkers who were also 
heavy smokers had a Relative Risk of 15.6 when compared with persons who 
neither smoked nor drank. These results are in agreement with the findings of 
Wynder et al (1975a), while Graham et al. (1977) found an additive effect of 
smoking and drinking. In the study of Tuyns et al (1988) a synergistic effect of 
alcohol and tobacco use on the risk of hypopharyngeal/epilaryngeal cancer was 
observed. 
In the induction of laryngeal cancer, some investigators have reported 
synergism between alcohol and tobacco (Hinds et al, 1979; Zagraninski et al, 
1986). In the study of Tuyns et al (1988), a synergistic model provided an 
adequate description of the data. 
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The joint actions of alcohol and tobacco and of alcohol and nutrition on 
oesophageal cancer have been the subject of several epidemiological 
investigations. In their studies in north-western France, Tuyns et al. (1977,1979) 
found a synergistic combined effect of alcohol and tobacco, which they described 
as multiplicative. 
Hirayama (1981) found an interaction between tobacco smoking and 
alcohol drinking in the causation of primary liver cancer. The rate ratios between 
daily drinkers and other males were 0.9 among nonsmokers, 1.3 among smokers of 
up to 200,000 cigarettes (life time), 1.2 among smokers of 200,000-400,000 
cigarettes per life time, and 1.5 among smokers of more than 400,000 cigarettes. 
Austin et ai. (1986) found no interactive effect of tobacco and alcohol 
consumption on the risk for hepatocellular carcinoma. 
4.3 Modifying effects of ethanol on the activity of known carcinogens 
N-nitrosodimethylamine (NDMA): 
In a study by Griciute et al. (1981) in animals given NDMA plus ethanol, several 
animals developed olfactory tumours that infiltrated the frontal lobe of the brain; 
no such tumour was observed in animals given only NDMA. No significant 
difference in the incidence of other tumours was observed. No differences 
between groups with and without ethanol administration were found in studies by 
Litvinov et al. (1986a) and Teschke et ai (1983). 
N-iùtrosodiethylamine (NDEA): 
Griciute et al. (1984) found the incidence of malignant oesophageal/forestomach 
tumours to be higher in the NDEA plus ethanol group than in the NDEA group. 
Litvinov et al. (1986) found an increased incidence of pulmonary tumours. The 
combination of NDEA plus ethanol increased the incidence of papillomas in the 
oesophagus and/or forestomach. In contrast, the incidence of epidermoid 
carcinomas of the oesophagus and/or forestomach was increased only in the high 
dose group in a study by Gibel (1967). 
Other N-nitroso compounds: 
In studies of Griciute et al. (1982,1987) a higher tumour incidence was seen in 
mice given //-nitroso di-n-propylamine and ethanol. 
In studies with A^utrosomemylbemylamine (NMBzA) (Gabrial et ai, 1982), 
//-nitrosomethylphenylamine (NMPhA) (Schmähl, 1976), //-nitrosopiperidine 
(NPIP) (Konishi et al, 1986), W,A^dinitrosopiperazine (DNPIP) (Gibel, 1967), 
ЛГ-nitrosonornicotine (NNN) (Castonguay et al, 1984; McCoy et al, 1981), 
Af-memyl-N-iùnO-N-iutrosoguarudine (MNNG) (Takahashi et al, 1986), 
/V-hydroxy-2-acetylaminofluorene (OH-AAF) (Yamamoto et al, 1967), 
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7,12-dimethylbenz[a]anthracene (DMBA) (Kuratsune et al, 1971) no significant 
treatment-related increase in tumour yield was observed after co-administration 
with ethanol. 
1,2-dimethylhydrazine (DMH): 
With DMH ambiguous results were obtained. In the studies of Seitz et al. (1984, 
1985) a higher number of rectal tumours was seen in rats treated with DMH and 
ethanol but no difference was seen in tumour incidences at other sites in the 
intestine. The studies of Howarth & Pihl (1985) and of Nelson & Samelson (1985) 
showed no significant difference in the incidence of intestinal cancer in the groups 
given ethanol solution or beer as compared to those given water. 
jV-nitrosopyrrolidine (NPYR): 
A study of NPYR and ethanol in Syrian golden hamsters showed an increased 
incidence of nasal cavity tumours and tracheal tumours (McCoy et ai., 1981). In a 
subsequent experiment an increased incidence of hepatic neoplastic nodules was 
observed (McCoy et al., 1986). 
Azoxymethane: 
The carcinogenicity of azoxymethane was studied by Hamilton et al. 
(1987a, 1987b) in Fisher 344 rats. They found the number of right colonic tumours 
inversely correlated with ethanol consumption in all animals, but no correlation 
was found with left colonic tumours. The total number of colonic tumours in the 
high-dose ethanol group was markedly reduced in comparison with controls but 
not in the low-dose ethanol group. Similar effects were found in the group given 
23% calories as beer. In a further study the incidence of tumours of the left, right 
and transverse colon were significantly reduced by the 33% liquid-ethanol diet 
given prior to and during administration of the carcinogen. 
JV-nitrosobis(2-oxopropyl)amine (NDOPA): 
NDOPA and ethanol were studied in Syrian hamster by Tweedie et al. (1981). 
Histopathological examination of the exocrine pancreas showed fewer neoplastic 
lesions in animals treated with NDOPA plus ethanol compared with those treated 
with NDOPA alone. In another study, Pour et al. (1983) found no significant 
difference in the incidence of pancreatic tumours. 
Vinyl chloride (VC): 
Radike et al. (1981) studied vinyl chloride (VC) in Sprague-Dawley rats that 
received 5% ethanol in water or water alone as the drinking fluid for life. Rats 
exposed to VC plus ethanol had more hepatocellular carcinomas and more liver 
angiosarcomas. 
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4.4 Modifying effects of ethanol on the toxicokinetics of xenobiotics 
The induction of cytochrome P450 by ethanol is associated with an increase in 
metabolism and toxicity of several xenobiotics, including N-nitxosodimethylamine 
(Garro et al., 1981; Olson et ai, 1984), acetaminophen (paracetamol, Strubelt et 
al, 1978; Sato et ai, 1981; Walker et al, 1983), carbon tetrachloride (Hasumura 
et al, 1974), anatoxin В, (Glinsukon et al, 1978), benzene (Nakajima et al, 
1985) and benzo(a)pyrene (Seitz et al. 1978; Murphy and Hecht, 1986). The 
unique cytochrome P450 isozyme (ΠΕΙ) induced by ethanol catalyses the 
oxidation of some alcohols, aniline and 7V-nitrosodimethylamine (Yang et al, 
1985a,b; Morgan et al, 1981; Villeneuwe et al, 1976). 
In contrast, ethanol inhibits the metabolism of xenobiotics in vitro like 
benzene, styrene and toluene (Sato, et al) and benzo(a)pyrene (Rubin and Lieber, 
1968). Acute administration of ethanol also inhibits the metabolism of some drugs 
in vivo (Rubin et al, 1970; Mezey, 1976; Sato et al, 1985). There are two 
possible explanations for this phenomenon; direct competition for cytochrome 
P450 (Sato, et al, 1981) or a decrease in the supply of a cofactor for the 
monooxygenase system (Reinke et al, 1980). 
The hepatic enzymes that catalyse conjugation of xenobiotics, such as 
UDP-glucuronyl-transferase (Sweeny & Reinke, 1987) and 
glutathione-S-transferases, are reported to be induced by feeding ethanol 
(Schnellmann et al, 1984). Glucuronidation was inhibited by concomitant ethanol 
administration in isolated hepatocytes and in rat liver microsomes (Sundheimer & 
Brendel, 1984). Glucuronidation and sulphation were inhibited in perfused rat 
liver (Reinke et al, 1986). 
Pretreatment of rats with ethanol increases the metabolism of 
N-nitrosamines in the lung, oesophagus (Farinari et al, 1985) and nasal mucosa 
(Castonguay et al, 1984). This contrasted with the observations when ethanol was 
given concomitantly with NDMA. Concentrations of the unmetabolised 
nitrosamine in brain, lung, liver, kidney and blood were then increased markedly 
(Anderson et al, 1986). First-pass clearance of NDMA by the liver in rats was 
prevented when it was administered in ethanol (1 ml, 5% v/v) instead of in water. 
The prevention of first-pass clearance had a dramatic effect on alkylation of 
kidney and oesophageal DNA: at dose levels of 30 μg/kg body weight NDMA, 
methylation of kidney DNA of ethanol-treated rats was five times that in controls; 
lower doses of NDMA induced methylation in the kidneys of ethanol-treated rats 
but not in controls (Swann, 1984). Similarly, aclrninistration of 
TV-nitrosodiethylamine (NDEA; 20 μg/kg bw) in ethanol (1ml; 5% v/v) led to a 
five-fold increase in N7 ethylation of guanine in oesophageal DNA over that seen 
with a similar dose of NDEA alone (Swann et al, 1984; see also figure 10 in par. 
4.1). 
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After ethanol intake, blood xylene levels in volunteers exposed to xylene by 
inhalation were increased 1.5-2.0 fold, while urinary excretion of methyl hippuric 
acid, a xylene metabolite, declined by about 50% (Riihimäki et al, 1982). During 
exposure to toluene by inhalation (3.2 mmol/m3) for 4.5 h, moderate doses of 
ethanol (15 mmol/kg body weight) given orally to volunteers almost doubled the 
maximum toluene concentration in blood and decreased the blood clearance of 
toluene by approximately 44% (Wallén et al, 1984). Trichloroethylene 
concentrations in plasma increased twofold, and decreased urinary excretion of a 
major metabolite of trichloroethylene -trichloroethanol- was observed when 
ethanol was ingested immediately prior to exposure to trichloroethylene by 
inhalation (Müller et al, 1975). Drinking of alcoholic beverages inhibits liver 
metabolism of nitrosamines, such as N-nitrosodimethylamine and 
N-nitrosodiethylamine. As a result, nitrosamines are excreted in urine of beer 
drinkers and volunteers given amines and ethanol (Eisenbrand et al, 1981; 
Spiegelhader & Preussmann, 1985). 
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5. OUTLINE OF THE THESIS 
Consumption of alcohol and tobacco smoking belong to the most common joint 
exposures in humans. A more than additional cancer risk due to this exposure has 
been observed in several organs {Chapter I). The purpose of the present study was 
to obtain insight in possible sites and levels of interaction. As stated in Chapter I, 
paragraph 4, interaction can take place at the exposition phase, at the toxicokinetic 
phase and at the toxicodynamic phase. Ethanol and B(a)P were chosen to 
represent exposure to alcoholic beverages and PAHs (major constituents of 
tobacco smoke, Bos & Henderson, 1984) respectively. In our studies possible 
interactions were investigated on the toxicokinetic level (metabolism and 
excretion) and on the toxicodynamic level (effect at target organ) (Table 3). 
We started with the design of a method of ethanol administration to rats 
via the drinking water {Chapter IT). A dosage procedure is developed that 
corresponds to 'moderate' drinking in humans. Moderate drinking is defined as 
long-term consumption of about 20% of the daily caloric intake as ethanol. 
In an in vivo study, benzo(a)pyrene [B(a)P] metabolites excreted after 
oral and intraperitoneal administration were compared to detect differences 
between these routes of administration and to study the influence of 
ethanol-pretreatment. B(a)P-metabolites excreted in male and female rats were 
compared to detect sex differences and the inluence of ethanol-pretreatment 
{Chapter III). 
Data on the effects of long-term ethanol treatment on the microsomal 
biotransformation of B(a)P are presented in Chapter IV. Microsomes of lung, liver 
and small intestine from male and female rats were used. In this way a comparison 
could be made of possible sex-related differences in B(a)P biotransformation in 
the three organs. To determine which isoenzyme of P450 was most important in 
B(a)P biotransformation, liver microsomes were incubated with monoclonal 
antibodies to the P450 isoenzymes 1A1\2, 2E1, 2B1\2 and 2C11\6 respectively, 
measuring the amount of inhibition of B(a)P metabolite formation. 
The influence of long-term ethanol treatment on biotransformation 
capacity is monitored by measuring the metabolism of several substrates that are 
indicative for isoenzymes of P450. Ethoxyresomfin O-deethylase is measured as 
an indicator enzyme for the activity of P4501A1. The increase in aniline 
hydroxylarion is used as a marker for ethanol-dependent increases in P4502E1. 
Pentoxyresorufin O-deethylase activity is used as a marker for P4502B1/P4502B2 
isoenzymes. Testosteron metabolism is correlated with the sex specific 
isoenzymes. Besides P450 biotransformation activities, glutathion S-transferase 
activity and subunit composition were studied because of the important role this 
enzyme plays in the detoxification of reactive B(a)P metabolites. Because epoxide 
hydrolase plays an important role in detoxification and toxification of B(a)P, this 
62 · Outline of the thesis 
enzyme was also monitored. Again male and female rats were used to observe 
possible sex differences {Chapter V). 
In Chapter VI and Chapter VII DNA adduci measurement in ¡η vivo 
studies is described. DNA adducts may play an important role in the initiation of 
B(cr)P-induced cancer. We choose them to measure the influence of 
ethanol-pretreatment on the toxicodynamic phase of B(a)P. In one study, the level 
of DNA adducts in liver and small intestine of ethanol-pretreated and 
non-pretreated rats was measured at various time intervals after a single oral dose 
of B(o)P In another study B(a)P was applied several times, combmed with 
ethanol treatment DNA adducts were analyzed in oesophagus and forestomach, 
being target organs for B(o)P/ethanol carcinogenicity and in liver and small 
intestine as the major metabolizmg organs 
Table 3 sums up the sites of ethanol and B(a)P interaction and the 
measurements described in our study. 
absorption 
distribution 
elimination 
metabolism 
effect 
phenolic and diolic metabolites in unne and feces 
microsomes of liver, lung and small intestine 
DNA adducts in liver, lung and small intestine 
Table 3 Sites of ethanol and B(o)P interaction investigated in our 
studies All assays were performed on (samples from) male and 
female rats chronically treated with ethanol, orally or 
mtrapentoneally treated with B(a)P 
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SUMMARY 
Ethanol was administered to female and male Wistar rats by mixing it with their 
drinking water. Ethanol concentrations were gradually increased up to either 8% 
or 15%. Female rats receiving 8% ethanol in their drinking water consumed 5-13 
g, males 4-10 g daily. The ethanol/total food caloric intake percentages were 13 to 
20% and 9 to 15% for female and male rats, respectively. There was no difference 
in body weight and relative liver weight between treated rats and their controls. 
Female and male rats receiving 15% of ethanol in their drinking water consumed 
8-14 g ethanol per kg body weight per day. The percentages of ethanol/total food 
caloric intake were stabilised at about 25% for both sexes. Growth of the rats 
differed only slightly from controls; a tendency for a higher increase of body 
weight of the control rats was found. No difference in relative liver weight 
between ethanol-treated and control rats was observed. Microscopic examinations 
revealed that the ethanol treatment resulted in fat accumulation in the liver cells. A 
proliferation of the Smooth Endoplasmic Reticulum (SER) was more marked in 
the 15% dosed rats than in the 8% dosed rats and more distinct in female rats than 
in male rats in both dosage groups. 
INTRODUCTION 
Several methods of administration of ethanol to rats have been reported in the 
literature, varying from injection of daily doses (Farbiszewski et al., 1988) to 
synthetic liquid diets (Lieber & DeCarli, 1967, 1982; French, 1968). Ethanol is 
often added to the drinking water (Nadkami & D'Souza, 1988; Prasad et al, 1985; 
Benedetti et al, 1988; Vaananen & Lindros, 1985; Liu et al, 1975; Dobbins et al, 
1972; Thorpe & Shorey, 1965). 
In this paper a method of administering ethanol to rats via the drinking water is 
described. A dosage procedure is developped that corresponds to 'moderate' 
drinking in humans. Moderate drinking is defined as long term consumption of a 
maximum of 20% of the daily caloric intake as ethanol (Prasad et al, 1985; 
Zentella de Pina et al, 1989). Treated animals should have similar weight gain 
and caloric intake as controls. No severe hepatocellular damage should be 
observed, although liver enzymes could be induced. 
MATERIALS AND METHODS 
Animals 
Homebred Cpb:WU (Wistar) rats were used. The initial weights varied between 
100-120 g (females) and 120-150 g (males). The rats were about 6 weeks old. 
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They were of specified pathogen free quality (antibodies against Pneumonia virus 
of mice and the pin-worm Syphacia muns were found, no other pathogens). Rats 
were kept in Macroion type 3 cages on sterilized softwood granules as bedding 
with 3 animals per cage. Rats were housed in stainless steel metabolism cages on a 
wire mesh for measurements on individual rats The rats were weighed three times 
a week 
The animals were provided with RMH-TM pellets (Hope Farms b v., Woerden, 
The Netherlands). Groups of 12 rats were used in each experiment (six females 
and six males) Three rats of each sex were ethanol-treated, the other three 
received tap water The ethanol-treated rats had free access to water with an 
increasing ethanol percentage reaching 8 or 15% (called the 8% and 15% ethanol 
treatments) after 2 and 3 weeks respectively Details of the ethanol treatment 
schemes are given in table 1. 
Room temperature was regulated (22 ± 2°C), relative humidity varied between 40 
and 60% The animals were exposed to artificial light between 1900 h and 0700 h 
so that blood ethanol concentrations could be measured during the active period of 
the rats Blood samples were taken from the rats via a cánula m the arteria 
femoralis The animals did not need to be anaesthetized using this method 
8% ethanol treatment 
15% ethanol treatment 
4 days 2% (w/v) ethanol in lap water 
3 days 4% (w/v) ethanol in tap water 
7 days 6% (w/v) ethanol in tap water 
28 days 8% (w/v) ethanol in tap water 
4 days 2% (w/v) ethanol in tap water 
3 days 4% (w/v) ethanol in tap water 
4 days 6% (w/v) ethanol in lap water 
3 days 8% (w/v) ethanol in tap water 
4 days 10% (w/v) ethanol in tap water 
3 days 12% (w/v) ethanol in tap water 
21 days 15% (w/v) ethanol in tap water 
Table 1 Scheme of ethanol treatment of rats 
Ethanol consumption 
The amount of ethanol consumed was calculated from the volumes of the 
ethanol/water mixture the rats drank and food pellets were weighed The 
percentage of the total caloric intake due to ethanol was calculated from these 
values. 
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Microscopy 
The rats were killed by cervical dislocation at the end of the period of ethanol 
treatment. The livers were excised and weighed and the ratio liver to body weight 
was determined. The samples for light microscopy were fixed in McDowell (1% 
glutardialdehyde and 4% paraformaldehyde in 0.08M NaH2PO4.H20 [pH=7.4]) at 
room temperature for at least 24 hours. They were embedded in paraplast. 
Sections of 6 μια were cut on a Leitz microtome and stained with a 
hemateine-eosine mixture. Samples for electron microscopy were fixed in 2% 
glutardialdehyde in 0.1 M phosphate buffer (pH=7.4) at 4C for 24 hours and were 
embedded in EPON 812. Semithin (1 μιη) sections for light microscopy were cut 
on a Reichert ultra microtome OMU3. These were stained with toluidine blue. 
Ultrathin sections of 60 nra were contrasted with uranylacetate and lead citrate. 
They were studied in a Philips EM301 Electron Microscope at 60 KV. 
Chemicals 
The ethanol used was Ethanol absolute GR supplied by Merck (Darmstadt, 
Germany). The ethanol in blood concentrations were determined using the 
Boehringer testkit Cat no. 176290 (Boehringer Mannheim GmbH, Mannheim, W. 
Germany). 
EPON 812, paraplast and stains were supplied by Merck (Darmstadt, Germany). 
Leadnitrate was obtained from Analar BDH Chemicals Ltd. (Poole, England). 
Statistical analysis 
Results are presented as mean values. Statistical analysis was carried out using the 
SAS (Statistical Analysis System) package on a VAX785 minicomputer. The 
procedures used were ANOVA for analysis of variance with equal cells and GLM 
(general linear model) for analysis of variance with unequal cells. 
RESULTS 
Blood ethanol concentrations 
Ethanol concentrations in the blood of 3 female and 3 male rats consuming 8% 
ethanol in their drinking water varied widely between the animals (figure 1). 
There was also great variability in the values measured during one day. 
Comparison of the data from several days did not show a consistent pattern in the 
values for individual rats. The niinimum blood ethanol value measured was 0 g/1, 
the maximum value was 0.9 g/1. 
A blood sample was taken at time intervals of 4 hours from the rats and 
the volume of water drunk was measured. The blood ethanol concentration was 0 
g/1 when a rat did not drink the ethanol/water mixture and greater than 0 g/1 when 
a rat drank. However, there was no quantitative relationship between the amount 
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of ethanol/water mixture drunk during 4 hours and the blood alcohol levels at the 
end of that period. 
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Figure 1. Blood ethanol concentrations. Ethanol concentrations 
measured three times during a dark period in blood of three female 
and three male rats from the 8% ethanol treatment group. 
(—) ; female rats, (—) ; male rats). 
Ethanol consumption and growth 
The daily ethanol consumption of rats receiving the 8% treatment is shown in 
figure 2a. Female rats consumed more ethanol than male rats; 5-13 and 4-10 
g/kg/day respectively. Rats receiving the 15% ethanol treatment consumed 6-14 
g/kg/day for both, female and male rats (figure 2b). 
The ethanol consumption as a fraction of total food caloric intake during the 8% 
ethanol treatment is shown in figure 3 a. Levels of 13 to 20% and 9 to 15% for 
female and male rats, respectively were attained. In the 15% ethanol treatment 
group the level stabilized in the last two weeks of ethanol-treatment at about 20% 
of total caloric intake for both female and male rats (figure 3b). 
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Figure 2 Amount of ethanol consumed The amount of ethanol 
(g/kg/day) consumed by female (—) and male ( ) rats with the 
8% ethanol treatment (a) or 15% ethanol treatment (b) Each point 
represents the mean (± SD) of three rats 
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Figure 3 Relative calorie intake Ethanol consumption as a 
percentage of total caloric intake during the 8% ethanol treatment 
(a) or 15% ethanol treatment (b) Each point represents the mean 
(±SD) of three female (—) or three male (—) rats. 
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Figure 4 Growth of rats Weights of female rats drinking only 
water ( ) or with the 8% ethanol treatment (a) or with the 15% 
ethanol treatment (c) ( ) Weight of male rats drinking only 
water ( ) or with the 8% ethanol treatment (b) or with the 15% 
ethanol (d) treatment (-=—) Each point represents the mean (±SD) 
of three rats 
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Figure 4 Growth of rats Weights of female rats drinking only 
water ( ) or with the 8% ethanol treatment (a) or with the 15% 
ethanol treatment (c) ( ) Weight of male rats drinking only 
water ( ) or with the 8% ethanol treatment (b) or with the 15% 
ethanol (d) treatment ( ) Each point represents the mean (±SD) 
of three rats 
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The body weights of female and male rats during the 8% ethanol treatment period 
were compared with controls (figures 4a and 4b). Growth rate of ethanol-treated 
and control rats was equal (differences were not statistical significant). The body 
weights of female and male rats during the 15% ethanol treatment period were 
slightly lighter than the control rats and grow more slowly (figures 4c and 4d) but 
this difference was not statistically significant. 
Relative liver weight 
There were no statistically significant differences in liver weights expressed as a 
percentage of the total body weight between ethanol and non-ethanol treated rats 
using analysis of variance. There was also no statistical significant difference in 
the relative liver weights between the two sexes (table 2). 
Percentage 
ethanol 
0 
0 
8 
β 
15 
15 
Sex 
F 
M 
F 
M 
F 
M 
N 
20 
21 
9 
9 
12 
12 
Relative liver 
weight (%) 
4.1 
4.1 
3.9 
4.0 
3.8 
4.1 
SD 
06 
0 4 
0 2 
0.4 
0.5 
05 
Table 2 Relative liver weight of rats after 6 weeks on different 
diets (liver weight/body weight) N=number of rats, SD standard 
deviation 
Microscopic examination 
The livers of ethanol-treated and control animals appeared under light microscopy 
to have a rather homogeneous structure. Fat droplets were observed in the 
hepatocytes of ethanol treated rats but little glycogen. 
Electronmicrographs of the liver of rats on the ethanol diet showed an 
accumulation of fat droplets especially near the sinusoides. The proliferation of 
the Smooth Endoplasmic Reticulum (SER) was clearly seen; the nuclei were often 
lobed and sometimes possessed clumped chromatin. The Rough Endoplasmic 
Reticulum (RER) did not appear swollen and ribosomes were still attached to the 
membrane. The number of mitochondria in ethanol-treated rats was not increased 
and their appearance not changed; giant mitochondria and crystalline enclosed 
particles were not found. No bile obstruction was observed. The effects on the 
liver described above were more obvious in female rats than in male rats; as well 
as more obvious in the 15% ethanol group than in the 8% ethanol group (figure 5a 
and 5b). 
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5a 
5b 
Figure 5. Electronmicrographs of rat liver. Electronmicrograph of 
a control female rat liver (a) and of a liver of a female rat from 
15% ethanol treatment (b). N=nucleus, RER=Rough Endoplasmic 
Reticulum, SER=Smooth Endoplasmic Reticulum, G=glycogen, 
M=Mitrochondrion. (Magnification 5a-7100, 5b=6100 |- |=1цт). 
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DISCUSSION 
A common method of chrome exposure of rats to ethanol is the feeding of a liquid 
diet containing essential dietary components supplemented with ethanol. This diet 
produces a reproducible animal model for the study of several pathological events 
observed in 'heavy' drinking humans (Lieber & DeCarli, 1967) Another method is 
the addition of ethanol to the drinking water, with the rats obtaining their protein, 
fat, carbohydrate, vitamins and minerals from food pellets. The results obtained 
with the two kinds of diets differ greatly, not just because of the use of different 
treatment methods but also because of differences in rat strains, periods of 
treatment and amount of fat, protein and carbohydrate in the diet. Lieber & 
DeCarli, (1973) observed fat deposition in the liver after feeding the liquid diet. 
They compared an original diet containing 35% fat with a low fat diet (12%) and 
found that livers were less fatty with the same ethanol ingestion in the low fat diet 
(Lieber and DeCarli, 1982). 
Several investigators have proposed modifications to the liquid diet. A 
higher content of lipotrophic factors and amino acid nitrogen (Porta et al., 1968) 
produced less steatosis, although swelling of mitochondria and loss of cristae 
organisation was observed by Banks et al. (1969). Neither chemical nor 
histological evidence of liver fat accumulation was found with the AIN-76A 
standard diet (Bieri et al, 1977) containing 21% of protein, 12% of fat and 30% 
of carbohydrate (Schoemaker & Visek, 1988). 
The importance of the carbohydrate content of the diets was emphasized 
by Rao et al., 1987. They found that rats consumed more diet and grew faster 
when the concentration of ethanol in the liquid diet was decreased from 36% to 
20%, and the carbohydrate content was increased. A lower fat content of the liver 
was found. The rats consumed an equal amount of ethanol-derived calories per 
day with both diets. 
The food pellets used in our study contained 22.4% of the energy content 
as protein, 10.8% as fat and 49.3% as carbohydrates. They, therefore formed a 
rather low fat, high carbohydrate diet. 
The absolute amount of ethanol ingested in g/kg/day and the percentage 
of the total caloric intake due to ethanol seem good parameters to determine and 
compare the ethanol dose due to the different diets. The rats consumed 36% of 
their daily caloric intake as ethanol using the method of Lieber and DeCarli 
(1982). This is equivalent to an ethanol intake of 12-18 g/kg/day. Blood ethanol 
levels varied between 1.0 and 1.5 g/1. The ethanol intake in absolute amounts was 
comparable with the results of our study although the percentage of total caloric 
intake due to ethanol by our rats was lower; 20% compared with 36%. In our 
study only the blood ethanol levels in rats receiving the 8% ethanol treatment were 
measured and these were rather low. 
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Rubin et a!. (1970) described morphological changes such as hepatic steatosis, 
proliferation of hepatic SER, increased microsomal protein and enlarged 
mitochondria using the Lieber/DeCarli diet. In our study steatosis and proliferation 
of the SER was also observed. These also have been observed by other 
investigators giving rats ethanol in their drinking water with other nutrients in food 
pellets. Benedetti et al. (1988) observed areas of proliferated SER in hepatocytes 
containing lipid droplets of various size. They also observed bizarre shaped 
mitochondria. Their laboratory animal diet contained 41% of calories as 
carbohydrate, 21% as protein and 6% as fat. The chronic ethanol group received 
ethanol solution supplemented with 6% sucrose. The ethanol concentration was 
gradually increased from 5% (v/v) to 25% (corresponding to a mean daily ethanol 
intake of 14.8 g/kg), which was reached on the 29th day. Two control groups were 
used; one with 6% of the calories as sucrose and one with tap water. Blood 
ethanol levels reached a level of 1.1 g/1 in the fifth week. Dobbins et al. (1972) 
performed a morphometric analysis of the effects of ethanol upon rat liver. They 
compared three diets in their study; chow with 25% of calories as ethanol in the 
drinking water, chow with isocaloric sucrose and chow supplemented with 2% 
choline plus 25% ethanol. In the 25% ethanol group they observed an increased 
hepatic cell size, an increased total volume of mitochondria and many lipid 
droplets. These phenomena were partially reversed by choline supplementation. 
The surface area of both SER and RER was reduced to 50% in the ethanol treated 
animals. The diets consisted of 19% of the calories as protein, 7.5% as fat and 
43.5% as mixed starches. 
Thorpe and Shorey (1965) added ethanol to the drinking water with a 
final concentration of 20%. Their diet was also low in fat and high in 
carbohydrate. The control group received diet and plain water ad libitum. The 
ethanol dose was equivalent to 5.7 g/kg/day; ethanol providing 22% of the total 
caloric intake. No change in liver lipid content was observed. 
Most diets in which normal food pellets are used in combination with 
ethanol in drinking water are low in fat content and high in carbohydrate. The 
ethanol dose has to be at least 15% to lead to observable damage. The method we 
have described and chosen is relatively simple and led to a considerable intake of 
ethanol (5-13 g/kg/day) which is 20% of the daily caloric intake. 
Electron microscopy of the rat livers confirmed proliferation of SER as 
an effect of ethanol as previously described by Rubin et al. (1968). The livers of 
female rats which received 15% ethanol in their drinking water contained more fat 
droplets than the livers of male rats. Small fat droplets were observed in the livers 
of the rats that received 8% ethanol. No effects on mitochondria nor severe 
pathological effects such as liver necrosis or cirrhosis were observed. 
The growth and development of the rats was normal during the treatment 
based on the body weight curves. The ratio of liver weight to body weight did not 
differ significantly between ethanol-treated and control rats. 
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Our results confirm that addition of ethanol to the drinking water enabled the 
ingestion of high amounts of ethanol, 5-13 g/kg/day which is comparable to the 
Lieber/DeCarh diet This resulted m a considerable caloric intake from ethanol 
(12-20%) Human alcoholics are defined as those who are chronically consuming 
at least 20% of their daily caloric intake as ethanol (Lelbach, 1974) This rat 
model therefore seems realistic We think that this model is suitable for further 
studies on the effects of long term ethanol exposure on the toxicokinetics of 
xenobiotics 
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SUMMARY 
The urinary and fecal excretion of benzo(a)pyrene [B(a)P] and its main 
metabolites were studied after oral and intraperitoneal administration of B(a)P to 
male and female ethanol-treated and non-ethanol-treated rats. After oral 
administration of B(a)P more mutagenic compounds as well as Β(σ)Ρ metabolites 
were found in feces than after intraperitoneal administration. The excretion of 
B(a)P metabolites in urine and feces after oral administration were maximal at 
days 1 and 2 whereas after intraperitoneal atiministration excretion was maximal 
at days 2 and 3. In males, the amounts of excreted phenolic metabolites in urine 
and feces were generally higher than in females. The amounts of mutagenic 
products in urine and feces of males were also higher than in females after 
intraperitoneal and oral administration of B(a)P. In urine of female rats that 
received B(a)P intraperitoneally, a decreased excretion of phenolic metabolites 
was found after ethanol treatment. In feces of both male and female rats, a 
decreased excretion of 3-hydroxy-B(o)P was found after ethanol treatment. In this 
study, the influence of sex and administration route on the excretion of B(a)P 
metabolites was more pronounced than the effect of ethanol treatment. 
INTRODUCTION 
The impact of human life-style factors on uptake, distribution, biotransformation 
and excretion of xenobiotics is clearly recognized. The main, non-work related, 
life-style associated parameters are alcohol use, smoking, drug and alimentary 
habits (Fournier & Thomas, 1986). Interactions between alcohol use and 
pharmacokinetics of Polycyclic Aromatic Hydrocarbons (PAHs) are of interest 
because PAHs are ubiquitous environmental pollutants produced by common 
industrial and transportational sources and tobacco smoking. Alcohol use is a 
widespread life style factor. The risk of cancer of the larynx, pharynx and 
oesophagus was additive or multiplicative for people that smoke and drink alcohol 
(IARC, 1988). Effects of ethanol on the organism are dependent on the amounts 
of ethanol consumed. Consumption of 15-20% of the total daily caloric intake is 
defined as 'moderate' drinking in humans (Prasad et al., 1985). We have developed 
an animal model in which rats receive such amounts of ethanol (van de Wiel et ai, 
1990). 
Several researchers have investigated the pharmacokinetics of PAH in laboratory 
animals by analyses of excretion products. Mostly benzo(a)pyrene [B(a)P] is used 
as a model substrate for the study of the pharmacokinetics of PAH. Elimination of 
B(a)P proceeds via the bile. Foth et ai, (1988) reported that 42.5% of an i.v. dose 
of [3H]B(a)P appeared in the bile as total radioactivity during the first 4 h. Only 
2% of this dose was excreted in the urine in 36 h. After a subcutaneous injection 
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of [3H]B(a)P, it was found that the feces contained the highest amounts of 
radioactivity, which were 2-4 fold higher than the amounts found in urine (Uziel 
&Haglund, 1988). 
The biological availability of PAH is expected to be dependent on the route of 
administration. Grimmer et al. (1988) found that after oral application of chrysene 
60% of the dose was recovered as excretion products in urine and feces (1.5% and 
72.3%, respectively), while after an i.p. application this was only 5% (urine 
0.55%, feces 5.6%). After oral and intraperitoneal administration of pyrene, Jacob 
and Brune (1989) found 53.4% and 3.1% as pyrene (metabolites) respectively, in 
urine and feces. 
Sex differences in the hepatic metabolism of drugs in the rat have been reported 
by several investigators. Gurtoo and Parker (1977) measured a sex dependent 
regulation of B(a)P metabolism in rat tissues. Aryl Hydrocarbon Hydroxylase 
(АНН) activity in hepatic microsomes was 4-6 fold greater in male rats compared 
with female rats. No differences in АНН activity were seen in the lung and spleen 
of male and female rats. АНН activity in kidneys from female rats was 86% higher 
than that of male rats. We wondered whether in vitro measured sex differences in 
PAH metabolism would be observed in in vivo excretion profiles of В(д)Р and 
metabolites in urine and feces. 
In this study benzo(a)pyrene [B(a)P] is used as a model substrate for the study of 
the influence of several parameters on the excretion of PAH. The excretion of 
B(a)P and metabolites in urine and feces of ethanol-treated rats and control rats 
were studied after oral (p.o.) and intraperitoneal (i.p.) administration of B(o)P. 
B(a)P-metabolites excreted in male and female rats were compared to detect sex 
differences and the influence of ethanol treatment. 
METHODS 
Animals 
Homebred Cpb:WU (Wistar) rats were used. The initial weights varied between 
100-120 g (females) and 120-150 g (males). The rats were about 6 weeks old 
when the ethanol treatment started and about 3 months at the time of the B(a)P 
administration. They were of specified pathogen free quality (antibodies against 
Pneumonia virus of mice and the pin-worm Syphacia muris were found, no other 
pathogens). Rats were kept in Macrolon type 3 cages on sterilized softwood 
granules as bedding with 3 animals per cage. At the time of the in vivo 
experiments the rats were housed in stainless steel metabolism cages designed for 
the separate collection of urine and feces. The animals were provided with 
RMH-TM pellets ad libitum (Hope Farms B.V., Woerden, the Netherlands). Four 
groups of 12 rats were used; two groups of males and two groups of females. One 
group of males and one group of females received B(a)P intraperitoneally, the 
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others orally. In each group six rats were treated with ethanol, the other six 
received tap water. The ethanol-treated rats had free access to water with an 
increasing ethanol percentage reaching 15% w/v after 3 weeks. Ethanol treatment 
continued during B(a)P administration. Details of the ethanol treatment were 
described previously (van de Wiel et al., 1990). 
Room temperature was regulated (22 ± 2°C), relative humidity varied between 
40% and 60%. The animals were exposed to artificial light between 0700 h and 
1900 h. 
Chemicals 
Ethanol absolute GR was obtained from Merck, Darmstadt, Germany. 
Benzo(a)pyrene [B(a)P] was purchased from Sigma, St Louis, MO, USA, and was 
about 98% pure. B(a)P metabolites were obtained from the NCI Chemical 
Carcinogen Repository, Midwest Research Institute, Kansas city, MO, USA: 
B(a)P-trans-9,10-dihydrodiol and B(a)P-trans-4,5-dihydrodiol purity was >99%, 
B(a)P-cis-7,8-dihydrodiol purity was >97%, 9-hydroxy-B(a)P purity was >96% 
and 3-hydroxy-B(a)P purity was >98% (determined by HPLC). 
ß-glucuronidase/arylsulfatase (from Helix pomatia) was from Boehringer 
Mannheim GmbH, West-Germany. Aroclor 1254 was from Alltech Associates, 
Deerfield, IL, USA. 
Experimental design 
Groups of 12 rats received one dose of 1 mmol B(a)P/kg, either orally or 
intraperitoneally. A large dose of B(a)P was used because the metabolizing 
capacity of the rats was not known. Besides the dose had to be large enough dose 
to detect DNA adducts (not described in this manuscript). One ethanol-treated and 
one control rat were dosed with the vehicle (olive oil) only. Urine and feces were 
collected individually over periods of 24 h, one day before treatment, during four 
days after treatment and on the seventh day after B(cr)P treatment. The 
ethanol-treated rats were continuously exposed to ethanol in their drinking water 
throughout the experiment. Urine and feces of days four and seven of the females 
that received B(a)P i.p. were not collected. Urine samples were adjusted with 
demineralized water to a volume of 20 ml urine per 200 g bodyweight of rats. This 
allowed a direct comparison of the metabolite concentrations and mutagenicity 
data of individual samples. After centrifugation about 10 ml was filter sterilized 
(0.2 μτη from Millipore) for use in the Ames test. All samples were kept at -20°C 
until assayed. 
Preparation of feces extracts 
3 g of feces were boiled with 25 ml methanol under reflux for 60 minutes in a 
water bath of 70°C. The solid fraction was separated by centrifugation and 
reextracted with 15 ml methanol using ultrasonification for 10 minutes. After 
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filtration of this extract over glasswool both methanol extracts were pooled, and 
methanol was evaporated under nitrogen at 60°C. The residue was dissolved in 3 
ml DMSO, ultrasonicated for 10 minutes and transferred into small glass vials 
until use (Willems & de Raat, 1985). If less than 3 g feces were produced, the 
residue was dissolved in DMSO at a final concentration of 1 g feces/ml DMSO. In 
a pilot study, the effectiveness of preliminary overnight incubation of feces with 
ß-glucuronidase/arylsulfatase was studied. No significant effect resulted from aryl 
sulfatase/ß-glucuronidase treatment. Consequently, it was not added to the 
standard analytical procedure. Either the ß-glucuronidase activity of the bacteria in 
colon and rectum is quite effective (and consequently the glucuronide conjugates 
are hydrolysed and found in feces as the deconjugated product), or the conjugates 
are hydrolysed during the methanol extraction. The ethylacetate extraction as 
performed by Bowes and Renwick (Bowes & Renwick, 1986) with or without 
enzymatic hydrolysis was less effective than the methanol extraction (data not 
shown). With the applied methanol extraction, the recovery of the metabolites 
from the feces were as follows; 3-hydroxy-B(a)P 92%, 9-hydroxy-B(a)P 95%, 
B(a)P-4,5-dihydrodiol 91%, B(a)P-7,8-dihydrodiol 94%, B(a)P-9,10-dihydrodiol 
92%. In the Ames test, dilutions of the feces extract in DMSO were used. For 
HPLC analysis the feces extract was diluted to 5 mg/ml with methanol. 
Pretreatment of urine for HPLC analysis 
3 ml of a 24-hours urine sample were adjusted to pH=5.0 with 1.0 N HCl and 
buffered with 27 ml 0.1 M acetate buffer (pH=5.0). This solution was incubated 
overnight with 12.5 μΐ ß-glucuronidase/aryl sulphatase (1250 I.U.) at 37°C. A 
Sep-рак С18 cartridge (Waters, Milford, MA, USA) was used for the solid phase 
extraction of PAH metabolites. After priming the cartridge with 5 ml methanol 
and 10 ml distilled water, respectively, the hydrolysed sample was drawn through 
the cartridge at a rate of approximately 10 ml per min. Subsequently, the cartridge 
was washed with 10 ml distilled water. Retained solutes were eluted using 10 ml 
methanol. The solvent was evaporated at 60°C under nitrogen and the residue 
dissolved in 2.0 ml methanol (Jongeneelen et al, 1984). 
Reversed-phase HPLC analysis 
Analyses were performed with a Kipp Analytica HPLC equipped with two solvent 
pumps (model 9208), a solvent programmer (model 9224), an automatic sampler 
(model 9209) and a column thermostat (model 9222). Using a sample loop, a 20 μΐ 
aliquot was injected onto a 150 χ 4.6 mm ID Nucleosil С18 (5 μπι) column. 
Column temperature was 40°C, flow 1.0 ml per min. The following solvent 
program was commenced: 5 min 90% solvent A (60% aqua pure, 40% methanol), 
a linear gradient to 90% solvent В (100% methanol) in 40 min. followed by 10 
min 90% solvent B. 
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Fluorescence detection was performed with a Perkin Elmer LS-4 
spectrofluorimeter. The program for excitation and emission wave lenghts during 
each ran is given in table 1. The retention times of 9-hydroxy-B(a)P and 
3-hydroxy-B(a)P were 36 and 37.0 ± 0.5 min, respectively. The retention times of 
B(a)P-9,10-dihydrodiol, B(a)P-4,5-dihydrodiol, B(a)P-7,8-dihydrodiol and B(a)P 
were 19, 26, 27 and 43 minutes, respectively. Quantification was done by 
measuring peak heights and comparing these with a standard range. For analysis of 
urine the standards were prepared in a urine matrix and extracted following the 
same procedure as the urine samples. The recovery of metabolites from the urine 
matrix was about 45% for the concentrations used in the standard range. 
The metabolites in the feces extracts were quantified using a standard range of 
the metabolites in methanol. Unconjugated metabolites had a recovery of more 
than 90%, B(a)P was recovered for about 85%. 
time 
(min) 
0 
21 
31 
41 
58 
excitation 
(nm) 
280 
265 
265 
296 
С 
emission 
(nm) 
406 
405 
430 
407 
С 
metabolites detected 
B(a)P-9,10-dihydrodiol 
B(a)P-4,5-dihydrodiol, 
B(a)P-7,8-dihydrodiol 
3-hydroxy-B(a)P, 
9-hydroxy-B(a)P 
B(a)P 
Table I. Program of Perkin Elmer LS-4 detector 
Ames test 
The Salmonella mutagenicity test was performed with the Salmonella 
typhimurium strain TA98 as described by Maron and Ames (1983). This strain 
was subjected to quality control including checks for the presence of the strain 
characteristics and mutability by diagnostic mutagens like 2-aminofluorene and 
4-nitro-O-phenylenediamine. Amounts of 0.3 ml of filter sterilized urine were 
used in the Ames test (Bos et ai, 1980). 
The amount of mutants found were standardized for 20 ml of urine produced per 
rat per day, the rat having a bodyweight of 200 g. Thereto corrections were made 
(see below). Feces extract concentrations varied from 0-20 mg feces equivalents 
per plate. The highest concentration at which no direct toxicity was observed was 
used to determine the amount of mutants per mg feces. It was found that 0.5 
mg/plate showed no toxic effects towards the bacteria. The Ames test was 
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performed with and without activation. When performed with activation, S9 
mix and ß-glucuronidase were added. The S9 mix contained 100 μΐ of a hepatic 
9000 g supernatant from Aroclor 1254 induced rats per ml. To detect mutagenic 
compounds that are inactive due to glucuronidation, ß-glucuronidase was applied 
to the top agar. Every sample was determined in triplicate. After 48 h incubation 
at 37°C, the revertant colonies were counted. 
For adjustment of the different doses of B(a)P the rats received, and the different 
weights of feces they produced, the following formula was applied: 
Mutagenicity = exlra induced revertants χ 1 о Ы ^ ^ 
°
 J
 dosefactor weight feces plated 
This means that the mutagenicity is defined as the revertants of TA98 induced by 
extract of 24 hours feces of a rat having a bodyweight of 200 g after a dose of 1 
mmol B(a)P/kg. 
-Extra induced revertants: Number of revertants due to feces extract on one day 
after the administration of B(a)P minus number of revertants due to feces extract 
before B(a)P administration. 
-Dosefactor: Factor for adjustment of the different doses the rats received. (For a 
rat of 200g the factor=l, for a rat of 220g the factor=l. 1 etc.) 
-Total weight of feces: Total weight of feces produced on a certain day (mg). 
-Weight feces plated: Equivalent of the amount of feces plated (mg) in the Ames 
assay. 
Statistical analysis 
Results are presented as average values. Statistical analysis was carried out using 
the SAS (Statistical Analysis System) package on a VAX6410 minicomputer. The 
procedure used was GLM (general linear model) for analysis of variance with 
unequal cells. The data of total excretion of mutagenicity and metabolites per rat 
were logtransformed before analysis, because of the very different amounts of 
excreted metabolites after p.o. and i.p. B(a)P administration. Of the 
intraperitoneally dosed females only urine and feces of the first 3 days after B(a)P 
administration were available for the test, so for statistical analysis only the totals 
of these days were compared for all groups of treated rats. A p-value <0.05 was 
considered to be of statistical significance. 
RESULTS 
B(a)P metabolites m urine 
3-hydroxy-B(a)P was the predominant metabolite (up to 1500 nmoles in 5 days) 
in all groups of rats. Amounts of 9-hydroxy-B(a)P and of B(o)P-9,10-dihydrodiol 
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and B(a)P-4,5-dihydrodiol were 1/100 of 3-hydroxy-B(a)P (to 15 nmoles). The 
amount of B(a)P-7,8-dihydrodiol was about 1/1000 of 3-hydroxy-B(a)P. 
The amounts of B(o)P and metabolites excreted in urine in 3 or 5 days are shown 
in tables 2a and 2b. The rats that received B(o)P intraperitoneally showed a 
maximum in the excretion of metabolites on days 2 and 3 (Data not shown). In 
general, after oral administration of B(a)P a maximum in the excretion of 
metabolites appeared on day 1. Male rats had more metabolites in their urine than 
female rats (pO.0001). The total excretion over 3 days of B(a)P metabolites after 
i.p. administration of B(a)P in female rats was significantly lower in 
ethanol-treated rats in comparison with non-ethanol-treated rats. In male rats, no 
significant effect was observed in the excretion of B(a)P metabolites due to 
ethanol treatment. 
Mutagenic metabolites m urine 
The mutagenicity in urine after intraperitoneal and oral administration of B(a)P is 
shown in table 3. The intraperitoneally dosed rats showed a maximum in the 
excretion of mutagenic metabolites in their urine on days 2 and 3 after B(a)P 
administration. After oral administration of B(a)P the rats had a maximal excretion 
of mutagenic compounds in their urine on days 1 and 2 (data not shown). The 
male rats had a significantly higher excretion of mutagenic compounds in their 
urine compared with female rats after intraperitoneal and oral aciministration of 
B(a)P (p=0.0001). The difference between the sexes was largest in the i.p. dosed 
animals. There were no statistically significant differences between ethanol-treated 
and control rats measured within each group. 
B(a)P metabolites and unmetabohzed B(a)P m feces 
The excreted amounts of B(a)P metabolites and unmetabolized B(a)P in feces are 
shown in tables 2a and 2b. After i.p. administration, the main metabolite excreted 
was 3-hydroxy-B(a)P. The average amount excreted during the period measured, 
in males and females, with or without ethanol treatment was 5 moles. After oral 
administration the amounts of B(cr)P excreted, and also of its metabolites, were 
much higher than after intraperitoneal administration (p=0.0001). In the i.p. 
treated animals, maximal excretion was found on days two and three, whereas in 
the p.o. treated rats, maximal excretion was found on days one and two (data not 
shown). In general after i.p. or p.o. treatment 3-hydroxy-B(a)P, 9-hydroxy-B(a)P, 
B(a)P-4,5-dihydrodiol, B(a)P-7,8-dihydrodiol and B(a)P-9,10-dihydrodiol were 
higher in feces extracts of males compared to females. However, this was not 
significant for 9-hydroxy-B(a)P and the opposite was true for 
B(a)P-4,5-dihydrodiol in the non-ethanol group after i.p. B(o)P administration. 
The excretion of 3-hydroxy-B(a)P was significantly lower in 
ethanol-treated rats in comparison with control rats after oral as well as after 
intraperitoneal treatment, in both males and females.. 
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Metabolite 
3-hydroxy-B(a)P* ** 
(μΙΤΙΟί) 
9-hydroxy-B(a)P 
(nmol) 
B(a)P-4 5-dihydrodiol 
(nmol) 
B(a)P-7,8-dihydrodiol* 
(nmol) 
B(a)P-9 10-dihydrodiol* 
(nmol) 
B(a)P 
(цгпоі) 
Feces/μιτιοΙ 
total 
% of dose 
Unne/nmol* 
total 
0% EtOH 
Male Pemale 
5 0 ± 0 8 
(1 9%) 
391 ± 1 0 7 
3 9 2 ± 1 4 3 
14 7 ± 13 1 
26 7 ± 6 1 
0 38± 0 26 
5 5 ± 1 0 
2 0 
1161 ±210 
2 9 ± 0 4 
(1 5%) 
9 4 ± 3 0 
63 4 ± 7 5 
nd 
13 2 ± 1 5 
0 02 ± 0 009 
3 0 ± 0 5 
1 6 
38 ± 8 " 
15% EtOH 
Male Female 
2 4 ± 0 2 
(0 9%) 
14 9 ± 5 4 
46 7 ± 6 8 
4 0 ± 3 7 
22 8 ± 6 1 
0 08 ± 0 04 
2 6 ± 0 2 
1 0 
1646 ±400 
2 0 ± 0 4 
(1 0%) 
1 3 6 ± 3 3 
44 1 ± 8 9 
nd 
9 0 ± 2 3 
0 1 0 ± 0 0 1 
2 2 ± 0 4 
1 1 
19 ± 3 
Table 2a Amounts of B(a)P and metabolites excreted during 5 
days ш feces and unne of rats after intraperitoneal B(o)P 
administration N = 5 or 6 Values are means ± Standard Error of 
the Mean (SEM) Of the females that were administered B(a)P 
ι ρ, only unne and feces of days one, two and three were 
collected The percentage of the dose recovered is indicated When 
no value is added, this was smaller than 1 % of the dose 
* Significant difference between male and female rats P<0 01 
** Significant difference between ethanol-treated and non-treated 
ratsP<0 01 
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Metabolite 
3-hydroxy-B(a)P* " 
(цтоі) 
9-hydroxy-B(a)P 
(nmol) 
BCa)P-4,5-dihydrodiol* 
(nmol) 
B(a)P-7,8-dihydrodior 
(nmol) 
B(a)P-9,10-dihydrodiol* 
(nmol) 
B(a)P 
(μπποΙ) 
Feces/μΓΤΐοΙ 
total 
% of dose 
Unne/nmol* 
total 
0% EtOH 
Male Female 
33 6 ± 5 2 
(11 2%) 
492 5 ± 94 1 
202 6 ± 30 5 
153 9 ±20 7 
40 8 ± 4 5 
206 2 ± 30 5 
240 7 ± 35 7 
80 2 
309 ± 98 
19 0±1 8 
(10 9%) 
346 5±34 1 
83 0±13 3 
37 7±8 3 
25 8±1 7 
83 8±10 9 
103 3 ±12 7 
59 4 
90 ±21 
15% EtOH 
Male Female 
17 5±0 7 
(5 8%) 
686 6±163 8 
175 8±28 1 
107 9±22 0 
35 9±7 8 
172 1±24 4 
190 6±25 1 
63 5 
290 ±61 
14 6±3 4 
(8 4%) 
429 3±79 6 
66 1±5 4 
42 4±8 7 
32 5±3 2 
66 7±8 3 
81 9±11 7 
11 7 
96 ±23 
Table 2b Amounts of Β(α)Ρ and metabolites excreted durmg 5 
days in feces and urine of rats after oral B(o)P administration 
N = 5 or 6 Values are means ± Standard Error of the Mean 
(SEM) Of the females that were administered B(a)P ι ρ , only 
urine and feces of days one, two and three were collected The 
percentage of the dose recovered is indicated When no value is 
added, this was smaller than 1 % of the dose 
* Significant difference between male and female rats P<0 01 
** Significant difference between ethanol-treated and non-treated 
ratsPOOl 
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GROUP" 
sex B(a)P diet 
Μ ι ρ 0% EtOH 
Μ ι ρ 15% EtOH 
F ι ρ 0% EtOH 
F ι ρ 15% EtOH 
Μ po 0% EtOH 
M ρ о 15% EtOH 
F ρ о 0% EtOH 
F po 15% EtOH 
MUTAGENICITY 
FECES/1000' 
with* without 
activation 
210 ±51 
149 ±33 
185 ±16 
176 ±50 
4162 ±356 
3116 ±434 
3978 ±156 
4271 ± 402 
28 ± 10 
33 ± 8 
89 ± 25 
74 ± 8 
213± 36 
95 ± 26 
320 ±192 
251 ± 43 
REVERTANTS 
URINE"* 
622 ± 65 
428 ± 34 
2557 ±134 
2549 ±103 
603 ± 88 
600 ± 53 
1157 ± 87 
1146 ± 75 
Table 3 Mutagenicity in feces and m urine 
a Total amounts of five days measured are given for each group, 
however, of the females that received Β(α)Ρ ι ρ , only samples of 
days 1, 2 and 3 were collected 
b Each group consisted of five or six animals (mean values are 
presented) 
с Mutagenicity 
extra induced revertants χ total weight feces 
dosefactor weight feces plated 
Amounts ± standard deviations (SD) are given 
d Filter sterilized unne is used in the Ames test, 0 1 ml per plate 
Amount of revertants are given (± SD) 
* Significant difference between male and female rats P<0 01 
** Significant difference between ethanol-treated and non-treated 
ratsP<0 01 
Mutagenic metabolites in feces 
The mutagenicity of the feces extracts in the Salmonella mutagenicity test with 
and without the addition of an activating system is shown in table 3. Each plate 
contamed an amount of feces extract equivalent to 0.5 mg feces. The mutagenicity 
values were calculated from the formula presented in the Materials and Methods 
section. The mutagenicity measured using the activating system was far greater 
than the mutagenicity when no activating system was added In the Ames test, 
В(я)Р is mutagenic only when a liver S9-fraction is added. 
The i.p. dosed rats showed a maximum excretion of mutagenic metabolites 
m their feces on days 2 and 3, and sometimes on day 4 (males) after В(л)Р 
administration. The p.o. dosed rats showed a maximum excretion of mutagenic 
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compounds in their feces on days 1 and 2 (Data not shown). After intraperitoneal 
administration of B(o)P, the amounts of mutagens in the feces were considerably 
lower than after oral dosing in both sexes; approximately 200x103 mutants versus 
4000x103 mutants measured with an activating system. Without an activating 
system this was on average 65x103 versus 200x103 mutants. The total mutagenicity 
of feces extracts of male rats was higher than that of female rats (p=0.02) when no 
S9-mix was used. There were no statistically significant differences between the 
ethanol-treated and non-ethanol-treated groups with respect to the total excretion 
of mutagenic compounds in the feces. However, the ethanol-treated female rats 
showed a tendency towards a decreased excretion of mutagenic compounds after 
oral B(a)P administration. 
DISCUSSION 
This paper presents a study of the excretion of benzo(a)pyrene and metabolites 
after oral and intraperitoneal administration in rats of both sexes. Moreover, the 
effect of chronic alcohol consumption was investigated. 
Route of B(a)P administration was a major determining factor with respect 
to differences in excretion time and amounts of excreted products. Also sex 
differences occurred; males excreted larger amounts of certain metabolites than 
females. Statistically significant differences due to ethanol treatment were 
observed only with 3-hydroxy-B(a)P. After ethanol treatment, a smaller amount of 
this metabolite was found in feces. 
Administration route 
The administration route largely determined the total amount of excreted 
metabolites. Both after p.o. and i.p. treatment, much more metabolites were found 
in feces compared to urine. These results are in agreement with those of other 
investigators. With respect to the total amount of B(a)P-metabolites in rats, Uziel 
and Haglund (1988) found that excretion in feces was 3 times higher than in urine. 
Kawamura (1988) found a difference with a factor 20 after oral administration. 
Although the factors vary, it is clear that the excretion of B(a)P and metabolites 
mainly took place via the bile and feces. This is well known for compounds of 
high molecular weight like B(cr)P metabolites (Korin et al., 1959; Chipman et al, 
1981). 
The total amount of the Β(α)Ρ dose that was excreted in urine and feces in 
rats after oral administration was about 72% (63% unmetabolized Β(σ)Ρ, 9% 
3-hydroxy-B(a)P and 1% other metabolites). After oral administration of the PAH 
chrysene to rats, Grimmer et al. (1988) found 59.2% hydroxychrysene and 13.1% 
chrysene in urine and feces in 72 hours. After oral administration of pyrene, Jacob 
et al. (1989) found a total recovery in urine and feces in three days of 53.4%; 
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7.2% as pyrene and 46.2% as 1-hydroxypyrene. Although the total recovery of the 
dose is comparable, we found relatively more of the unmetabolized compound. 
Non-polar compounds like unmetabolized B(a)P are only excreted as such 
in the bile in very small amounts after entering the systemic circulation (Smith & 
Bend, 1979; Takahashi et al, 1977). We may conclude that, after oral 
administration, a large amount of B(a)P has not been absorbed. The low rate of 
absorption may be due to the high dose we gave (1 mmol/kg versus 10-400 μg 
given by other investigators). This could saturate the absorption capacity of the gut 
or form a bolus from which the B(a)P is not readily absorbed. Besides the 
relatively high excretion of unmetabolized B(a)P, metabolites and mutagenic 
products in feces were much higher after p.o. compared to i.p. B(a)P 
administration. The rate of excretion of B(a)P and metabolites was higher, as well. 
Grimmer et al (1988), Jacob et al (1989) and Egestad et al. (1987) found a 
maximal excretion on day 1 for both routes of aciministration, whereas we found a 
maximal excretion on days 2 and 3 after i.p. administration. Both larger and faster 
excretion of B(a)P metabolites could be due to a higher biological availability of 
B(o)P after oral administration. The absorption through the gut seems to cause a 
high liver load and B(a)P biotransformation in a short time. The small intestine 
may play a role in B(a)P metabolism after oral administration as well. 
Autoinduction in this tissue can already be measured within 12 hours after PAH 
administration (Aitio, 1974). Apart from that, other investigators reported that 
after i.p. administration at least 20% of the dose was not recovered with or without 
acid hydrolysis. This fraction most probably consists of glutathione conjugates or 
may be regarded as covalently bound (Egestad, 1987). Another factor that could 
reduce the availability of B(a)P for biotransformation after i.p. administration 
could be disposition in fat. 
After intraperitoneal administration, Grimmer et al. (1988) and Jacob et 
al. (1989) found a total recovery of 6.2% for chrysene and of 3.1% for pyrene, 
respectively. These percentages were in the same order of magnitude as that found 
in the present study for B(a)P (2.2% mostly as 3-hydroxy-B(a)P). Egestadt et al. 
(1987) found 25% of the radioactivity of a dose of 22 μg 14C-B(a)P to be 
extractable from feces. However, they used a combination of extraction with 
different solvents (80% ethanol, ethanol, hexane) and solid sorbente. 
Sex differences 
Males had a significantly higher excretion of mutagenic compounds as well as of 
3-hydroxy-B(ûf)P in their urine than females. In feces, generally male rats excreted 
a higher percentage of B(a)P as metabolites than female rats. The differences 
between the sexes were not in the same order of magnitude for all metabolites. In 
vitro sex differences in biotransformation of PAH are described in literature. The 
formation of 3-hydroxy-B(o)P is regarded as indicative for total B(a)P metabolism 
by several authors (Gurtoo & Parker, 1977). Quantitative differences in the 
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formation of 3-hydroxy-B(a)P were confirmed in this study but this was not 
representative for other metabolites. It is likely that several isozymes of P450 are 
involved in the B(a)P metabolism: sex specific as well as non-sex specific. 
Ethanol treatment 
In the four groups investigated (female i.p., male i.p., female p.o., male p.o.) one 
particular effect of ethanol treatment was observed in the urine of female rats that 
received an i.p. dose of B(a)P. In this group, the ethanol treatment resulted in a 
statistically significant reduction of B(a)P metabolites in urine. Also, after p.o. 
and i.p. administration of B(a)P, 3-hydroxy-B(a)P was significantly lower after 
ethanol treatment in feces of males and females. Consequently, only a quantitative 
effect could be observed in both sexes. A reduced amount of metabolites in 
excretion products after ethanol treatment could be due to changes in absorption, 
biotransformation or excretion. Since the decrease in metabolite excretion in feces 
was found both after i.p. and p.o. administration of B(a)P, an ethanol treatment 
effect on the absorption of B(a)P through the gut seems unlikely. 
There are several in vitro studies concerning the effect of ethanol treatment 
on biotransformation of B(a)P. Sato et al. (1986) measured a decrease, however 
not statistically significant, in B(a)P metabolism in rat liver microsomes of male 
Wistar rats. Murphy and Hecht also found a decrease in hepatic B(a)P metabolism 
in hamsters (Murphy & Hecht, 1986). In other studies, an increase in in vitro 
B(o)P metabolism was reported in liver and/or intestine (Seitz et al., 1978; Seitz et 
al., 1981) 
Oxygenation by the monooxygenase linked P450 isozyme complex is 
considered as a first step in the biotransformation of B(a)P. Ethanol is known to 
act as an inducer of the monooxygenase linked cytochrome P450 (Rubin & Lieber, 
1968; Onishi & Lieber, 1977; Koop & Coon, 1986). B(o)P is a compound 
activated by this enzyme system. The P450-isozyme that has the greatest affinity 
for B(a)P (LAI, characterized by Ethoxyresorufin O-deethylase [EROD] activity), 
however, is only slightly induced by ethanol treatment (Winston et al., 1990). The 
isozyme which is typically induced by ethanol treatment, IIE1, is characterized by 
aniline-4-hydroxylase activity and has a low affinity for B(a)P (Koop & Coon, 
1986). The reduction in the formation of some metabolites after ethanol treatment 
in the present analysis could be explained by a possible down regulating effect of 
ethanol on the constitutive isozymes that metabolize B(a)P (Wortelboer et αϊ, 
1991; van de Wiel et al., 1992). 
The arene oxides that are formed from Β(α)Ρ can be further metabolized by 
glutathione S-transferases. The phenols, quiñones and dihydrodiols of B(a)P may 
be converted by cytosolic sulfotransferases and by UDP glucuronyltransferases 
(Thakker et al., 1985) Chronic ethanol administration enhances the hepatic 
glutathione content but does not affect glutathione S-transferase activity (Muñoz 
et al, 1987; Yang & Carlson, 1991). Acute administration of ethanol shows 
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inhibition of glutathione synthesis and a decrease of glutathione S-transferase 
activity (Gonzalez et al, 1987) This could cause a decreased excretion of 
metabolites, but it is not likely to be selective for certain metabolites. 
In conclusion: In m vivo studies we have observed clear differences m the 
amounts of benzo(a)pyrene metabolites in urine and feces between the sexes and 
between orally or intraperitoneally treated rats Also, an influence of ethanol 
treatment was found, but only with respect to the amounts of 3-hydroxy-B(a)P. 
This effect was more pronounced in the male rats. Whether the differences that 
were detected after ethanol treatment were due to biotransformational effects or 
effects on excretion mechanisms or other pharmacokinetic/pharmacodynamic 
parameters remains to be determined. 
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ABSTRACT 
The influence of long-term ethanol exposure of rats on microsomal 
biotransformation of benzo(a)pyrene [B(a)P] was studied. Male and female Wistar 
rats received an increasing amount of ethanol in their drinking water: percentages 
rose to 15% (w/v) in 3 weeks. The ethanol content was kept at a concentration of 
15% for another 3 weeks. Liver, lungs and intestinal epithelial cells of the rats 
were then isolated and microsomal fractions prepared. In all organs, the metabolite 
most formed was 3-hydroxy-B(a)P. In liver, males showed significantly higher 
B(a)P hydroxylase activity than females. On the basis of experiments using 
monoclonal antibodies, a significant part of the B(a)P biotransformation in male 
rat liver microsomes can be attributed to the male specific P4502C11. In lung and 
intestine there were no significant differences between the sexes. In liver, ethanol 
treatment significantly decreased the microsomal formation of phenolic 
metabolites. In microsomes of intestinal epithelial cells ethanol treatment 
enhanced the formation of phenols and diols. In conlusion: in rats, ethanol 
consumption in moderate amounts leads to an alteration in the microsomal 
biotransformation of B(a)P. Effects are most prominent in liver, where the 
formation of phenols is significantly decreased. 
INTRODUCTION 
The impact of life style factors on toxicokinetics of foreign compounds is clearly 
recognized. The main, non professional, life style associated parameters are use of 
alcohol, smoking, drug and dietary habits (Fournier & Thomas, 1986). Interactions 
between alcohol intake and toxicokinetics of polycyclic aromatic hydrocarbons 
(PAHs) are of interest because PAHs are ubiquitous environmental contaminants 
and components of cigarette smoke. The risk of cancer of the larynx, pharynx and 
oesophagus is found to be additive or multiplicative for people who smoke and 
drink alcohol (IARC, 1988). 
Ethanol has a broad spectrum of direct toxic effects (Lieber, 1984). 
Indirectly it acts as an inducer of the monooxygenase-linked cytochrome P450 
complex (Rubin & Lieber, 1968; Onishi & Lieber, 1977; Koop & Coon, 1986; 
Johansson et ai, 1988). Conceivably, the additive or multiplicative effect of 
drinking and smoking on carcinogenesis could be attributed to an enhanced 
biotransformation of B(a)P into its reactive intermediates by ethanol-induced P450 
monooxygenases. Findings by Seitz et al. (1978, 1981) support this idea. They 
measured enhanced aryl hydrocarbon hydroxylase activity in microsomes of liver 
and small intestine of female rats and in intestinal microsomes of male rats that 
were on an alcohol-containing diet (Seitz et ai, 1978, 1981, 1981a). Also, 
enhanced biotransformation of PAHs in the cheek pouch epithelium (but not in the 
liver) of Syrian golden hamsters was measured after long term ethanol treatment 
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(Murphy & Hecht, 1986). However, other authors found a decrease or no change 
in the in vitro metabolism of B(a)P by rat and hamster liver microsomes 
(DeMarco & McCoy, 1984; Sato et al., 1986). The specific ethanol inducible 
P450 isoenzym (P4502E1) demonstrated little affinity for PAHs (Koop & Coon, 
1986). 
We have recently described the in vivo toxicokinetics of B(a)P after 
long-term ethanol treatment (van de Wiel et ai, 1993). After one i.p. or p.o. dose 
of Β(α)Ρ given to rats chronically exposed to ethanol via their drinking water, the 
excretion of 3-hydroxy-B(a)P was significantly decreased. The effect of ethanol 
treatment on B(o)P metabolite excretion measured in vivo was attributed to 
changes in absorption, biotransformation and/or excretion. 
This paper presents data on the effects of long-term ethanol treatment on 
the biotransformation of B(a)P. Microsomes of lung, liver and small intestine from 
male and female rats were used. This allowed for a comparison of possible 
sex-related differences of B(a)P biotranformation in the three organs. Finally, to 
determine which isoenzyme of P450 was most important in B(a)P 
biotransformation, liver microsomes were incubated with monoclonal antibodies 
(Mabs) to the P450 isoenzymes; 1A1/2, 2E1, 2B1/2 and 2C11/6 to measure the 
inhibition of B(a)P metabolite formation. 
MATERIALS AND METHODS 
Chemicals 
Ethanol used for the treatment was Ethanol absolute GR, supplied by Merck 
(Darmstadt, Germany). Benzo(a)pyrene (CAS 50-32-8), was purchased from 
Sigma (St. Louis, MO, USA). B(a)P metabolites were obtained from the NCI 
Chemical Carcinogen Repository, Midwest Research Institute (Kansas city, MO, 
USA). All other chemicals were of analytical grade, obtained from local 
commercial sources and used without further purification. 
Animals 
Homebred Cpb:WU (Wistar) rats of both sexes were used. Initial weights varied 
between 100-120g (females) and 120-150g (males). The age of the rats was about 
6 weeks at the beginning of the experiments and 12 weeks at the end. The animals 
were of Specified Pathogen Free (SPF) quality. Antibodies against the PVM virus 
and the Pin-worm Syphacia muris but no other pathogens were found. The 
animals were kept in Macrolon type 3 cages on sterilized softwood granules as 
bedding. Per cage, three animals were housed. 
The animals were provided with RMH-TM pellets (Hope Farms B.V. 
Woerden, The Netherlands). The rats had free access to water with an increasing 
ethanol content reaching up to 15% w/v after 6 weeks. Details of the method of 
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alcohol exposure have been described previously (van de Wiel et al., 1990). Room 
temperature was regulated (22 ± 2°C), relative humidity varied between 40 and 
60%. The animals were exposed to artificial light between 7.00 a.m. and 7.00 
p.m.. 
Preparation of microsomes 
Six weeks after the start of the alcohol treatment the rats were anaesthetized with 
pentobarbital and perfused with ice-cold saline via the ventricle of the heart until 
the liver and lungs were decoloured. The livers were excised, weighed, collected 
in ice-cold 0.25 M sucrose, sliced and homogenized in 3 volumes ice-cold 0.25 M 
sucrose, using a Potter-Elvehjem glass teflon homogenizer. The cell debris and 
nuclei were removed at a first centrifugal run at 600 g (4°C). Lungs were also 
removed, sliced and homogenized in 5 volumes ice-cold 1.15% KCl in 10 mM 
Tris-HCl/2 mM EDTA and 10% (v/v) glycerol (pH=7.4). An intestinal segment 
consisting of the first 60 cm distal to the pylorus was excised, perfused free of 
intestinal content with an ice-cold isotonic KCl solution containing 0.05 M 
Tris-HCl buffer (pH=7.8), and slit open. The upper villous layer of the mucosa 
was removed by scraping with the edge of a glass slide. Next it was suspended in 
4 ml of Tris-KCl with glycerol (20% v/v) and heparin (3 U/ml). To this 
suspension, trypsin inhibitor (5 mg/g wet weight of small intestine) was added, 
according to Stohs et al. (1976). 
From all tissue homogenates mitochondria were removed by 
centri fugation for 20 min at 9000 g. The floating fat layer was removed and the 
underlying supernatant fraction was decanted and homogenized. The 
post-mitochondrial fraction was centrifuged at 105000 g for 75 min at 4°C. For the 
liver, the pellet was resuspended in ice-cold 1.15% KCl in 10 mM Tris-HCl 
(pH=7.4). The final suspension corresponded to 1 g liver per ml suspension. The 
microsomal pellet of the lungs was resuspended in 10 mM Tris-HCl (pH=7.4), 
according to Boyd et al. (1978). The final suspension corresponded to 2 grams 
tissue per ml. The intestinal microsomes were resuspended to a concentration 
corresponding to 2 g/ml in 10 mM Tris-HCl containing 1.15% (w/w) KCl, 
pH=7.4. 
Microsomes of all organs were distributed in small samples, frozen in 
liquid nitrogen and stored at -80°C until use. 
Assays 
Protein concentrations were determined according to Lowry et al. (1951) using 
bovine serum albumin as the standard. The reduced, СО-bound cytochrome P450 
difference spectra were determined according to Omura & Sato (1964) with 
modifications according to Rutten et al. (1987). 
The frozen microsomes were thawed quickly at 37°C just prior to use. 
Benzo(a)pyrene metabolism was assayed with modifications of the procedure of 
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Yang et al. (1975). The reaction mixture contained 1.9 ml 0.1 M Sörensen buffer 
with NADPH (0.72 mM) and MgCl2.6H20 (3.75 mM), 60 μΐ microsomal 
suspension and 50 μΐ Β(α)Ρ in acetone (100 nmol/ml incubation mixture). After a 
preincubation of two minutes at 37°C and shaking at 110 rpm (Gyrotory Water 
Bath Shaker, New Brunswick Scientific Co, Edison N.J. USA), the incubation was 
started by adding 50 μΐ of B(a)P solution. After 10 (liver) or 20 (lung, intestine) 
minutes the incubation was stopped by the addition of 2 ml acetone. B(a)P and 
metabolites were extracted in 4 ml ethyl acetate. After 30 minutes 3 ml of the 
organic layer was removed and evaporated under nitrogen. The residue was 
dissolved in methanol to a volume of 1.7 ml for liver and 0.5 ml for intestine and 
lung. The samples were kept in vials at -20°C until HPLC analysis. 
Mab inhibition 
Monoclonal antibodies (MAbs) were produced at the US National Cancer 
Institute, Laboratory of Molecular Carcinogenesis using a modification of the 
method of Koehler and Milstein (1975). They were tested and characterized as 
described by Park et al. (1986, 1989) and Ko et al. (1987). In the present study 
four MAbs shown to be specific towards different cytochromes P450s were used 
as follows; clone 1-7-1 to MC-inducible P4501A1, which cross-reacted with 
P4501A2, clones 2-66-3 to PB-inducible P4502B1, which cross-reacted with 
P4502B2, clone 1-91-3 to ethanol-inducible P4502E1 and clone 1-68-11 to 
P4502C11, which cross-reacted with P4502C6 (Nakajima et al, 1991). Antibody 
was added at concentrations of 0, 10, 50 and 100% of the microsomal protein in 
the incubation mixture. Control MAb (Hy-Hel) was used in the same amounts to 
determine any non-specific reaction. MAbs were added to microsomes and 
buffered at room temperature 30 min prior to starting the B(a)P metabolism assay 
at 37°C by adding NADPH and substrate. 
Reversed-phase HPLC analysis and detection ofB(a)P metabolites 
Analyses were performed with a Spectra Physics HPLC (SP8800) equipped with 
two solvent pumps, a solvent programmer and an automatic sampler (SP8775). 
Using a sample loop, a 20 μΐ aliquot was injected onto a 150x4.6 mm ID Nucleosil 
C18 (10 μπι) column. Column temperature was 40°C, flow 1.0 ml per min. The 
following solvent programme was 5 min 90% solvent A (60% aqua pure, 40% 
methanol), a linear gradient to 10% solvent A and 90% solvent В (100% 
methanol) in 40 min followed by 10 min 90% solvent B. 
Fluorescence detection was performed with a Perkin Elmer LS-4 
spectrofluorimeter. The programme for excitation and emission wavelengths 
during each run is given in Table 1. The retention times of 
B(a)P-9,10-dihydrodiol, B(o)P-4,5-dihydrodiol, B(a)P-7,8-dihydrodiol and B(o)P 
were 19, 26, 27 and 43 minutes respectively. The retention times of 
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9-hydroxy-B(a)P and 3-hydroxy-B(a)P were 36.5 and 37.0 ± 0.5 min, 
respectively. Detection limits for 3-hydroxy-B(a)P, B(a)P-4,5-dihydrodiol, 
B(a)P-7,8-dihydrodiol, and B(a)P-9,10-dihydrodiol were 0.05 nmol/ml injected 
volume. For 9-hydroxy-B(a)P it was 0.01 nmol/ml. Quantification was done by 
measuring peak heights and comparing these with a standard range incubated and 
extracted as described for the microsomal incubation samples. 
Time 
(min) 
0 
21 
31 
41 
58 
excitation 
(nm) 
280 
265 
265 
296 
C* 
emission 
(nm) 
406 
405 
430 
407 
С 
metabolites 
detected 
B(a)P-9,10-dihydrodiol 
B(a)P-4,5-dihydrodiol/ 
B(a)P-7,8-dihydrodiol 
3-hydroxy-B(a)P/9-hydroxy-B(a)P 
B(a)P 
Table l Program of Perkin Elmer LS-4 detector 
*End of program, back to position at time=0 
Statistical analysis 
Results are presented as mean values ± standard errors of the mean. Statistical 
analysis was carried out using the SAS (Statistical Analysis System) package on a 
VAX6410 minicomputer. The procedure used was GLM (general linear model) for 
analysis of variance with unequal cells. A p-value <0.05 was considered to be of 
statistical significance. 
With the analysis of variance procedure, it was possible to take more than 
two groups (of rats) and more than one variable (metabolites) into account. The 
procedure was always applied to four groups (male ethanol, male control, female 
ethanol, female control). The number of variables (metabolites) tested in one 
procedure was different for each organ. With the liver samples, each individual 
metabolite was tested for statistical difference between males and females and 
ethanol-treated and control animals. With lung and intestinal samples, all 
metabolites were used in one analysis because only few samples per group were 
obtained. 
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RESULTS 
Liver 
Mean levels of protein and P450 of microsomes from long-term ethanol treated 
male and female rats are shown in Table 2. The protein levels were significantly 
higher in ethanol-treated rats, in both males and females. The levels of P450 are 
significantly higher in males compared to females and in ethanol-treated rats 
compared to non-treated rats. 
Rats 
M 0% ЕЮН 
M 15% ЕЮН 
F 0% EtOH 
F 15% ЕЮН 
η 
6 
6 
6 
6 
protein mg/ml 
±sem 
15.6 ±0.5 
18.1 ±0.9* 
13.5 ±1.2 
21.3 ±0.7* 
P450 nmol/mg prot 
±sem 
0.77 ± 0.03 
1 06 ± 0 06* 
0.65 ± 0.02 
0.74 ± 0.02* 
Table 2. Protein and P450 levels of liver microsomes from 
ethanol-treated and non-treated male (M) and female (F) rats 
n=number of rats sem=standard error of the mean 
* significant difference between ethanol-treated and non-treated 
rats p<0 05 
The rate of formation of B(a)P metabolites after incubation of B(a)P with liver 
microsomes is shown in Table 3. Quantitatively, the most prominent metabolite 
formed was 3-hydroxy-B(a)P: it amounted to 75% of all metabolites. In males, 
B(a)P-9,10-dihydrodiol was 10% of all metabolites and B(a)P-4,5-dihydrodiol, 
B(a)P-7,8-dihydrodiol and 9-hydroxy-B(a)P were each 5% of all metabolites 
measured. In microsomes of female rats 9-hydroxy-B(a)P was the second 
important metabolite formed (10% of all metabolites measured) and the diols each 
amounted to 5% of the metabolite total. Male rats showed significantly higher 
specific B(o)P hydroxylase activity than females either per mg protein or per nmol 
P450 (pO.001). 
Ethanol-treated rats showed a significantly decreased rate of formation of 
3-hydroxy-B(a)P and 9-hydroxy-B(a)P per mg protein in comparison with 
non-treated rats. There is a curious sex-related difference in the mean diol levels. 
Female rats seem to have a higher diol formation rate after ethanol treatment. On 
the contrary, male rats have a lower diol formation rate after ethanol treatment. 
However, these differences were not statistically significant. 
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Metabolite 
3-hydroxy-B(a)P* 
9-hydroxy-B(a)P* 
B(a)P-4,5-dihydrodiol 
B(a)P-7,8-dihydrodiol 
B(a)P-9,10-d¡hydrod¡ol** 
0% EtOH 
males females 
601 ± 47 127 + 9 
23 ± 2 1 4 + 1 
27 ± 3 5 + 1 
42 ± 3 7 + 1 
94 ± 9 9 + 1 
15% EtOH 
males females 
425 ± 27* 9 8 + 4 
20 ± 5* 5 + 0 
25 ± 4 1 1 + 2 
35 ± 1 8 + 0 
73 ± 9 2 1 + 2 
Table 3. Rate of formation of B(o)P metabolites in liver 
microsomes of male and female rats 
Values are pmoL/mg protein/min, means + SEM 
N=6 sem=standard error of the mean 
* significant difference between ethanol-treated and non-treated 
rats, ** significant interaction between ethanol treatment and sex 
p>0 05. 
Lung 
Mean levels of protein and P450 of microsomes from male and female rats after 
long term ethanol treatment are shown in Table 4. There were no significant 
differences in the protein levels nor in the P450 levels (per mg protein) between 
the sexes and between ethanol-treated and non-treated rats. 
Rates of formation of B(a)P metabolites in in vitro experiments with lung 
microsomes are shown in Table 5. Only two samples could be measured in each 
group because of the very small amount of microsomes obtained from one animal. 
Both in males and females, 3-hydroxy-B(a)P comprised 70% of all metabolites 
measured and the diols 9% each. 9-Hydroxy-B(o)P was the least important 
metabolite, about 3% of all metabolites measured. With all metabolites taken 
together in the analysis of variance, no significant difference between males and 
females in the formation rate of B(o)P metabolites was found. No significant 
effect of ethanol treatment was observed either. 
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Rats 
M 0% EtOH 
M 15% EtOH 
F 0% EtOH 
F 15% EtOH 
Π 
2 
2 
2 
2 
protein mg/ml 
±sem 
9 9 ± 1 3 
9 3 ± 1 4 
9.7 ± 0 6 
8 9 ± 0 9 
P450 nmol/mg prot 
± sem 
0 062 ± 0 01 
0 124 ± 0 03 
0 093 ± 0 08 
0 080 ± 0 03 
Table 4 Protein and P450 levels of lung microsomes n=number 
of samples Each sample consisted of pooled lung microsomes of 
5-6 rats sem=standard error of the mean 
Metabolite 
3-hydroxy-B(a)P 
9-hydroxy-B(a)P 
B(a)P-4,5-dihydrodiol 
B(a)P-7,8-dihydrodiol 
B(a)P-9,10-dihydrodiol 
0% EtOH 
male female 
3 55 ± 1 15 3 34 + 016 
0 22 ± 0 04 0 13 + 001 
0 39 ± 0 15 0 34 + 002 
0 51 ± 0 20 0 37 + 0 07 
0 45 ± 0 22 0 37 + 016 
15% EtOH 
male female 
2 89 ± 0 25 2 92 + 0 02 
0 1 3 ± 0 0 1 010 + 000 
0 33 ± 0 02 0 35 + 0 06 
0 47 ± 0 02 0 35 + 0 00 
0 47 ± 0 01 0 26 + 0 07 
Table 5 Rate of formation of B(a)P metabolites in lung 
microsomes of male and female rats 
Number of samples=2 Each sample consisted of pooled lung 
microsomes of 5-6 rats Values are pmol/mg protein/mm, means + 
SEM 
sem=standard error of the mean 
Intestinal epithelium 
Mean levels of protein and P450 of microsomes from male and female rats after 
long-term ethanol treatment are shown in Table 6. Protein Levels were 
significantly decreased in ethanol-treated compared to non-treated rats. There 
were no statistically significant differences between the sexes and between 
ethanol-treated and non-treated rats with respect to the levels of P450 in the 
microsomes of small intestine. 
Both in males and females, 3-hydroxy-B(a)P comprised about 85% of all 
metabolites formed, while the other metabolites amounted to only a few percent 
each Taking all B(cr)P metabolites into account, B(a)P hydroxylation was 
significantly faster in males than in females (p=0.016) and they were significantly 
enhanced by ethanol treatment (p=0.035). These results are presented in Table 7. 
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Rats 
M 0% EtOH 
M 15%ЕЮН 
F 0% EtOH 
F 15% EtOH 
η 
4 
4 
4 
4 
Protein mg/ml 
± serti 
1 6 7 ± 0 9 
10 1 ± 2 6 * 
11 9 ± 0 5 
108 ± 0 8* 
P450 nmol/mg prot 
±sem 
0 068 ± 0 01 
0 085 ± 0 02 
0 070 ± 0 01 
0 053 ± 0 01 
Table 6 Protein and P450 levels of microsomes of small intestine 
n=amount of samples Each sample consisted of pooled intestinal 
microsomes of 2-3 rats 
sem=standard error of the mean 
* significant difference between ethanol-treated and non-treated 
rats p>0 05 
Metabolite 
3-hydroxy-B(a)P 
9-hydroxy-B(a)P 
B(a)P-4,5-dihydrodiol 
B(a)P-7,8-dihydrodiol 
B(a)P-9,10-dihydrodiol 
0% EtOH 
male female 
8 39 ± 1 27 6 70 + 1 08 
0 95 ± 0 16 0 9 1 + 0 1 2 
0 49 ± 0 14 0 45 + 009 
0 42 ± 0 07 0 20 + 0 05 
0 09 ± 0 05 0 03 + 0 03 
15% EtOH 
male female 
12 47 ± 1 3 0 8 00 + 220 
148 ± 0 12 106 + 017 
0 7 0 ± 0 1 5 0 6 1 + 0 1 0 
0 44 ± 0 23 0 16 + 009 
0 14 ± 0 08 0 03 + 003 
Table 7 Rate of formation of B(a)P metabolites m microsomes of 
small intestine of male and female rats 
Values are pmol/mg protein/mm, means + SEM 
Number of samples=4 Each sample consisted of pooled intestinal 
microsomes of 2-3 rats sem=standard error of the mean 
Significant difference between ethanol-treated and non-treated rats 
ρ < 0 05 for all metabolites 
Inhibition ofB(a)P metabolism by Monoclonal Antibodies 
In Table 8, the inhibition of B(a)P metabolite formation by MAb 1-68-11 
(anti-P4502Cll) is shown. The formation of all B(a)P metabolites was 
significantly inhibited. MAbs 1-7-1 (anti-P4501Al), 1-91-3 (anti-P4502El) and 
2-66-3 (anti-P4502Bl) did not inhibit the formation of B(o)P metabolites or only 
to a minor extent (data not shown). The residual activity of B(a)P hydroxylase 
after inhibition with MAb 1-68-11 differed considerably, depending on the 
metabolite measured. The formation of B(a)P-9.10-dihydrodiol was reduced to 
17% of the initial value, whereas the formation of B(a)P-4,5-dihydrodiol was 
reduced only to 79%. For 3-hydroxy-B(cr)P, B(e7)P-4,5-dihydrodiol and 
In vitro biotransformation ofB(a)P · 125 
B(a)P-7,8-dihydrodiol there was a significant difference in residual activity 
between ethanol-treated and non-treated rats when the amount of MAb protein in 
the incubation mixture was 50% of the amount of microsomal protein. The 
remaining activity was significantly higher in ethanol-treated rats. 
Treatment 
0% 
ЕЮ H 
15% 
ЕЮ H 
Metabolites' 
3-hydroxy-B(a)P 
9-hydroxy-B(a)P 
B(a)P-4,5-dihydrodiol 
B(a)P-7,8-dihydrodiol 
B(a)P-9,10-dihydrodiot 
3-hydroxy-B(a)P 
9-hydroxy-B(a)P 
B(a)P-4,5-dihydrodiol 
B(a)P-7,8-dihydrodio< 
B(a)P-9,10-dihydrodiol 
1-68-11(P450IIC11/6) 
(nmol/mg protein/min) 
0% 50% 100% 
1 460 ± 0 203 (100) 
0 013 ± 0 002 (100) 
0 024 ± 0 001 (100) 
0 052 ± 0 004 (100) 
0 126 ± 0 018 (100) 
1 240 ± 0 022 (100) 
0 015 ± 0 001 (100) 
0 026 ± 0 003 (100) 
0 054 ± 0 001 (100) 
0 1 3 2 ± 0 007 (100) 
0 435 ± 0 1 4 2 (46) 
0 006 ± 0 (42) 
0 018 ± 0 002 (75) 
0 0 2 5 1 0 002 (49) 
0 022 ± 0 001 (17) 
0 627 ± 0 0 1 Г (84) 
0 008 ± 0 (54) 
0 026 ± 0 · (87) 
0 042 ± 0 0 0 Г (67) 
0 034 ± 0 003 (26) 
0 435 ± 0 142 (31) 
0 006 ± 0 (43) 
0 018 ± 0 001 (75) 
0 021 ± 0 002 (40) 
0 0 2 2 ± 0 (17) 
0 4 7 2 1 0 207 (38) 
0 007 ± 0 001 (45) 
0 020 ± 0 006 (79) 
0 023 ± 0 003 (42) 
0 031 ± 0 006 (23) 
Table 8 Inhibition of B(o)P metabolite formation by MAb m 
microsomes of male Wistar rat liver 
Values are means of two rat liver samples + SEM 
In parenthesis the percentage of remaining activity after 
incubation with the antibody is shown, expressed as (activity with 
MAb/activity with Hy-Hel) χ 100 
* Significantly different from non-ethanol pretreated rats p>0 05 
DISCUSSION 
Microsomes from liver, lung and small intestine from male and female rats were 
used to estimate the effect of ethanol consumption on the biotransformation of 
Β(σ)Ρ. 
Quantitatively, the most important metabolite formed in all organs, 
3-hydroxy-B(a)P, reached up to 70-85% of all metabolites measured. Other 
authors quoted only 36% in liver microsomes from Sprague Dawley rats (Yang et 
al, 1975) and 10% in intestinal microsomes from Wistar rats (Gower & Wills, 
1986). In earlier studies in vivo, we found 95% of all excreted metabolites in urine 
and feces to be 3-hydroxy-B(a)P (van de Wiel et al., 1993). This percentage is in 
agreement with our present results in vitro. The second most important metabolite 
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was different in liver, lung and small intestine. In intestinal microsomes, 
9-hydroxy-B(a)P was the second important metabolite. In lung microsomes it was 
B(a)P-7,8-dihydrodiol and in liver microsomes B(a)P-9,10-dihydrodiol. 
There were large differences in microsomal activity between the three 
organs. In liver B(a)P hydroxylase activity was about 600 pmol/mg protein per 
minute. In lung, we found 3 pmol/mg protein per minute. In the small intestine it 
was 10 pmol/mg protein per minute. The different rates of metabolic activity 
found in these organs are in agreement with the results of other investigators 
(Benford & Bridges, 1983). 
Benford and Bridges (1983) found almost equal values in liver and small 
intestine of male Wistar rats. Only in lung microsomes they found higher activity 
than we did, about the same as in the small intestine. 
In vivo we measured sex differences with respect to 3-hydroxy-B(a)P 
excretion in urine and feces; the excretion in males was significantly higher than 
in female rats. This in fact was reproduced in the present experiments in vitro, 
especially in liver and intestinal microsomes. 9-Hydroxy-B(a)P showed no 
significant sex related difference in vivo, and no sex related difference in liver 
microsomes either. In the organs investigated in this study, males generally 
showed higher activity than females. Blanck et al. (1986) showed that oxidative 
pathways of B(a)P biotransformation are controlled by pituitary hormones in a 
way similar to the rat-liver metabolism of steroids. The results of Yamazoe et al. 
(1986) indicate that the concentration of P450-male (P4502C11) in liver 
microsomes correlates with B(o)P hydroxylation activity and that both could be 
regulated by the serum growth hormone level. Gurtoo and Parker (1977) showed a 
sex related difference with a factor 6 for АНН activity in liver microsomes of 
Wistar rats and no sex related difference in lung microsomes. We found a sex 
related difference, with a factor of 2-5 for formation of diols and phenols in liver 
microsomes, no difference in lung microsomes and a small difference in 
microsomes of the small intestine. Gurtoo and Parker (1977) suggest an organ 
specificity for sex dependent regulation of microsomal mixed function oxydase 
activity. Direct evidence concerning the participation of the male specific isozyme 
in B(a)P biotransformation was provided by Todorovic et al. (1991). These 
authors inhibited microsomal B(a)P metabolising activity using an antibody to 
P4502C11, a male specific isozyme. Using the same antibody we were able to 
inhibit 21-83% of the microsomal B(a)P metabolism, depending on the metabolite 
measured. Like Todorovic et al. (1991), we also measured the greatest inhibitory 
effect of Mab 1-68-11 on formation of B(a)P-9,10-dihydrodiol (83%) and the least 
inhibitory effect on formation of B(a)P-4,5-dihydrodiol (25%). We also found 
considerable inhibition in the formation of the phenolic B(a)P metabolites, 54 and 
58% for 3-hydroxy-B(a)P and 9-hydroxy-B(a)P, respectively. Todorovic et al. 
measured only 25%. In Sprague Dawley rats the amount of sex specific enzymes 
as constitutive forms of P450 is 20-25% of total P450 (Kamataki et al., 1983, 
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1986) Probably, P4502C11 plays an important role m Β(α)Ρ biotransformation in 
uninduced, as well as in ethanol-treated rats This is largely different from rats that 
are treated with the 'classic' inducers 3-methylcholanthrene (3-MC) and Aroclor 
1254 3-MC induces P4501A1 that largely metabolises B(a)P 
The effect of ethanol treatment was different m the three organs In liver 
the B(a)P biotransformation was significantly decreased for the formation of the 
phenols 9-hydroxy-B(a)P and 3-hydroxy-B(a)P. For other P450 mducers like 
phénobarbital, 3-methylcholanthrene or PCB's it is known that they leave the sex 
specific P450 isozymes unaffected or depress them (Wortelboer et al, 1991, 
Wiebel & Gelboin, 1975) This also seems to be true for ethanol When using 
antibodies to P4502C11/6, the percentage remaining activity of B(a)P metabolite 
formation was significantly higher m ethanol-treated, compared to control rats 
This confirmed the down-regulating influence of ethanol on sex specific P450 
isozyme activity and consequently on Β(σ)Ρ biotransformation In the lung also, a 
decrease m Β(σ)Ρ metabolism was observed, but not a significant one In small 
intestine, a significant mcrease m the metabolism of B(a)P was seen An increase 
m Β(α)Ρ biotransformation in small intestine was also decnbed by Seitz et al 
(1978) For the human situation, combmed exposure to alcohol and PAH often 
occurs It should be realized that ethanol induction could have implications with 
respect to an altered biologically effective dose of mutagemc/ carcinogenic PAH 
metabolites m several organs 
In conclusion, we found differences between the sexes in the ¡n vitro 
biotransformation of B(a)P m agreement with our studies m vivo Males m general 
have a greater metabolising capacity for B(a)P than females The influence of 
ethanol treatment on B(a)P biotransformation is different for each organ, but m 
liver the formation of phenolic metabolites is significantly decreased Most 
probably, m the liver a sex specific isozyme of P450 (P4502C11) is mvolved m 
the biotransformation of B(a)P This isozyme is depressed by ethanol treatment 
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ABSTRACT 
The influence of long-term ethanol consumption of rats on liver enzymes that 
could be involved in the biotransformation of benzo(a)pyrene [B(a)P] has been 
studied. Male and female Wistar rats received an increasing amount of ethanol in 
their drinking water up to 15% (w/v) in 3 weeks. The ethanol content was kept at a 
concentration of 15% for another 3 weeks. One group of rats also received B(a)P 
in the last week of the ethanol treatment. Livers were isolated and microsomal and 
cytosolic fractions were prepared. In every enzyme measurement sex differences 
were observed. Long-term ethanol consumption induced P450, especially aniline 
4-hydroxylase (P4502E1). However, testosterone 6ß-hydroxylase (P4503A2 and 
P4502C13) in males and testosterone 12ß-hydroxylase in females were decreased. 
The phase 2 enzymes glutathione S-transferase (subunit 1) and epoxide hydrolase 
were also decreased in their activity. Our results support the hypothesis that the 
effect of long-term ethanol consumption on B(a)P biotransformation as found in m 
vivo and m vitro studies, consisting of lowered formation of phenolic and diolic 
metabolites, is the result of a decrease of constitutive P450 isoenzymes. 
INTRODUCTION 
Ethanol acts as an inducer of the monooxygenase-linked cytochrome P450 
complex (Johansson et al., 1988; Koop & Coon, 1986; Lieber et al., 1968; Onishi 
& Lieber, 1977). Therefore, it is conceivable that the cancer risk due to 
compounds that are bioactivated into electrophilic intermediates by 
monooxygenase activity can be increased (Lieber, 1990). An increased incidence 
of cancer has been found in alcoholics (Tuyns, 1990). Alcohol use and smoking 
leads to a more than additional cancer risk for organs of the upper intestinal and 
respiratory tract (Wynder et al., 1957, 1961). Cigarette smoke contains polycyclic 
aromatic hydrocarbons (PAH), a widespread group of environmental 
contaminants. Some of them are mutagenic and carcinogenic such as 
benzo(a)pyrene [B(a)P]. This compound has to be activated by the 
monooxygenase system in order to become electrophilic. 
Earlier, we studied the pharmacokinetics of this compound in rats after 
long-term ethanol treatment (van de Wiel et al., 1993). In vivo, after one dose of 
Β(α)Ρ the excretion of phenolic metabolites was significantly decreased in urine 
and feces of ethanol-treated rats compared to controls. Although not significantly, 
the excretion of diols was also decreased. This was observed for both male and 
female rats. The decreased formation of these B(a)P metabolites was confirmed in 
an in vitro study using liver microsomal fractions (van de Wiel et ai, 1992). The 
results suggest that the effect of ethanol treatment on metabolite excretion levels 
measured in vivo is caused by changes in the biotransformation. 
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In the literature, data about effects of ethanol treatment on benzo(a)pyrene 
biotransformation seem to be conflicting. Benzo(a)pyrene hydroxylation has been 
reported to be increased in rat liver microsomal preparations after chronic ethanol 
feeding (Rubin & Lieber, 1968; Seitz et al, 1978) but to be decreased in mouse 
liver microsomal preparations (Capei et al., 1978). 
Much heterogeneity exists among the hepatic monooxygenases. Ethanol 
induces specific forms of P450; P4502E1 and P4502B1 and P4502B2 (Johansson 
et al., 1988). Purified rat P4502E1 has no significant activity towards 
benzo(a)pyrene (Ryan et al, 1985). Benzo(a)pyrene is known to be a good 
substrate for P4501A1, but also for the sex-specific isoenzymes P4502C11 and 
P4503A2 (Kobliakov et al, 1991). In the present study, the influence of long-term 
ethanol treatment on biotransformation capacity is monitored by measuring the 
metabolism of several substrates indicative for certain isoenzymes of P450. 
We have used the same protocol of ethanol induction as applied in our in 
vivo and in vitro studies (van de Wiel, 1992, 1993). Male and female rats were 
used to observe possible sex differences. One group of rats was treated with 
ethanol and B(o)P simultaneously to study the effect of long term exposure to both 
inducers on the biotransformation of B(a)P. 
Ethoxyresorufin O-deethylase is measured as an indicator enzyme for the 
activity of P4501A1. The increase in aniline hydroxylation is used as a marker for 
ethanol-dependent increases in P450 mediated metabolism (Koop & Coon, 1986). 
This represents the activity of the isoenzyme P4502E1 (Johansson el al, 1988). 
Pentoxyresorufin O-deethylase (PROD) activity is used as a marker for 
P4502B1/P4502B2 isoenzymes. Testosterone metabolism can be correlated with 
the sex specific isoenzymes. In males 2a- and 16a-hydroxy-testosterone (OHT) 
activity corresponds with P4502C11, 6B-OHT activity with P4503A2 and 
P4502C13 and 15a- and 7B-OHT activity with P4502A2 (Kobliakov et al, 1991). 
Besides P450 coupled biotransformation activities, glutathione S-transferase 
activity and subunit composition were studied because of the important role this 
enzyme plays in the detoxification of reactive B(a)P metabolites. For the same 
reason epoxide hydrolase was monitored. 
METHODS 
Chemicals 
Ethanol used for the treatment was Ethanol absolute GR, supplied by Merck 
(Darmstadt, Germany). Resorufin was obtained from Aldrich (Brussels, Belgium). 
Ethoxyresorufin and pentoxyresorufin were from Boehringer (Mannheim, 
Germany). l-C¡oro-2,4-dinitrobenzene was from Sigma (St Louis, MO, USA) and 
styrene oxide was obtained from Fluka (Buchs, Switzerland). Testosterone, 
androstenedione, and the hydroxytestosterone (OHT) metabolites (2a-OHT, 
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7α-0ΗΤ, 16α-0ΗΤ, 6Β-0ΗΤ, 1 lß-OHT, 16Β-ΟΗΤ and 19-OHT) were a gift from 
Dr. Heleen Wortelboer, RITOX Institute, Utrecht, the Netherlands. All other 
chemicals were of analytical grade, obtained from local commercial sources and 
used without further purification. 
Animals 
Homebred Cpb:WU (Wistar) rats of both sexes were used. Initial weights varied 
between 100-120 g (females) and 120-150 g (males). The age of the rats was about 
6 weeks at the beginning of the experiments and 12 weeks at the end. The animals 
were of Specified Pathogen Free quality. Antibodies against the pneumonia virus 
of mice and the pin-worm Syphacia muris but against no other pathogens were 
found. The animals were kept in Macrolon type 3 cages on sterilized softwood 
granules as bedding. The animals were housed three per cage. 
The animals were provided with RMH-TM pellets (Hope Farms b.v. 
Woerden, The Netherlands). The rats had free access to water with an increasing 
ethanol content reaching up to 15% w/v after 6 weeks. Details of the method of 
alcohol exposure are described in van de Wiel et al. (1990). Room temperature 
was regulated (22 ± 2°C); relative humidity varied between 40 and 60%. The 
animals were exposed to artificial light between 7.00 a.m. and 7.00 p.m.. Series of 
12, 20 or 24 rats were used. Each series was divided in four groups: male alcohol 
rats, male control rats, female alcohol rats, female control rats. 
One group of rats was orally treated with B(a)P in the last week of 
ethanol treatment. They received 5 mg Β(α)Ρ per kg bodyweight daily (in olive 
oil), or olive oil only, during 7 days. 
Preparation of microsomes 
Six weeks after the start of the alcohol treatment, the rats were anaesthetized with 
pentobarbital and the livers were perfused in situ with ice-cold 0.9% NaCl 
solution. The livers were excised, weighed, collected in ice-cold 0.25 M sucrose, 
sliced and homogenized in 3 volumes ice-cold 0.25 M sucrose using a 
Potter-Elvehjem glass teflon homogenizer. The cell debris and nuclei were 
removed at a first centrifugal run at 600g in a Heraeus Christ minifuge (Gonzalez 
et al, 1988) and mitochondria were removed by centrifugation for 20 min at 
9000g in an IEC B20. The floating fat layer was removed and the underlying 
supernatant fraction decanted and homogenized. The post-mitochondrial fraction 
was centrifuged at 105000g for 75 min at 0-4°C in an IEC B50 ultracentrifuge. 
The pellet was resuspended in ice-cold 1.15% KCL, the volume adjusted to the 
original liver weight. The suspension was distributed in samples of 1 ml in small 
plastic vials, frozen in liquid nitrogen and stored at -80°C until use. 
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Enzyme measurements 
Cytochrome P450 and protein content. Spectral analysis for cytochrome P450 
content was performed according to the standard procedure (Rutten et al, 1987). 
Protein concentrations of the samples were determined using the method of Lowry 
et al. (1951) with bovine serum albumin (fraction V Boehringer) as the protein 
standard. 
Aniline-4-hydroxylase (An-4-H) was determined with a modified method based on 
Ishidate et al. (1978). The reaction mixture contained 10 mM aniline, 0.5 mM 
NADP, 5 mM glucose-6-phosphate, 5 mM MgCl2, 1 unit glucose-6-phosphate 
dehydrogenase, 10 mM nicotinamide, 100 mM tris-acetatebuffer of pH 7.9 and 
100 μΐ microsomes in a final volume of 1 ml. The reaction was carried out for 20 
minutes at 37°C with moderate shaking and stopped by addition of 0.5 ml 20% 
ice-cold trichloroacetic acid. After centrifuging for 5 min at 800g, a 1 ml aliquot 
of the supernatant was taken out and 0.5 ml 10% NajCOj was added, followed by 
I ml of 2% phenol in 0.2 N NaOH. The resulting blue color was measured at 630 
run after 30 minutes. 
Ethoxyresorufin O-deethylase (EROD) and pentoxyresorufin O-deethylase 
(PROD) were measured as described by Burke et al. (1985). 
Testosterone hydroxylation. Determinations in microsomal preparations were 
carried out in a 1 ml incubation mixture containing potassium phosphate buffer 
(50mM, pH 7.4), MgCl2 (3 mM), EDTA (ImM), NADP+ (ImM), 
glucose-6-phosphate (5mM), glucose-6-phosphate dehydrogenase (1 unit/ml), 
testosterone (250 μΜ) and 200-300 μg microsomal protein. Incubation mixture 
and microsomes were mixed in an ice-cooled container. Reactions were started by 
heating the mixture in a 37°C shaking water bath and stopped after 15 min by 
addition of 6 ml dichloromethane. Extraction and subsequent analysis of 
metabolites by HPLC were performed as described by Wortelboer et al. (1990). 
II ß-OHT was used as internal standard. 
Glutathione S-transferase (GST). Quantification of glutathione S-transferases was 
performed as described by Bogaards et al. (1989). In short, liver cytosol (1 ml) 
was applied on S-hexylglutathione affinity chromatography columns. The eluate, 
containing the GST-isoenzymes, was applied to wide pore-reversed phase HPLC 
(Vydac 201TP5 (200 X 3 mm d.d.), which was eluted with a gradient of water and 
acetonitrile both containing 0.1 % trifiuoroacetic acid. The GST subunits, eluting 
as discrete peaks were quantified by peak area integration and comparison with 
known amounts of purified GST isoenzymes. Enzymatic activities were 
determined using l-chloro-2,4-dinitrobenzene as substrate, according to Habig et 
al. (1974). 
Epoxide hydrolase. The activity of epoxide hydrolase, performed by the addition 
of water to 1,2-epoxyethylbenzene (styrene oxide), was quantified by measuring 
the concentration of the produced phenylglycol (1-phenyl-1,2-ethandiol), 
according to Splinter et al. (1990). 
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Statistical analysis 
Results are presented as mean values ± standard deviation. Statistical analysis 
was carried out using the Statistical Analysis System package on a VAX6410 
minicomputer The procedure used was general linear model for analysis of 
variance with unequal cells A P-value <0.05 was considered to be of statistical 
significance With the analysis of variance procedure, it was possible to take four 
groups of rats into account (male ethanol, male control, female ethanol, female 
control) 
RESULTS 
The rats consuming drinking water containing up to 15% ethanol during six weeks 
showed a significant (P = 0.008) increase in microsomal P-450 content (nmol/mg 
protein) (Table 1) For male rats there was an increase of 38% and for females an 
increase of 14% due to the alcohol treatment. This increase enhanced the existing 
sex difference m P450 between males and females (P = 0 0001) Protein 
concentrations also showed a significant increase after ethanol treatment (P < 
0 0001) No significant sex differences were observed (Table 1) 
Rats 
M 0% ЕЮН 
F 15% ЕЮН 
M 0% EtOH 
F 15% ЕЮН 
η 
6 
6 
6 
6 
Protein 
(mg/ml) 
±sd 
15 6 ± 1 2 
18 0 ± 2 2* 
1 3 5 ± 3 0 
21 3 ± 1 7* 
P450 
(nmol/mg protein) 
±sd 
0 77 ± 0 07 
1 06 ± 0 13* 
0 65 ± 0 05 ** 
0 74 ± 0 04* ** 
Table 1 Effect of ethanol treatment on hepatic protein and 
cytochrome P450 content in liver microsomes from male and 
female rats 
* Value significantly different for ethanol treated and non-treated 
rats 
**Value significantly different for male and female rats 
Aniline hydroxylase activity was increased significantly in ethanol treated rats 
(Table 2). In male rats the increase was 57% and in female rats 38%. This епгуте 
activity also differed significantly (P = 0.001) between both sexes. 
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Rats 
M 0% ЕЮН 
M 15% ЕЮН 
F 0% ЕЮН 
F 15% ЕЮН 
η 
5 
5 
5 
5 
ρ -aminophenol formed 
(nmol/minxmg protein) ± sd 
0 65 ± 0 1 0 
1 02 ± 0 24* 
0 48 ± 0 03 ** 
0 66 ± 0 12*** 
• 
Table 2 Effect of ethanol treatment on aniline-4-hydroxylase 
activity in liver microsomes from male and female rats * Value 
significantly different for ethanol treated and non-treated rats 
** Value significantly different for male and female rats 
Ethanol treatment affected neither EROD, nor PROD activity of male and female 
rats (Table 3) After treatment with B(a)P, with or without ethanol, EROD activity 
was enhanced by a factor six 
Rats 
M 0% ЕЮН 
M 15% ЕЮН 
M ЕЮН+В(а)Р 
F 0% ЕЮН 
F 15% ЕЮН 
F ЕЮН+В(а)Р 
η 
5 
5 
3 
4 
4 
3 
EROD 
(nmol/minx 
mg protein)± sd 
0 20 ± 0 08 
0 25 ± 0 10 
1 42 ± 0 26*** 
0 21 ± 0 07 
0 20 ± 0 01 
1 15 ± 0 18*** 
PROD 
(nmol/minx 
mg protein)± sd 
0 069± 0 01 
0 065± 0 02 
0 049± 0 01** 
0 052± 0 01 
Table 3 Effect of ethanol treatment on ethoxyresorufin 
O-deethylase (EROD) and pentoxyresorufin O-deethylase 
(PROD) activity in liver microsomes from male and female rats 
** Value significantly different for male and female rats 
»••Values significantly different for B(a)P treated rats 
In males, the formation of 6ß-hydroxytestosterone (6B-OHT) was decreased by 
25% after ethanol treatment In females, 12B-OHT was significantly decreased to 
50% of the initial value With all metabolites, except for 15B-OHT and 19-OHT, 
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differences between the sexes were observed (Table 4) In males 6B-OHT, 
16a-OHT, 16B-OHT, 2a-OHT and androstenedione were formed in larger 
quantities In females the formation of 19-OHT, 7a-OHT and 12B-OHT was 
greater than in males 
Rats (n=5) 
testosteron 
metabolite 
(μπιοΙ/minx 
mg protein) 
±sd 
15S-OHT 
6S-OHT 
19-OHT 
7<x-OHT 
16a-OHT 
16U-OHT 
12Q-OHT 
2a-OHT 
androstene­
dione 
M 0% BOH 
0 02±0 00 
0 28±0 06 
0 81±0 11 
0 12±0 01 
1 34±0 18 
0 02±0 00 
0 00 
14 3±2 15 
0 60±0 07 
M 15%ЕЮН 
0 02±0 01 
0 21 ±0 04* 
0 65±0 22 
014±0 02 
1 35±0 34 
0 02±0 01 
0 00 
15 1±3 42 
0 61±0 11 
F 0%EtOH 
0 02±0 00 
0 02±0 0 0 " 
1 12±0 23 
0 33±0 0 3 " 
0 00 ** 
0 01 ±0 0 0 " 
2 72±1 0 0 " 
0 00 " 
0 08±0 0 0 " 
F 15%EtOH 
0 03±0 01 
0 02±0 01 
0 82±0 49 
0 36±0 08 
0 01 ±0 00 
0 01 ±0 00 
1 46±0 29* 
0 00 
0 09±0 03 
Table 4 Effect of ethanol treatment on testosterone hydroxylase 
activities (|jmol/minxmg protein) in liver microsomes from male 
and female rats "Value significantly différent for ethanol-treated 
and non-treated rats ** Value significantly different for male and 
female rats 
Using CDNB as a substrate, we found the activity of glutathione S-transferase to 
be significantly higher m male than in female rats. No influence of ethanol 
treatment could be detected (Table 5). When the amounts of the different 
glutathione S-transferase subunits were measured, we generally observed a slight 
decrease in the ethanol-treated groups Subunit 1 was significantly decreased after 
ethanol treatment with 20% in males and 27% in females (P = 0 048) (Table 5) 
Although the total amount of GST per mg protein did not differ significantly 
between the sexes, several subunits did. Subunits 1,3 and 4 were found at higher 
levels in males, suburut 2 in females. 
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Rats (n=3) 
CDNB 
(μΓηοΙ/minx 
mg protein) ± sd 
subunit GST 
(цд subunit/ 
mg protein) ± sd 
1 
2 
3 
4 
6 
total 
M 0% EtOH 
11.9±0 9 
10.8±2.9 
11 0±2 1 
5 3±1 3 
4 1±1 1 
0 2±0.1 
31.5±7 3 
M 15% EtOH 
10 6±1.1 
8 5±1 6* 
11.0±1 0 
4 9±0 0 
3 6±0 2 
0 2±0 1 
28 1 ±1.9 
F 0%EtOH 
10.0±1 2 " 
8.5±1 2** 
22 3±0 7** 
2 2±0 2** 
2.3±0 4 " 
0.3±0 1 
35.5±1 3 
F 15% EtOH 
9 5±0 5 
6 2±0.7* 
19 3±2 3 
2 0±0.1 
2.1±0 1 
0 2±0 1 
29.9±3 0 
Table 5 Effect of ethanol treatment on total glutathione 
S-transferase (GST) activity (CDNB as substrate) and subunit 
composition of glutathione transferase in liver cytosol from male 
and female rats *Value significantly different for ethanol treated 
and non-treated rats ** Value significantly different for male and 
female rats 
Epoxide hydrolase was measured in rat liver cytosol and in rat liver microsomes 
(Table 6). Cytosolic epoxide hydrolase activity was not influenced by ethanol 
treatment Microsomal epoxide hydrolase was significantly decreased to 70% of 
its initial value after ethanol treatment (P < 0.0001) in male and female rats. In 
liver microsomes, there was also a significant difference between the sexes, males 
showing a 20% higher activity than females (P < 0.001). 
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Rats 
M 0% EtOH 
M 15% EtOH 
F 0% EtOH 
F 15% EtOH 
η 
5 
5 
5 
5 
phenylglycol formed (nmol/minx 
mg protein) ± sd 
cytosolic microsomal 
1 5±0 1 9 8±1 0 
1 3±0 1 6 8±0 9* 
1.4±0 2 7 4±0 9 " 
1 4±0 2 5 3±0 7* 
Table 6 Effect of ethanol treatment on epoxide hydrolase activity 
in liver microsomes and cytosol from male and female rats 
*Value significantly different for ethanol treated and non-treated 
rats ** Value significantly different for male and female rats 
DISCUSSION 
Biotransformation enzymes were measured in liver fractions from male and 
female rats to estimate whether the effects observed earlier of ethanol 
consumption on the pharmacokinetics and the biotransformation of B(a)P could be 
explained. 
So far, most studies on the effects of ethanol treatment focused either on 
changes in liver morphology and function as in alcoholists (Lieber, 1984), or on 
the inducing capacity of ethanol on specific isoenzymes of P450 (Koop & Coon, 
1986). We have measured the influence of ethanol treatment on a broad spectrum 
of enzymes that could be involved in or associated with the biotransformation of 
benzo(a)pyrene. In our ethanol treatment model the animals consume a moderate 
amount of ethanol. As we described earlier, this does not lead to considerable liver 
damage Also the growth of the rats is not significantly influenced (van de Wiel, 
1990). Our treatment, comparable in the last three weeks to the intake in human 
'social' drinking (Zentella de Pina et al., 1989) leads to an increase of P450 content 
This increase can be largely attributed to a rising amount of P4502E1 (Koop & 
Coon, 1986), and is measured as a maximal two-fold increase in 
aniline-4-hydroxylase activity as was also described by Liu et al. (1975) and 
Prasad et al. (1985). 
EROD activity was not changed after ethanol treatment This activity is 
associated with P4501A1, so there are no indications for a change in P4501A1 
activity. However, when several doses of B(a)P were given, with or without 
ethanol, the inducing effect of B(a)P was clear and EROD activity increased with 
a factor six. 
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PROD (P4502B1/2B2) activity was not changed by ethanol treatment as was 
described for other specific P4502E1 inducers. After treatment of rats with 
acetone, Puccini et al. (1989) found no effect on PROD activity. 
Testosterone metabolism is differentially influenced by ethanol treatment. 
A 25% decrease in the formation of 6B-OHT was measured in males, representing 
the activity of the male specific P450's 3A2 and 2C13. In females, 12B-OHT was 
lowered to 50% of the initial value. In non-induced rats, the constitutive 
sex-specific enzymes (Kato et ai, 1986; van de Wiel et al, 1992) and not 
P4501A1 (Thomas et ai, 1981) are probably responsible for most of the B(a)P 
biotransformation activity. We also observed this in our in vitro study (van de 
Wiel et ai, 1992). Sex differences in testosterone metabolism were described by 
Kobliakov (1991). He found 16α-ΟΗΤ and 6B-OHT formation to be higher in 
males. We found five of the nine testosterone metabolites formed in larger 
amounts in males than in females. In females two metabolites were higher than in 
males. 
The phase II enzymes which are important in B(a)P biotransformation, 
glutathione S-transferase and epoxide hydrolase, were both affected by ethanol 
treatment. Gonzalez (1988) measured a decrease of GST and GSH after acute 
ethanol treatment. Other authors reported that GST and GSH maximally increased 
after 2 weeks of ethanol treatment and did not differ from the controls from 6 
weeks onward (Mierha Yang & Carlson, 1991; Muñoz et ai, 1987). In our 
experiments the total activity of GST was decreased, but not significantly. The 
amount of subunit 1 of GST was significantly decreased in males and females, 
whereas the other remained unchanged. Up to now at least eight GST subunits 
have been identified and characterized. On the basis of their primary structure, 
they belong to 4 gene families, namely the alpha family (subunits 1,2 and 8), the 
mu family (subunits 3,4 and 6), the theta family (subunit 5) and the pi family 
(subunit 7). The pi family (GST 7-7) was described to be the most important 
enzyme in conjugating anti-BPDE (7ß,8a-dihydroxy-9a,10a-epoxy-
7,8,9, lO-tetrahydro-benzo(a)pyrene) and other electrophilic metabolites of 
benz(a)anthracene and chrysene (Jemström et ai, 1989). In that case a reduction 
in subunit 1 should have little impact on the amount of anti-BPDE conjugated. 
The relative proportion of subunit composition of GST between adult male and 
female rats found by us was the same as described by Igarachi (1987). 
Epoxide hydrolase (EH) catalyzes the formation of diols from 
B(a)P-epoxides and the formation of tetrols from B(a)P-dihydrodiolepoxides. 
Epoxide hydrolase activity was decreased considerably by ethanol treatment. In in 
vivo and in vitro studies we earlier observed a decreased formation/excretion of 
B(a)P phenol and diol metabolites (9-hydroxy-B(a)P, 9-hydroxy-B(a)P, 
B(a)P-4,5-dihydrodiol, B(a)P-7,8-dihydrodiol, B(a)P-9,10-dihydrodiol (van de 
Wiel et ai, 1992; van de Wiel et ai, 1993). In a study by Selkirk (1975), 
inhibition of epoxide hydrolase was correlated with an increase of phenol 
142 · Long-term ethanol treatment 
metabolites, while diols disappeared The decrease in EH activity measured m our 
present study therefore cannot be the source of a decreased formation of both 
phenols and diols. However, it is conceivable that this could have an effect on the 
amount of reactive anti-BPDE formed. 
We practised a mild induction with a moderate amount of ethanol in the 
drinking water, comparable with 'social' drinking in humans. This caused moderate 
effects on the biotranformation enzymes. Increases and decreases in activity varied 
from 20-50%. However, these small effects on enzyme activity could have large 
consequences on bioactivation of compounds like B(a)P. 
The differences we found earlier in excretion of B(a)P metabolites 
between ethanol and control rats can be linked to the enzyme measurements that 
are described in this paper. Bioactivation of B(a)P seems to be lowered after 
ethanol induction The meaning of this kind of observations for the human 
situation is not fully clear In our rat studies no evidence is obtained to support the 
possibility of enhanced bioactivation of B(a)P due to chronic alcohol use as a 
mechanism to enhance the risk of alcohol consuming people to develop cancer 
(IARC, 1988). There have been several suggestions about this (Lieber, 1984) 
Nevertheless no significant differences in АНН activity were measured in human 
liver samples of people that consumed alcohol or not (Rubin & Lieber, 1968) A 
change in phase II metabolism, for instance a decrease in epoxide hydrolase 
activity could be important. 
In conclusion, it was shown in rats that long-term ethanol treatment 
induces 2E1, and does not alter 1A1 or 2B1/2B2 Reduction of 2C13 and 3A2 
related activity is observed. This correlates with the lowered formation/excretion 
of certain B(a)P phenol and diol metabolites after long-term ethanol treatment 
observed in vivo and m vitro in our earlier work. A considerable reduction of 
epoxide hydrolase was also measured 
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ABSTRACT 
The influence of long-term ethanol exposure of rats on the formation of 
benzo(a)pyrene [B(a)P]-DNA adducts in rat liver and intestinal epithelial cells has 
been studied. One group of rats had free access to tap water without ethanol, the 
other group received tap water with an ethanol content increasing from 0 to 15% 
over 3 weeks, and kept at 15% for another 3 weeks. Rats of both groups were 
treated with a single dose of Β(σ)Ρ by gavage (50 mg/kg bodyweight). Liver and 
intestinal samples were analyzed at 6, 12, 18, 24 and 36 h after B(a)P 
administration by use of the 32P-postlabelling method. DNA adducts were detected 
at each of these time points. In liver and intestine, 5 and 4 different adducts were 
detected, respectively. Adducts В, С and F were detected both in liver and in 
intestinal cells. In liver, adducts С and F were quantitatively the most prominent. 
In intestine, adduct В was the predominant adduct. The level of DNA adducts was 
significantly higher in intestinal epithelial cells than in liver cells. The effect of 
ethanol on adduct levels in liver was opposite to that in intestinal cells. In liver of 
long-term ethanol-treated rats, a clear maximum of the levels of adducts С and F 
was reached at 24 h after the administration of B(a)P. In non-treated rats, a plateau 
was reached after 12 h at a much lower level. In intestinal cells of ethanol-treated 
and non-treated rats, the levels of adducts В and С reached a maximum at about 
18 h. However, the adduct levels in ethanol-treated rats were decreased at 24 h, 
whereas those in non-treated rats were still high at this time point. Thirty-six hours 
after administration of B(a)P, the adduct levels in both groups of rats were at a 
low level again. The enhancing effect of ethanol treatment on the level of adduct С 
in liver was significant. This paper demonstrates that long-term ethanol 
consumption has an effect on B(a)P-DNA adduct formation in rats. 
INTRODUCTION 
The impact of life style factors on toxicokinetics of foreign compounds is clearly 
recognized. The main, (non-professional) life-style associated effects stem from 
the use of alcohol and tobacco, the intake of medication and general dietary habits 
(Founier, 1986). Effects of alcohol use on the toxicokinetics of polycylic aromatic 
hydrocarbons (PAHs) are of interest because PAHs are ubiquitous environmental 
contaminants and components of cigarette smoke. The risks of cancer of the 
larynx, pharynx and oesophagus have been found to be additive or multiplicative 
for people who smoke as well as drink alcohol (IARC, 1988). 
Ethanol is known to give rise to a broad spectrum of effects (Lieber, 
1984). In animal experiments it has not shown to be a carcinogen, but ethanol may 
alter the extent and/or the route of absorption, biotransformation and excretion of 
environmental carcinogens, such as N-nitrosamines (Swarm et ai, 1987) and 
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PAHs (Lieber, 1984). PAHs have to be activated by the monooxygenase system to 
become genotoxic (Brookes and Lawley, 1964). Ethanol acts as an inducer of the 
monooxygenase-linked cytochrome P450 complex but the specific 
ethanol-inducible P450 isozyme (P4502E1) does not have a high affinity for PAHs 
(Rubin and Lieber, 1968, Onishi and Lieber, 1977, Koop and Coon, 1986, 
Johansson et al., 1988). Conceivably, the additive and/or multiplicative effect of 
drinking and smoking on cancer risks could be attributed to a changed metabolism 
of PAHs by the ethanol-induced P450-monooxygenases. Indeed, a higher activity 
of aryl hydrocarbon hydroxylase in microsomes of female rat liver and gut and of 
male rat liver was observed by some authors, after giving ethanol in a synthetic 
liquid diet (Seitz et ai, 1978, 1981, 1981a). An enhanced metabolism of 
benzo(a)pyrene [B(a)P] in the cheek-pouch epithelium, but not in the liver of 
Syrian golden hamsters was measured after long-term ethanol treatment (Murphy 
& Hecht, 1986). Other authors, however, described a decrease or no change in the 
in vitro metabolism of B(a)P by rat and hamster liver microsomes isolated from 
ethanol-pretreated animals (DeMarco & McCoy, 1984). We also measured a 
decreased formation of B(a)P metabolites m vivo and in liver microsomes after 
long-term ethanol pretreatment (van de Wiel et al., 1992, 1993). 
It is known that DNA adducts may play an important role in the initiation 
of B(a)P-induced cancer (Swenberg et al., 1985). Because we were interested in 
the effect of chronic ethanol consumption on B(a)P-DNA adduct formation, we 
examined the levels of DNA adducts in liver and small intestine of 
ethanol-pretreated and non-pretreated rats at various time intervals after a single 
oral dose of B(a)P. 
MATERIALS AND METHODS 
Chemicals 
Ethanol absolute GR, supplied by Merck (Darmstadt, Germany) was used for the 
pretreatment. Benzo(a)pyrene (CAS 50-32-8), micrococcal endonuclease, spleen 
exonuclease and trypsin inhibitor were purchased from Sigma (St. Louis, MO, 
USA). Heparin was from Organon Teknika (Boxmeer, The Netherlands). Nuclease 
P„ RNAse A, RNAse T, and proteinase К were purchased from Boehringer 
(Mannheim, Germany). T4 polynucleotide kinase was from Biolabs (Amersfoort, 
The Netherlands). PEI-cellulose thin-layer chromatography (TLC) sheets were 
from Merck (Darmstadt, Germany). (32P) ATP (specific activity >5000 Ci/mmol) 
was purchased from Amersham Corporation (Arlington Heights, Ireland). XAR-5 
film was from Kodak (Driebergen, The Netherlands). 
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Animals and treatment 
Homebred Cpb:WU (Wistar) male rats were used. Their initial weights varied 
between 120-150 g. The age of the rats was about 6 weeks at the beginning of the 
experiments and 12 weeks at the end. The animals were of SPF quality (antibodies 
against PVM virus and the pin-worm Syphacia muris were found, no other 
pathogens). The animals initially were kept in Macrolon type 3 cages on sterilized 
softwood granules as bedding, 3 animals per cage. During the last week of the 
ethanol treatment the animals were housed individually in stainless steel 
metabolism cages. 
The animals were provided with RMH-TM pellets (Hope Farms b.v. 
Woerden, The Netherlands). A group of 12 rats had free access to tap water 
without ethanol, another group of 12 animals received tap water with an ethanol 
content increasing from 0 to 15% over 3 weeks, and then kept at 15% for another 
3 weeks. The body weights at the beginning of the ethanol pretreatment did not 
differ significantly in both groups. After the pretreatment, the average body weight 
of the rats in the ethanol group was 9.6% less than that of the control group (not 
statistically significant). The relative liver weights (liver weight/body weight) of 
the rats of the two groups showed no difference. Details of the method of alcohol 
exposure have been described previously (van de Wiel et al, 1990). Room 
temperature was regulated (22 ± 2°C), relative humidity varied between 40 and 
60%. The animals were exposed to artificial light between 7.00 a.m. and 7.00 p.m. 
After 6 weeks of ethanol pretreatment, 10 rats of each group received one 
oral dose of B(a)P, administered by gavage (50 mg/kg in 1 ml olive oil), the other 
2 received olive oil only. At 6, 12, 18, 24 and 36 h after B(a)P treatment, 2 
animals of each group were sacrificed. Two (one ethanol-treated, one non-treated) 
of the animals that received the vehiculum only, were sacrificed at 6 h, the other 
two at 24 h after treatment. During this period, the ethanol treatment was 
continued. 
The rats were anaesthetized with pentobarbital and perfused with ice-cold 
0.9% NaCl via the heartchamber until the liver and lungs were decoloured. Livers 
were excised, frozen in liquid nitrogen and stored at -80°C until use. An intestinal 
segment consisting of the first 20 cm distal to the pylorus was immediately 
excised, perfused free of intestinal content with ice-cold 15% KCl solution 
containing 0.05 M Tris-HCl buffer (pH 7.4), slit open and washed. The upper 
villous layer of the mucosa was removed by scraping with the edge of a glass 
slide. The epithelial cells were suspended in 4 ml of the KCl-Tris buffer. To this 
suspension, trypsin inhibitor (5 mg/g wet weight of small intestine), glycerol (20% 
v/v, final concentration) and heparin (3 U/ml) were added, as described by Stohs 
et al. (1976). The cells were frozen in liquid nitrogen and stored at -80C until use. 
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DNA isolation 
Livers were thawed in 250 mM sucrose/100 mM EDTA, pH 7 4 (9 ml/g liver) and 
thoroughly minced in a Potter Elvejhem apparatus (Braun, Melsungen) while kept 
in ice The nuclear fraction was isolated by centnrugaüon for 1 min at 4000 g The 
pellet was resuspended in sucrose/EDTA (9 ml/gram tissue) and centnfuged for 10 
mm at 700 g The pellet was then resuspended m 250 mM sucrose/25 mM EDTA/ 
1% Triton X-100 (5ml/gram tissue) and incubated for 30 mm at 4°C Chromarm 
was isolated by centnfugation (10 mm at 700 g), resuspended m ice-cold lOmM 
Tns-HCl/25mM EDTA pH 7 4 (TE-buffer, 5 ml per gram tissue) and again 
centnfuged at 700 g and 4°C The last two steps were performed thnce Finally, 
the pellet was resuspended in TEN-buffer pH 7 4 (20 mM Tns-HCl, 1 mM EDTA, 
0 1 M NaCl)(2 5 ird/gram tissue) This was also the first step (after thawing) m the 
isolation of DNA from cells of the small intestine To this suspension an equal 
volume of TEN-buffer with 1% SDS and protemase К (100 μξ/πύ) was added, 
followed by overnight incubation at 37°C 
To purify the DNA, extractions were performed with phenol, 
phenol chloroform isoamyl alcohol (25 24 1) and chloroform isoamyl alcohol 
(24 1) The procedure for the three extractions was identical To the water-phase 
containing the DNA, an equal volume of organic solute was added This mixture 
was shaken for 10 mm at room temperature and then centnfuged for 10 nun at 700 
g at 4°C The upper layer was removed and extracted agam Finally, ice-cold 
ethanol was added to the aqueous phase to precipitate the DNA The DNA was 
collected around the end of a heat-sealed glass pipette It was washed twice with 
70% ethanol and dned m a vacuum desiccator The DNA was resuspended 
overnight m TE-buffer pH 7 4 (5ml per gram tissue) 
After addition of 7 5 μΐ RNAse A (10000 U/ml) and 7 5 μΐ RNAse T, (10 
μg/ml) the DNA suspension was mcubated for 3 h at 37°C Per ml suspension 0 1 
ml 1 Ox-concentrated TEN-buffer, 0 1 ml 10% SDS and 10 μΐ proteinase К (10 
mg/ml) were added This was mcubated at 37°C for 1 h The DNA was isolated by 
extractions, precipitation, washing and drying as above The DNA was 
resuspended overnight m Millipore-filtered (MQ) water 
The DNA concentration m the various samples was determined 
spectrophotometncally (1 mg/ml of DNA= 20 absorbance units at 260 nm) 
"P-postlabelhng 
This assay for adducts in DNA was performed according to the nuclease 
Pl-modified procedure descnbed by Reddy and Randerath (1986) and Randerath 
et al (1989) Isolated DNA was digested with micrococcal nuclease and spleen 
phosphodiesterase From each sample an aliquot was taken for quantification of 
the DNA (see below) The rest was dephosphorylated with nuclease PI The 
nucleotides denved from 8-12 samples of DNA (5 μg DNA/sample) were labelled 
simultaneously (3 25 MBq [32P] ATP/sample) by incubation with T4 
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polynucleotide kinase for 30 mm at 37°C and -per sample- applied to 10cm * 
20cm polyethylenimme (PEI)-cellulose TLC sheets A paper wick was attached to 
the top of each sheet Chromatography occurred for 60 h m 1 1 M LiCl (Dl) at 
room temperature The paper wick was removed and discarded After two washes 
with water the chromatograms were developed m 8 5 M urea, 3 M lithium 
formate, pH 3 5 (D3) for 3 5 h and then in 8 5 M urea, 0 8 M LiCl, 0 5 M 
Tns-HCl, pH 8 0 (D4) for 3 h In order to remove any remaining impurities, the 
chromatograms were developed for 16 h m 0 35 M MgCl2 (D5, m the direction of 
Dl) The adducts were localized by autoradiography by use of a Kodak XAR-5 
film and an intensifying screen, at -70°C The adduci areas on the PEI-cellulose 
sheets detected by autoradiography were cut out and the radioactivity was 
determined by liquid scintillation counting The level of DNA adducts was 
calculated on the basis of the analysis of standard samples containing known 
amounts of modifications (Steenwinkel et al, in preparation) 
Aliquots of the digests obtained after micrococcal and spleen nuclease 
treatments (see above), were analysed for DNA content by 
fast-protein-hquid-chromatography (FPLC) on a Mono Q anion-exchange column 
(Pharmacia) For each postlabelhng sample, the input DNA was quantified on the 
basis of the area of the З'-GMP-peak in the FPLC elution pattern (19 9% of total 
nucleotides is guanine) For quantification of this peak a standard calibration curve 
was used 
Statistical analysis 
Results are presented as mean values Statistical analysis was earned out by use of 
the SAS (Statistical Analysis System) package on a VAX6410 minicomputer The 
procedure used was GLM (General Linear Model) for analysis of variance with 
unequal cells A p-value < 0 05 was considered to indicate statistical significance 
RESULTS 
Rats that had been chronically treated with ethanol for 6 weeks via the dnnkrng 
water, were compared with untreated rats The m vivo bmdmg of B(a)P 
metabolites to DNA of rat liver and intestinal epithelium was examined after 
administration of a single oral dose of B(a)P After DNA isolation, the 
32P-postlabellrng assay was applied to detect and quantify DNA adducts 
Autoradiograms obtained upon "P-postlabelling of DNA from liver and intestinal 
cells are shown m Figures 1 and 2, respectively 
In liver, the total adduci level was maximal 0 3-0 6 fmoLVg DNA Five 
adduct spots were detected, coded B,C,F,Y and Ζ (Figure 1) 
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Figure 1. Autoradiogram of B(a)P-modified rat liver DNA, 
obtained from a rat treated orally with B(a)P at 100 mg/kg body 
weight. The positions of spots F,Y and Ζ indicate that migration 
of these components has occurred in the direction of Dl. 
The levels of adducts B,C and F at various time points after B(a)P treatment are 
shown in Figure 3. Adducts С and F were quantitatively the most prominent ones. 
In the ethanol-treated rats, a maximum of the levels of adducts С and F was 
reached at 24 h after the administration of B(a)P. In non-treated rats, in general 
lower levels than those in the ethanol-treated rats were observed, with a kind of 
plateau reached after 12 h. For adduct C, when all time points were considered, 
ethanol-treated rats had a significantly higher level (p=0.02). At 6 and 24 h the 
p-values were 0.03 and 0.003 respectively. Adduct F was significantly higher in 
ethanol-treated rats at 6 h (p=0.04). At 36 h after B(a)P administration the level of 
all three adducts still seemed to be increased in ethanol-pretreated rats, although 
the differences are not statistically significant. 
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Figure 2. Autoradiogram of 32P-postlabeled DNA. Sample of 
B(a)P-modified intestinal epithelial cell DNA, obtained from a rat 
treated orally with 100 mg/kg body weight 
In the epithelial cells of the rat intestine the adduci levels were much higher than 
those in liver DNA. At 18 h, the total adduci level was 3.5 fmol^g DNA. Four 
adducts were detected, coded B,C,F and G (Figure 2). In intestinal DNA, adduct В 
was dominant. The levels of adducts В, С and F at various time points after B(a)P 
treatment are shown in Figure 4. 
At first no differences between ethanol-treated and control rats were 
observed. In both cases the levels of adducts В and С strongly increased, in a 
comparable way, between 0 and 18 h after B(a)P administration. Between 18 and 
24 h, however, the adduct levels in ethanol-treated rats decreased, while those in 
non-treated rats stayed high. Thirty-six hours after administration of B(a)P, the 
adduct levels were low again in both groups of rats. In intestinal DNA, adduct F 
was the minor adduct; there were no differences between the two groups. 
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Figure 3 Levels of B(a)P adducts in rat liver after administration 
of 50 mg B(a)P/kg body weight. Each point is the mean of two 
rats ± standard error of the mean. * Means a significant 
difference between ethanol-treated and non-treated rats (a) 
Adduct B, (b) adduct C, (c) adduct F. ( — ) control rats, ( ) 
ethanol-treated rats 
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Figure 3 Levels of B(o)P adducts in rat liver after administration 
of 50 mg B(o)P/kg body weight Each point is the mean of two 
rats ± standard error of the mean * means a significant difference 
between ethanol-treated and non-treated rats (a) Adduct B, (b) 
adduci С, (с) adduct F ( — ) control rats, ( ) ethanol-treated 
rats 
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Figure 4. Levels of B(a)P adducts in rat intestine after 
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DISCUSSION 
Both in rat liver and intestinal epithelium, B(a)P-DNA adducts were already 
detected at 6 h after the administration of B(cr)P. The adduct levels in gut were 
generally about 10-fold higher than those in liver. This difference can probably be 
explained by the fact that after oral administration B(a)P reaches the intestinal 
epithelium as the first metabolizing tissue. Autoinduction can reinforce higher 
adduct levels in gut (Aito, 1974). 
Both in liver and intestine the quantitatively predominant adduct С could 
be tentatively identified as the B(a)P desoxyguanosine-N2-adduct (B(a)P-N2-dG). 
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Adduct С cochromatographed with the adduct derived from the reaction of 
B(a)P-7,8-dihydrodiol-9,10-epoxide with calf thymus DNA in vitro. 
The identity of the other adducts is not known; they could be formed upon 
binding of the B(a)P-7,8-dihydrodiol-9,10-epoxide to other sites in the DNA, for 
instance adenosine. It is also possible that they represent adducts of other B(a)P 
metabolites like the (+)- and (-)-enantiomers of the o«//-dihydrodiol epoxide of 
B(fl)P(Canellae/a/., 1991). 
In comparable studies (Ross et ai, 1990, Willems et ai, 1991,) the value 
of total adduct levels is of the same order of magnitude as reported here. 
Melikian et al. (1990) compared ethanol-treated hamsters with non-treated 
animals. A significant increase in the DNA-adduct level was seen in the cheek 
pouch. 
In our study, ethanol treatment affected the level of certain DNA adducts 
in liver and intestine. A significant enhancement was found for the main adduct in 
liver after ethanol treatment. In the gut ethanol treatment tended to have the 
opposite effect. Possibly, ethanol treatment affects gut epithelial tissue in such a 
way that it becomes more permeable for non-metabolized B(o)P (Persson, 1991). 
This would give rise to a lower adduct level in the intestinal epithelium, but at the 
same time the amount of B(a)P that reaches the liver may be increased and 
consequently more reactive metabolites could be formed there. 
In our earlier studies (van de Wiel et ai, 1992) a lowered formation of 
phenolic Β(α)Ρ metabolites in liver microsomes was found, this correlates with an 
enhanced DNA-adduct formation. In small intestine we measured an increase of 
the formation of phenolic metabolites and a decreased DNA-adduct level. Ethanol 
treatment influences enzymes like epoxide hydrolase that deactivate reactive 
intermediates of B(a)P. In the liver this enzyme is lowered after ethanol treatment 
(van de Wiel et al., in press). It is conceivable that this effect enhanced the 
B(a)P-DNA adduct formation in the liver. 
Adduct levels are a result of formation and breakdown. Breakdown of adducts is 
caused by DNA repair mechanisms, necrosis of cells and cell turnover. Epithelial 
cells of the gastro-intestinal tract have a relatively high turnover. The faster 
decline in adduct levels in the small intestine of ethanol-treated rats could be 
partly explained by the fact that this turnover is even further enforced by ethanol. 
DNA adducts can be easily diluted in this way. In contrast DNA adducts are better 
preserved in the liver with its low cell turnover. 
It is yet to be assessed what our observations mean when transferred to 
the human situation. Our rat studies did not provide evidence to support the 
hypothesis that alcohol drinkers' increased risk of cancer is due to enhanced 
bioactivation of B(a)P (IARC, 1988). However, a change in phase II metabolism 
might play a role. The decrease in epoxide hydrolase activity we measured earlier 
can be related to the increased amounts of DNA adducts in the livers of 
ethanol-treated rats reported here. 
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ABSTRACT 
The effect of a combination of short-term oral benzo(a)pyrene [B(a)P] treatment 
(13 times 5 mg/kg) and prolonged oral ethanol administration (15% in the drinking 
water) on B(a)P-DNA adducts was investigated with the 32P-postlabeling assay. 
The four most prominent B(a)P-DNA adducts were measured in liver, small 
intestine, forestomach and oesophagus. The adduct level was highest in liver > 
small intestine > forestomach > oesophagus. In liver, adduct 4 was most 
prominent, while in forestomach, small intestine and oesophagus adduct 2 was 
most important. Adduct 2 co-chromatographed with the 
benzo(a)pyrene-7,8-diol-9,10 epoxide (BPDE)-DNA adduct. In the liver, one 
adduct was significantly (PO.05) increased in ethanol- and B(a)P-treated rats 
compared to rats that only got B(a)P. In the small intestine one adduct and in the 
forestomach two adducts were significantly decreased. It is concluded that ethanol 
treatment has an organ specific effect on B(o)P DNA-adduct formation. 
INTRODUCTION 
Apart from other pathological consequences, alcohol-abuse is recognized as a 
major risk factor for cancer of the upper alimentary tract and the upper respiratory 
tract. Cancer of the large intestine, breast, pancreas and liver is also correlated 
with alcohol consumption (Fraumeni, 1979; Garro & Lieber, 1990; Lieber et al, 
1979). 
Cigarette smoking is a well known risk factor for developing cancer too 
(IARC, 1986). Combined use of alcoholic beverages and tobacco has a synergistic 
effect on the risk of developing cancer in pharynx, larynx, oesophagus and oral 
cavity (Garro & Liber, 1990; Lieber et ai, 1979). About 76% of these cancers 
could be avoided if alcohol and tobacco use were given up (Rothman & Keller, 
1972). The mechanism underlying this synergism has not been discovered yet, 
although various explanations have been suggested (Fraumeni, 1979; Garro & 
Lieber, 1979). In one of these hypotheses ethanol is supposed to act as a 
cocarcinogen by inducing metabolic enzymes. Ethanol is an inducer of several 
enzymes, including the mono-oxygenase system. This enzyme complex is known 
to be important in the biotransformation of several carcinogens (IARC, 1988; 
Ioannides & Parke, 1990). Some of these compounds are known to be present in 
tobacco, for example PAH (Polycyclic Aromatic Hydrocarbons) or nitrosamines 
(IARC, 1986). PAH are formed as products of the incomplete combustion of 
organic materials (Phillips, 1983). Apart from smoking, humans can be exposed to 
PAH orally through contamination of food or drinking water or, mostly in 
occupational situations, by inhalation and by skin contact (Kriek et ai, 1989). One 
of the 11 PAH known to be carcinogenic in experimental animals is 
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benzo(a)pyrene (Β(α)Ρ) (IARC, 1983). The ultimate carcinogenic metabolite of 
Β(α)Ρ is (+)7,8-dihydroxy-9,10-epoxy-7,8,9)10-tetrahydro-benzo(a)pyrene 
(BPDE). Following in vivo treatment, the major B(a)P metabolite DNA-adduct 
formed is (+)-7ß,8a dmydroxy-9a,10a-epoxy-7,8,9,10-tetrahydro benzo(a)pyrene 
[(+)-anti-BPDE] bound by a trans addition to the exocyclic amino group of 
deoxyguanosine (N2) (Bodell et ai, 1989). The formed adduct (BPDE-dG) can be 
found in tissues of exposed animals and cells of humans (Hall & Grover, 1990). 
Covalent binding to DNA (DNA-adducts) is a well known genetic endpoint for 
analyzing carcinogenic risks (Phillips, 1990). In a previous study (van de Wiel et 
al., Influence of long-term ethanol pretreatment on DNA-adduct formation in liver 
and intestinal epithelial cells of rats after one oral dose of benzo(o)pyrene, 
submitted) the effect of prolonged ethanol administration on B(a)P induced 
DNA-adducts was studied in liver and small intestine of rats with the sensitive 
32P-postIabeling method. At several points in time, DNA-adducts were measured. 
24 Hours after B(a)P administration the maximal B(a)P-DNA adduct level was 
achieved in all organs. The results showed that ethanol treatment of the rats 
resulted in an increase in adduct formation in the liver and a decrease in the small 
intestine. However, in that study, B(a)P was applied only once and it is known 
that B(a)P itself also induces the mono-oxygenase system. To make a better 
comparison with the "real-life situation", the present study was performed using 
short-term exposure with several daily doses, instead of a single B(a)P dose. All 
samples were taken 24 hours after the last B(a)P administration. DNA adducts 
were analyzed in oesophagus and forestomach as target organs for B(a)P/ethanol 
carcinogenicity and in liver and small intestine as the major metabolizing organs. 
MATERIALS AND METHODS 
Chemicals 
1,2 Cyclohexamine diamine tetra-acetic acid (CDTA), natriumacetate, chloroform, 
ethanol, isopropanol, succinate, CaC12 dihydrate, MgC12 hexahydrate and bicine 
were purchased from Merck, Darmstadt, Germany. 32P-Pi was from Amersham 
Corporation, Arlington Heights, Ireland. T4 polykinase was from Pharmacia, 
Uppsala, Sweden. Micrococcal endonuclease, Benzo(o)pyrene (CAS 50-32-8), 
Na-pyruvate (type II), Na-ADP (grade 1), dithiothreitol, ZnC12, Spermine and 
Na-2'-deocyadenosine-3-monofosfate were obtained from Sigma Chemicals Co., 
St. Louis, USA. Proteinkinase К., (2x) Lysis buffer, chloroform and 70% 
phenol/chloroform/water were from Applied Biosystems, Foster City, USA. Other 
chemicals (or enzymes) were obtained from Boehringer-Mannheim, Germany. 
Animals 
16 Male homebred Cpb:WU (Wistar) rats (120-150 grams) were used. The age of 
the rats was about 6 weeks at the beginning of the experiment. The animals were 
164 · Long-term ethanol treatment 
of Specified Pathogen Free quality. The only antibodies found, were those against 
the pneumonia virus of mice and the pin-worm Syphacia muris. During six weeks 
the animals were housed three per cage in Macrolon cages on sterilized softwood 
granules as bedding. During the last 3 weeks they were housed individually in 
stainless steel metabolism cages. Room temperature was regulated (22±2°C), 
relative humidity varied between 40 and 60%. The animals were exposed to 
artificial light between 7.00 a.m. and 7.00 p.m.. Food (RMH-TM pellets, Hope 
Farms BV, Woerden, the Netherlands) was given ad libitum. 8 rats had free access 
to tap water without ethanol. The other group of 8 rats received a rising percentage 
(w/v) of ethanol in their drinking (tap)water during three weeks: 4 days 2%, 3 days 
4%, 4 days 6%, 3 days 8%, 4 days 10%, 3 days 12%. After that they received 15% 
ethanol in their drinking water during the rest of the experiment (van de Wiel et 
al., 1990). Every other day drinking fluid was renewed. Benzo(o)pyrene, 
dissolved in olive oil, was administered orally in a dose of 5 mg/kg to all rats; 5 
times in the 7th week, 5 times in the 8th week and 3 times in the 9th week. 
Ethanol treatment was continued during this period to the appropriate group. 
The initial body weights of the animals in both groups did not differ 
significantly. After the treatment, the average body weight of the rats in the 
ethanol-treated group was significantly less (PO.01) than the non-treated group 
although the intake of calories of both groups was comparable. The relative liver 
weights (liver weight/ body weight) of the two groups showed no significant 
difference. 
24 Hours after the last B(a)P treatment all rats were anaesthetized with 
pentobarbital and perfused with ice-cold 0.9% NaCl via the left ventricle of the 
heart. Liver, small intestine, oesophagus and forestomach were isolated, frozen in 
liquid nitrogen and stored at -80°C. 
Isolation of DNA 
All organs were homogenized (15%) in Hanks solution. 100 μΐ α-Amylase 
(10.000 U/ml and 63 μΐ of the chelating agent CDTA (500 mM, pH=8.0) were 
pipetted into 1.5 ml of the homogenate and incubated for one hour at 37°C. Then 
100 μΐ RNAse (RNAse Tl + RNAse A; both 1000 U/ml 30 mM sodium acetate 
buffer pH=6) was added to the homogenate. The samples were loaded onto the 
Nucleic Acid Extractor Model 340A (Applied Biosystems). The homogenate was 
enzymaticly digested in Lysis buffer (at 60°C) by RNAse and Proteinase К (1500 
U dissolved in 12 ml sterile 20 mM TR1S-HCL pH=8.5) and extracted by 70% 
Phenol/chloroform/water (twice) and chloroform (once) at ambient temperature. 
DNA was precipitated in 300 mM sodium acetate (pH=5.5) by isopropanol, 
collected onto a filter and washed with ethanol. Finally, the DNA was dissolved in 
TRIS.HCL (5mM, pH 7.4). 
The DNA concentration of the samples was determined by measuring UV 
absorbance (260 nm). Contamination of the sample with protein (280 nm) and 
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organic solvents (230 nm) was also checked. The average concentration of DNA 
(mg/ml TRIS-HCl) in liver samples was 0.63 mg/ml (sd = 0.11), in forestomach 
samples 0.31 mg/ml (sd = 0.14), in small intestine samples 0.9 mg/ml (sd = 0.4) 
and in oesophagus samples 0.22 mg/ml (sd = 0.12). Because the DNA 
concentration in the postlabeling assay should be between 0.250 mg/ml and 1.0 
mg/ml, the oesophagus samples were concentrated to 0.385 mg DNA/ml by 
vacuum-drying. 
Postlabeling assay 
This was largely derived from Gupta and Randerath (1982,1985) with some 
modifications (SOP, 1991). With one labeling-assay 8 organs (4 B(o)P-treated rats 
and 4 B(a)P- and ethanol-treated rats) were analyzed. In every postlabeling, a 
standard (lung of rat treated with B(a)P) and a (TRIS-HCl) blank were also 
examined. 
With 8 μΐ hydrolyse-mix (1.17 μΐ (6 μg/μl) micrococcal endonuclease 
2.63 μΐ (2.67 μg/μl) spleen phosphodiesterase in 1.17 μΐ (360 mM) succinate 
pH=6.0, 1.17 μΐ (180 mM) CaCl2 and 0.86 μΐ aqua dest), 5 μg DNA in 13 μΐ 5mM 
TRIS-HCl was hydrolysed to deoxyribonucleotide 3'-monophosphates (dNp) in 4 
hours at 37°C. 
To 15 μΐ of the 21 μΐ DNA-digest 1.2 μΐ Nuclease PI (5 μg/μl) in 1.8 μΐ 0.3 mM 
ZnClj with 0.417 M sodium acetate pH=5.0 was added. The samples were 
incubated at 37°C. After 40 minutes the reaction was stopped with 2.4 μΐ 0.5 M 
TRIS (free base). 
To label the nucleotides, 20.4 μΐ DNA digest and 6 μΐ Kinasemix were 
mixed and incubated for 30 minutes at 37°C. The kinasemix contained: 2.4 μΐ 
kinase-buffer (0.1 M Bicine NaOH buffer, 0.1 M MgCl2, 0.1 M Dithiothreitol and 
10 mM Spermidine), 0.82 μΐ T4 Polynucleotidekinase (4.33 U), 75 uCi 32P[ATP] 
and was completed with aqua dest. 22.4 μΐ of the labeled DNA was slowly 
applied to the origin of a TLC-sheet (Polychram eel 300 PEI Macherey-Nagel). 
The original sheet (20 χ 20 cm) was previously wetted in aqua dest, dried 
and cut along the line (0,16) - (20,16). On top of the now 16 χ 20 cm sheet a 
"wick" (Whatman paper, 17 χ 14 cm) was stapled on the short side. With a pencil 
the OR was stated at (14,14). The part of the sheet under the OR was soaked in Dl 
solvent (2.3 M NaH2P04 pH=5.75), before the 32P labeled nucleotides were added. 
The sheets were placed in a TLC-tank (Sigma). After a development in Dl for 
23-24 hours, the sheets were cut from (0,16) to (16,16). Next the sheets were 
washed in a plastic tray with aqua dest (250 ml) on a shaker for 15 minutes (after 
10 minutes aqua dest was renewed). After this the sheets (16 χ 16 cm) were dried 
with a cold hah dryer and a wick of 17 χ 10 cm was stapled on the opposite site. 
For a better separation of the adducts, the bottom of the sheets were soaked (1-2 
cm) in aqua dest before placing the sheets in D2 (8.5 M urea, 3.6 M 
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lithium-formiate). After developing in the opposite direction of Dl for 14-15 hours 
(overnight), the wicks were removed and the same washing-procedure took place 
Without a wick, the sheets were placed in D3 (0 72 M N a ^ P O , H20, 0 45 M 
TRIS and 7.6 M Urea, pH=8 2) The direction of running was perpendicular to Dl 
and D2 When the solution reached the top of the sheets (mostly after 6-7 hours), 
the sheets were washed and dried again A wick of 17 χ 10 cm was attached (OR 
right and down) and without wetting the bottom, the sheets were placed in D4 (1 7 
M NaH 2 P0 4 pH=6 0) for overnight development in the same direction as D3 
Eventually (after D4) the wicks were cut off and the sheets were dried The OR's 
of the sheets were also removed because of the high amount of radioactivity The 
other edges of the sheets were marked with colored H C , the number of the sheet (1 
to 10) was also indicated with 14C The sheets were wrapped m foil and put into 
cassettes with radioactivity sensible layers After at least 24 hours the sheets were 
removed and the cassettes were screened on the Phosphonmager (Molecular 
Dynamics) The activity on each screen was measured and all data were stored on 
a 120 mbyte tape (3M) 
Determination of nucleotides and Specific Activity 
4 μΐ of hydrolysed DNA was diluted m 9254 μΐ TRIS (5 т М рН=7 4) This 
solution was mixed twice carefully and 5 μΐ was applied to an eppendorf cup In 2 
other eppendorf cups 5 μΐ of a known amount of deoxyadenosine (which functions 
as standard for the amount of nucleotides) was pipetted The dAp solution was 
made by dissolving 6 6 mg З'-dAp (Na+-salt) in 1 liter 5 mM TRIS-HC1 pH=7 0, 
dAp was estimated spectrophotometrically using E
nux
=152000/M/cm at 260 nm 
This solution was diluted to 10 pmol in 25 μΐ aqua dest (1'50) Then 2.5 μΐ 10 mM 
bicine was applied to the nucleotide and dAp cups Together with the labeled 
DNA-samples, the nucleotide and dAp samples were labeled with 2 5 μΐ 
Kinase(32P)mix and incubated After applying 22 4 μΐ 32P-DNA to the PEI-sheets, 
the remaining 4 μΐ was used for checking the excess of 32P[ATP] m the samples 
22 Cups (2 for specific activity, 10 for nucleotides and 10 for examination of 
excess) were diluted 10000 rimes by adding first 990 μΐ 0.20 mM bicine-NaOH 
pH=9 6 and diluting 100 μΐ of this m 900 μΐ Bicine. 4 μΐ of this diluted solution 
was spotted on a TLC-sheet (Merck DC-plasttkfolien PEI-cellulose F; 20 χ 20 
cm) The sheet was placed in a tank with 100 ml 0.12 M phosphate-buffer pH=6.1 
for 1 5 hour After this time the sheet was taken out, dried, wrapped in plastic foil 
and stored till the adduct-sheets were finished. The sheet was screened using the 
Phosphonmager 
Counting 
Data were analyzed in ImageQuant (software going with the Phosphonmager) 
The level of radioactivity was measured in the blank-sample. This value was used 
as background-activity for every sheet The color range was set from 
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blank-activity to 50 times blank-activity. Each adduct on the 9 other sheets was 
encircled on the computer screen with the help of a mouse. The volume activity 
was determined by integration of each pixel of the circle. ATP,G,A,C,T and Pi 
were encircled too and the resulting 132 volumes (22 χ 6) were integrated (without 
background subtraction). The mean recovery efficiency for the adducts was 54%. 
Statistical evaluation 
The four most important adducts were analyzed. The average of the adducts for 
ethanol-treated and control rats were compared and evaluated with the SAS 
(Statistical Analytical System) package on the VAX 6410. The procedure used 
was GLM (General Linear Model). A P-value <0.05 was considered to indicate 
statistical significance. 
RESULTS 
In the liver, small intestine and forestomach, 4 adducts could be determined. In the 
oesophagus only three of these adducts were found. 
In both ethanol/B(a)P treated rats and in B(o)P-treated rats the same 
adduct spots were observed. The results are shown in Table 1. 
Ethanol 
adduct 
1 
adduct 
2 
adduct 
3 
adduct 
4 
Liver 
-
31 
(20) 
76 
(49) 
7 
(6) 
379 
(203) 
+ 
8 
(15) 
79 
(39) 
34* 
(30) 
456 
(173 
Forestomach 
-
55 
(44) 
166 
(95) 
21 
(12) 
45 
(26) 
+ 
24 
(19) 
67* 
(60) 
7* 
(8) 
20 
(18) 
Small 
Intestine 
-
40 
(20) 
232 
(155 
20 
(11) 
53 
(35) 
+ 
21 
(17) 
109 
(75) 
9* 
(6) 
56 
(56) 
Oesophagus 
-
3 
(2) 
34 
(15) 
1 
(2) 
_b 
+ 
5 
(2) 
36 
(24) 
2 
(4) 
-
Table 1 RAL (Relative Adduct Level; adducts per 1010 
nucleotides) in liver, forestomach, small intestine and oesophagus 
in ethanol/B(a)P and B(a)P treated rats*. Values are means of 5-8 
samples for each adduct in each subgroup (standard deviation) 
*)Sigmncantly different (P<0 05) from control rats (-) a) For 
ethanol and B(Ö)P treatment see Materials and Methods section 
b) No adduct measured 
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The total adduct level was highest in liver > small intestine > forestomach > 
oesophagus. 
In liver, adduct 4 was the most prominent, while in the forestomach, small 
intestine and oesophagus adduct 2 was most important. Adduct 2 
cochromatographed with the BPdG adduct. Adduct 3 was significantly (PO.05) 
increased in ethanol/B(a)P-treated rats compared to B(o)P-treated rats. 
In the small intestine adduct 3, and in the forestomach adducts 2 and 3 
were significantly decreased in ethanoI/B(a)P-treated rats compared to 
B(a)P-treated rats. The other adduct levels in forestomach and small intestine were 
also decreased, but not significantly. 
In the oesophagus, ethanol treatment seemed to have no effect on B(a)P 
DNA-adduct formation. 
The variation in adduct-values between individual rats was considerable 
for all organs. As can be seen in Table 2, the adduct percentage (percentage of one 
adduct compared to the total adduct level observed) was less variable. Ethanol 
treatment seemed to have no influence on the kind of adducts formed, but it did 
influence the amount of adducts formed. This effect was organ dependent. 
Ethanol 
adduci 
1 
adduct 
2 
adduct 
3 
adduct 
4 
Liver 
_a 
5 
(4) 
16 
(4) 
2 
(2) 
77 
(8) 
+ 
1 
(2) 
13 
(2) 
5 
(3) 
81 
(5) 
Forestomach 
-
18 
(6) 
58 
(4) 
7 
(1) 
16 
(5) 
+ 
22 
(4) 
56 
(5) 
5 
(3) 
16 
(5) 
Small 
Intestine 
-
12 
(4) 
66 
(7) 
6 
(2) 
15 
(5) 
+ 
12 
(6) 
59 
(10) 
5 
(1) 
24 
(12) 
Oesophagus 
-
6 
(6) 
91 
(10) 
3 
(4) 
_b 
+ 
17 
(21) 
79 
(21) 
4 
(9) 
-
Table 2: RAL as percentage of total (1-4) adducts. Values are 
expressed as mean (and standard deviation), a) For ethanol and 
В(я)Р treatment see Materials and Methods section, b) No adduct 
measured 
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DISCUSSION 
This study was performed to get more insight in the mechanism of interaction of 
ethanol and B(a)P. In a previous study (van de Wiel et al. Influence of long-term 
ethanol treatment on DNA-adduct formation in liver and intestinal epithelial cells 
of rats after one oral dose of benzo(a)pyrene, submitted), using the same strain of 
rats and the same ethanol treatment procedure, it was found that after a single dose 
of B(a)P (50 mg/kg) individual and total adduci levels in liver were significantly 
increased. In small intestine, adduct levels were significantly decreased after 
ethanol pretreatment. Because Β(α)Ρ itself may induce biotransformational 
enzymes (Phillips, 1983) and multiple exposure is more realistic than a single 
exposure, the present study was performed subjecting rats to a subchronic B(a)P 
treatment (13*5 mg/kg). 
In the present study, it was demonstrated that the adduct level was 
highest in liver > small intestine > forestomach > oesophagus. Ethanol 
pretreatment resulted in higher adduct levels in liver, while in forestomach and 
small intestine lower adduct levels were present. In the oesophagus no difference 
was detected. This is in agreement with the findings of the previous study. Ethanol 
treatment influenced the absolute adduct level, but not the kind of adducts formed. 
There are several ways of interaction between ethanol and B(a)P to enhance 
carcinogenesis as outlined by Villa et al. (1991) with respect to 
hepatocarcinogenisis. Alcohol can inhibit DNA repair and influence sister 
chromatid exchanges, exerting a promoting activity. There is also sound 
experimental evidence that alcohol can act as a promotor at metabolic level by 
inducing the biotransformation enzymes that turn a procarcinogen into a 
carcinogen. However, this is true for compounds like nitrosamines and small 
organocyclic molecules that are substrate for the ethanol inducible P4502E1. 
B(a)P is no substrate for this isozym (Ryan et al, 1985), so the enhanced 
formation of B(a)P-DNA adducts in liver cannot be explained by this proces. On 
the contrary, in our earlier studies (van de Wiel et al. 1992), a lowered formation 
of phenolic Β(α)Ρ metabolites in liver microsomes of ethanol-treated rats was 
found. This correlates with an enhanced DNA-adduct formation. In small intestine 
we measured an increase of the formation of phenolic metabolites and a decreased 
DNA-adduct level after ethanol treatment. 
Alcohol can also influence the enzymes that deactivate a reactive 
intermediate, like epoxide hydrolase. In the liver, this enzyme is lowered after 
ethanol treatment (van de Wiel et al, 1993). It is conceivable that this enhanced 
the B(a)P DNA adduct levels in the liver as was measured. 
Ethanol treatment seems to have an organ dependent effect on B(a)P 
DNA-adduct formation. Adduct levels are a result of formation and breakdown. 
Breakdown of adducts is caused by DNA repair mechanisms, necrosis of cells and 
cell turnover. The difference between effects in the liver and that in the 
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forestomach and small intestine could be explained by the fact that epithelial cells 
of the gastro-intestinal tract have a relatively high turnover. DNA-adducts can be 
easily diluted and this can be enforced by ethanol. In contrast, the liver has a low 
cell turnover, so DNA adducts are probably conserved better. Opposite effects in 
different organs were also reported by Brauze et al. (1991). They used genetically 
responsive [to aryl hydrocarbon hydroxylase induction, C57BL/10 (BIO)] and 
nonresponsive [DBA/2 (D2)] mice. The responsive mice had lower levels of 
adducts in the liver but higher ones in the small intestine than the non-responsive 
mice. 
Large differences between the highest and the lowest value of one adduci 
m one organ of rats of the same group were found. Part of this variation is due to 
the postlabeling assay. The inter-labeling variance can range to 40%. Biological 
variance also contributes to this variability. 
It is concluded that ethanol treatment has an organ specific effect on 
B(o)P adduct levels. Ethanol treatment results in a decrease in individual adduci 
levels in forestomach and small intestine and an increase in liver adduct levels No 
significant differences in adduct levels in oesophagus were detected. The kind of 
adduct does not seem to alter after ethanol treatment, pointing to a quantitative, 
rather than a qualitative effect. 
It is yet to be assessed what our observations mean when transferred to 
the human situation Our rat studies did not provide evidence to support the 
hypothesis that alcohol drinkers'increased risk of cancer is due to enhanced 
bioactivation of B(a)P (IARC, 1988). However, a change in phase II metabolism 
might play a role. The decrease in epoxide hydrolase activity we measured earlier 
(van de Wiel et al, \99Ъ) can be related to the increased amounts of DNA adducts 
in the liver of ethanol-treated rats reported here. 
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CHAPTER VIII 
SUMMARY AND GENERAL DISCUSSION 
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Epidemiologists estimate that in principle 70% of human cancer would be 
preventable if the main risk and antirisk factors could be identified (Doll & Peto, 
1981). Risk factors can interact, resulting in synergistic or antagonistic effects. 
Human data show that joint exposure to tobacco smoke and alcoholic beverages 
significantly increases the relative cancer risk at various sites (General 
Introduction par. 4.2). This findings suggest that PAHs and ethanol (from tobacco 
smoke and alcoholic drinks respectively) do not act independently. This thesis is a 
contribution to the study of such toxicological interactions. Using a rat model, it 
describes the combined effect of ethanol and B(a)P, two of the many carcinogenic 
chemicals people are exposed to by themselves and others (Group 1 according to 
the IARC classification, 1ARC 1983, IARC 1988). 
In Chapter I human exposure patterns, toxicokinetics and health effects are 
described for the two compounds individually. Ethanol is mostly consumed 
voluntarily as part of alcoholic beverages. In the Netherlands, the pure ethanol 
consumption per citizen increased from 2.6 1 per year in 1960 to 8.3 1 per year in 
1988 (de Zwart, 1989). There are 200000 alcoholics and half a million heavy 
drinkers who consume 8-12 drinks a day (Schoemaker-Hol, 1988). Moderate 
alcohol consumption is hard to define, but 17-21 drinks a week is mentioned in 
several studies (Anderson, 1986; McDonald, 1982). 
The enzyme with the highest affinity for ethanol is the alcohol 
dehydrogenase; it performs the first step in ethanol metabolism (Lieber & DeCarli, 
1970). However, ethanol is also converted by the hepatic cytochrome P450 (Rubin 
et al, 1971). An isozyme of cytochrome P450 typically induced by ethanol is 
P4502E1. Other isozymes of P450 are also influenced. Alcohol consumption is 
associated with many health problems. There is an association with cancer of the 
oesophagus, mouth, pharynx, stomach and liver.Tobacco smoking and alcohol 
drinking are often correlated at the individual level, and tobacco smoke is a cause 
of cancer at many of the sites also related to alcohol consumption (IARC, 1986). 
Polycylic Aromatic Hydrocarbons (PAHs) are important constituents of 
cigarette smoke. PAHs can be formed by thermal decomposition of any organic 
materials containing carbon and hydrogen. Thermal decomposition of pit coal, 
cellulose, tobacco and also of polyethylene and Polyvinylchloride which is carried 
out at 100°C yields very similar PAH profiles (Grimmer, 1983). The routes of 
environmental exposure to PAHs for the general population are the inhalation of 
cigarette smoke, and the consumption of water and food. The general population 
has a relatively low exposure. In occupational situations however, this can be 
considerably higher. Pathways for exposure of workers to PAHs are the inhalation 
of vapors or particles, contamination of the skin and ingestion. When PAHs with 
four or more rings occur in the atmosphere, they are primarily associated with 
particles. The inhalation of particles may represent an indirect route of ingestion. 
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The inhaled larger particles will be trapped in the mucous fluids of the upper and 
middle respiratory system. After transport to the pharynx, they will be swallowed. 
Epidemiological studies have demonstrated that smoking of tobacco is 
causally related to cancer of the respiratory tract, the upper digestive tract, 
pancreas, renal pelvis, bladder, and cervix (IARC, 1986). Excess of leukaemia, 
lung and scrotum cancer and of cancer of the gastro-intestinal tract was found in 
occupationally exposed individuals. Metabolism of PAHs is dominated by 
oxidation through the microsomal cytochrome P450 dependent monooxygenase 
system (Nebert & Gonzalez, 1987). Certain Ъау region diol epoxides' are the main 
DNA binding metabolites of B(a)P (Sims et al, 1974). These are held responsible 
for the initiation of cancer. 
Finally Chapter I discusses possible levels of interaction between ethanol 
and PAHs. The compounds can interact during the absorbtion phase, the 
biotransformation phase and during DNA-adduct formation. 
Chapter II deals with the design of a method to administer ethanol at moderate 
levels to rats during a longer period. A diet is chosen of standard food pellets that 
are low in fat content and high in carbohydrate. Ethanol is added to the drinking 
water as the only source of fluid. The ethanol dose had to be gradually increased 
from 2% to 15% in three weeks. Then the rats stayed for three weeks at a level of 
15% ethanol in their drinking water. This method led to a considerable intake of 
ethanol (6-14 g/kg bw/day) that is 20% of the daily caloric intake. Electron 
microscopy of the rat livers confirmed proliferation of SER as an effect of ethanol. 
The livers of ethanol-treated female rats contained more fat droplets than the livers 
of male rats. No effects on mitochondria nor severe pathological effects such as 
liver necrosis or cirrhosis were observed. The growth and development of the rats 
as based on the body weight curves was normal during the treatment. The ratio of 
liver weight to body weight did not differ significantly between ethanol-treated 
and control rats. Human alcoholics are defined as those who are chronically 
consuming at least 20% of their daily caloric intake as ethanol (Lelbach, 1974). 
This rat model therefore seems realistic. We used this model for further studies on 
the effects of long-term ethanol exposure on the toxicokinetics and DNA adduct 
formation of B(a)P. 
Chapter III excretion of B(a)P and metabolites in urine and feces of rats 
is described. The influence of the route of administration, sex and long-term 
ethanol treatment was studied. The administration route largely determined the 
total amount of excreted metabolites. Both after oral (p.o.) and intraperitoneal 
(i.p.) treatment, much more metabolites were found in feces compared to urine. 
Besides the relatively high fecal excretion of unmetabolized B(a)P, metabolites 
and mutagenic products in feces were much higher after p.o. compared to i.p. 
B(a)P administration. The rate of B(a)P-(metabolite) excretion was higher as well. 
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Males had a higher urinary excretion of mutagenic compounds as well as of 
phenolic metabolites than females. In feces, male rats excreted a higher percentage 
of B(a)P as metabolites and as mutagenic products than female rats. 
In the four groups investigated (female i.p., male i.p., female p.o., male 
p.o.) ethanol treatment caused a lowered 3-hydroxy-B(o)P excretion in feces. In 
the urine of female rats that received an i.p. dose of B(a)P, the ethanol treatment 
resulted in a statistically significant reduction of 9-hydroxy-B(a)P and 
3-hydroxy-B(a)P. 
In this study the influence of sex and administration route on the excretion 
of B(a)P metabolites was more pronounced than the effect of ethanol treatment. 
A reduced amount of B(a)P metabolites in urine and/or feces after ethanol 
treatment could be due to changes in absorption, biotransformation or excretion. 
Possible changes in biotransformation were further investigated as described in 
Chapter IV. The influence of long-term ethanol treatment on in vitro 
biotransformation of B(a)P was studied in microsomal fractions of liver, lung and 
small intestine from male and female rats. Quantitatively, the most important 
metabolite formed in all organs, 3-hydroxy-B(a)P, accounted for 70-85% of all 
metabolites measured. This was in accordance with our in vivo studies. In 
intestinal microsomes, 9-hydroxy-B(cr)P was the second important metabolite. In 
lung microsomes it was B(a)P-7,8-diol and in liver microsomes B(a)P-9,10-diol. 
There were large differences in microsomal activity between the three organs. In 
liver samples nmoles of B(a)P were metabolized per mg protein per min, in lung 
samples and samples of small intestine pmoles of B(a)P were metabolized per mg 
protein per min. The sex difference concerning B(o)P metabolism, found in m vivo 
studies proved organ dependent in in vitro studies. In liver microsomal fractions of 
male rats we found a 2-5 times higher formation of diols and phenols compared to 
females. However, no sex difference in lung microsomes and a small sex 
difference in microsomes of the small intestine were observed. Direct evidence for 
the participation of the male specific isozyme in B(a)P biotransformation in liver 
was obtained using an antibody to P4502C11/C6. We were able to inhibit about 
20-80% of the microsomal B(a)P metabolism, depending on the metabolite 
measured. Apparently, P4502C11/C6 plays an important role in B(cr)P 
biotransformation in uninduced, as well as in ethanol-treated male rats. 
The effect of the ethanol treatment was different in the three organs. In 
liver both 9- and 3-hydroxylation of B(a)P was significantly decreased. For other 
P450 inducers like phénobarbital, 3-methylcholanthrene or PCB's it is known that 
they leave the sex-specific P450 isoenzymes unaffected or depress them 
(Wortelboer, 1991). The latter possibility seems also to hold for ethanol. When 
using antibodies to Р4502СШ6, the percentage remaining activity of B(a)P 
metabolite formation was significantly higher in ethanol-treated, compared to 
control rats. This confirmed the down-regulating influence of ethanol on sex 
Summary and general discussion · 177 
specific P450 isoenzyme activity and consequently on B(a)P biotransformation. In 
the lung also, a tendency for decrease in B(a)P metabolism was observed after 
ethanol treatment. In the small intestine, however, a significant increase in the 
formation of B(a)P phenol metabolites was seen (+50% males, +20% females) 
after ethanol treatment. 
To study the observed effect of ethanol treatment on the biotransformation even 
further, several different enzyme activities were measured in liver microsomes of 
male and female rats {Chapter V). A significant induction of P450 and aniline 
4-hydroxylase activity (2E1) was found. EROD activity was not changed after 
ethanol treatment. This activity is associated with P4501A1, so there are no 
indications for a change in P4501A1 activity. When several doses of B(a)P were 
given, with or without ethanol, the self-inducing effect of B(a)P was clear and 
EROD activity increased with a factor 6. PROD (P4502B1/2B2) was not changed 
by ethanol treatment. Testosterone metabolism was differently influenced by 
ethanol treatment. A clear decrease of 25% in activity was measured for 
6ß-hydroxytestosterone in males. Formation of this metabolite represents the 
activity of the male specific P450's 3A2 and 2C13. In females 
12ß-hydroxytestosterone formation rate was lowered to 50% of the initial value 
(unknown P450). The constitutive sex specific enzymes in males and females are 
probably responsible for most of the B(a)P biotransformation activity in 
non-induced rats (Kato et al, 1986). Sex differences in testosterone metabolism 
were described by Kobliakov (1991). He found 16a-hydroxytestosterone and 
6ß-hydroxytestosterone formation to be higher in males. In livers of male rats, we 
found 5 of the 9 testosteron metabolites formed at higher level than in livers of 
females. Among them 16a- and 6ß-hydroxytestosterone. Two metabolites were 
formed at a lower level in male than in female rats. 
The earlier observed decreases in excretion {Chapter III) and in in vitro 
formation {Chapter IV) of B(a)P metabolites in ethanol-treated rats can be linked 
to the enzyme measurements {Chapter V). B(a)P metabolism was largely 
dependent on the sex specific P450s as shown by inhibition with the 
P4502C11/2C6 antibody. After ethanol treatment P4502C11/C6 dependent B(a)P 
metabolism was decreased. In line with this we expected a reduction of 16a- and 
2a-hydroxytestosterone after ethanol treatment since these are metabolites 
specially formed by P4502C11. However, a lowered in vitro formation of the 
6ß-testosterone metabolite was observed after ethanol treatment. This indicates a 
reduction of another sex specific P450: P4502C13/3A2. 
The phase II enzymes that are important in B(a)P biotransformation, 
glutathione S-transferase and epoxide hydrolase, were both influenced by ethanol 
treatment. In our measurements the activity of GST was not significantly changed. 
The amount of subunit 1 however, was significantly decreased in males and 
females. The pie-family (GST subunits 7-7) was described to be the most 
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important enzyme in conjugating anti-BPDE and other electrophilic metabolites of 
benz(a)anthracene and chiysene (Jemström, 1989). In that case a reduction in 
subunit 1 should have no great impact on the amount of anti-BPDE conjugated. 
Epoxide hydrolase is important in the formation of diols from B(a)P-epoxides and 
in the formation of tetrols from B(a)P-dihydrodiolepoxides. Epoxide hydrolase 
activity was decreased considerably by ethanol treatment. In in vivo and in vitro 
studies we observed decreased levels of B(a)P phenolic as well as diolic 
metabolites. In a study of Selkirk (1975) inhibition of epoxide hydrolase was 
correlated with an increase of phenol metabolites, while diols disappeared. 
According to that study the decrease in epoxide hydrolase activity could not be the 
source of a decreased formation of both phenols and diols. However, it is 
conceivable that the decrease in epoxide hydrolase activity we measured could 
have an effect on the amount of the reactive anti-BPDE formed from the B(a)P 
7,8-diol 9,10 epoxide. 
In Chapters VI and VII, the influence of long-term ethanol treatment on B(a)P 
DNA-adduct formation is described. We measured DNA-adduct formation in liver 
and intestinal epithelial cells of rats after one or several doses of B(a)P. 
Ethanol treatment affected the level of certain DNA adducts in liver and 
intestine. A significant enhancement was found for the main adduct in liver after 
ethanol treatment. In the gut, ethanol treatment tended to have the opposite effect. 
Possibly, ethanol treatment affects gut epithelial tissue in such a way that it 
becomes more permeable for non-metabolized B(a)P (Persson, 1991). This would 
give rise to a lower adduct level in the intestinal epithelium, but at the same time 
the amount of B(a)P that reaches the liver may be increased and consequently 
more reactive metabolites could be formed there. 
If the results are combined with our earlier studies a lowered formation of 
B(a)P phenol metabolites in liver microsomes is correlated with an enhanced 
DNA-adduct formation. In small intestine we measured an increase of the 
formation of phenolic metabolites and a decreased DNA-adduct level. 
For compounds like nitrosamines there was experimental evidence that 
alcohol could act as a promoter at metabolic level by inducing the 
biotransformation enzymes that turn a procarcinogen into a carcinogen. However, 
this is true for compounds like nitrosamines and small organocyclic molecules that 
are substrate for the ethanol inducible P4502E1. B(o)P is no substrate for this 
isoenzym, as was described in Chapter IV, so the enhanced formation of 
B(a)P-DNA adducts in liver cannot be explained this way. 
Ethanol can influence the enzymes that deactivate a reactive intermediate, 
like epoxide hydrolase. In the liver this enzyme is lowered after ethanol treatment. 
It is conceivable that this effect enhanced the B(o)P-DNA adduct level formation 
in the liver as was measured. 
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absorption 
distribution 
elimination 
metabolism 
effect 
phenol and diol metabolites in urine and feces 
-phenol and diol metabolites of B(a)P lowered 
after EtOH 
microsomes of liver 
-lowered formation of B(a)P phenols after EtOH 
microsomes of lung 
-lowered formation of phenols after EtOH 
microsomes of small intestine 
-enhanced formation of phenols after EtOH 
withantiP4502C11/2C6 
21-83% inhibition of B(a)P metabolism depending on the 
metabolite measured 
enzymes in liver microsomes 
-Phase I 
P450 total enhanced after EtOH 
P4502E1 (An 4-H) enhanced after EtOH 
P4501A1 (EROD) unchanged after EtOH 
P4502B1/2B2 (PROD) unchanged after ЕЮН 
Р4Ь03А2/2С13 (6U-OHT) lowered (*) after EtOH 
P450 t (12U-OHT) lowered (**) after EtOH 
P4502C11 (16a-OHT) unchanged (*) after EtOH 
P4502C11 (2a-OHT) unchanged (*) after EtOH 
P4502C6 "> 
-Phase II 
glutathion S-transferase unchanged after EtOH 
microsomal epoxide hydrolase lowered after EtOH 
DNA adducts after EtOH 
-in liver enhanced 
-lung enhanced 
-small intestine lowered 
chapter 
III 
chapter 
IV 
chapter 
IV 
chapter 
V 
chapter 
νι,νιι 
Table 1 Summary of ethanol and B(a)P interaction levels and 
findings m the present study 
* in male rats, ** in female rats 
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Adduct levels are a result of formation and breakdown. Breakdown of adducts is 
caused by DNA repair mechanisms, necrosis of cells and cell turnover. Alcohol 
can inhibit DNA repair and influence sister chromatid exchanges, exerting a 
promoting activity (Obe & Ristow, 1979; Garro, 1986). This effect could be organ 
dependent. 
Epithelial cells of the gastro-intestinal tract have a relatively high 
turnover. The faster decline in adduct levels in the small intestine of 
ethanol-treated rats could be partly explained by the fact that this turnover is even 
further enforced by ethanol. DNA adducts can be easily diluted in this way. In 
contrast, DNA-adduct are better conserved in the liver with its low cell turnover. 
The results of our studies are comprised in table 1. 
procarcinogen 
cell membrane 
activation-
/ 
ethanol 
ethanol 
Τ 
initiation promotion progression 
carcinogen 
inactivation -
binding 
to DNA, RNA, 
proteins 
cancer 
cell 
repair system 
1 
ethanol 
tumor 
invasion 
spread 
immune system 
1 
ethanol 
elimination reparation destruction 
Figure 1 Scheme of two-step carcinogenesis and possible sites of 
action of ethanol (Seitz, 1988) Double underlined interaction sites 
were the subject of this study 
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Table 1 is an extension of table 3 of paragraph 5 of the General Introduction. 
What our observations mean when transferred to the human situation is 
yet to be assessed. On the one hand, our rat studies did not provide evidence to 
support the hypothesis (IARC, 1988) that alcohol drinkers' increased risk of cancer 
is due to enhanced bioactivation of B(a)P. On the other hand, we did observe 
increased amounts of DNA-adducts in rat livers. There might well be a causal 
relationship 
We studied the influence of ethanol treatment on activation and 
inactivation of the carcinogen B(a)P by measuring excretion products, metabolic 
activity in several organs and DNA adducts. Not all possible levels of interaction 
between ethanol and B(a)P were measured Some more sites are shown m figure 1 
(identical to figure 6 in the General Introduction). 
with the measured change in phase II metabolism, the decrease in epoxide 
hydrolase activity. Many different techniques and samples, also of human origin, 
will have to be used in in vivo as well as in m vitro studies to elucidate further the 
epidemiological finding of the synergistic effect of ethanol consumption and 
tobacco smoking on carcinogenesis 
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SAMENVATTING EN ALGEMENE DISCUSSIE 
Epidemiologen schatten dat in principe kanker bij de mens voor 70% te 
voorkomen zal zijn als de belangrijkste nsico- en anti-nsicofactoren 
geïdentificeerd kunnen worden (Doll & Peto, 1981) Risicofactoren kunnen elkaar 
beïnvloeden, hetgeen kan resulteren in synergishsche of antagonistische effecten 
Uit onderzoek bij mensen is gebleken dat gecombineerde blootstelling aan 
tabaksrook en alcoholhoudende dranken het risico op kanker voor verscheidene 
organen verhoogt (General Introduction, par 4 2) Deze bevindingen suggereren 
dat polycyclische aromatische koolwaterstoffen (PAKs) en ethanol (respectievelijk 
bestanddelen van tabaksrook en alcoholhoudende dranken) niet onafhankelijk van 
elkaar hun effect hebben Dit proefschrift is een bijdrage aan het bestuderen van 
zulke toxicologische interacties Aan de hand van een proefdiermodel wordt het 
gecombineerde effect van ethanol en benzo(a)pyreen [B(a)P] beschreven Ethanol 
en B(a)P zijn twee voorbeelden van kankerverwekkende stoffen (classificatie m 
groep 1 volgens de IARC (IARC 1983, 1989) waaraan mensen zichzelf 
blootstellen en worden blootgesteld 
In Hoofdstuk I worden blootstellingspatronen, toxicokinetiek en gezondheids-
effecten van beide verbindingen afzonderlijk beschreven Ethanol wordt vrijwel 
altijd vrijwillig geconsumeerd als bestanddeel van alcoholhoudende dranken In 
Nederland steeg de ethanolconsumptie per persoon van 2,6 liter per jaar in 1960 
tot 8,3 liter per jaar in 1988 (de Zwart, 1989) Er zijn in ons land 200 000 
alcoholisten en een half miljoen 'zware drinkers', die 8-12 glazen per dag 
consumeren (Schoenmaker-Hol, 1988) 'Gematigde alcoholconsumptie' is moeilijk 
te definieren, volgens verschillende auteurs is hiervan sprake bij een gebruik van 
17-21 glazen per week (Anderson, 1986, McDonald, 1982) 
Het enzym met de hoogste affiniteit voor ethanol is het alcohol-
dehydrogenase, het is betrokken bij de eerste stap van het ethanol-metabohsme 
(Lieber & DeCarli, 1970) Ethanol wordt ook omgezet door het enzymcomplex 
cytochroom P450 (Rubm et al, 1971) Een ïso-enzym van cytochroom P450 dat 
specifiek door ethanol wordt geïnduceerd is het P4502E1 Ook andere 
iso-enzymen van P450 ondervinden deze mvloed 
Alcoholconsumptie is geassocieerd met uiteenlopende gezondheids-
problemen Er is een correlatie met slokdarm-, mond-, keel-, maag-, en lever-
kanker Het roken van tabak en het drinken van alcohol komen vaak samen voor 
Er is ook een correlatie tussen het roken van tabak en verschillende van de zojuist 
genoemde soorten kanker (IARC, 1986) 
Polycyhsche aromatische koolwaterstoffen (PAKs) zijn belangrijke 
bestanddelen van sigarettenrook PAKs kunnen ontstaan bij thermische ontledmg 
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van organisch materiaal dat koolstof en waterstof bevat. Thermische ontleding van 
steenkool, cellulose, tabak en ook van polyethyleen en polyvinylchloride bij 100 
°C geeft sterk op elkaar lijkende PAK-profielen (Grimmer, 1983). 
De blootstellingsroutes van de algemene bevolking aan PAKs lopen via 
het inhaleren van sigarettenrook en de consumptie van water en voedsel. De 
algemene bevolking heeft een relatief lage expositie. In arbeidssituaties kan de 
blootstelling veel hoger zijn. Blootstellingsroutes voor werknemers aan PAKs zijn 
de inademing van dampen of deeltjes, opname via de huid en inslikken. Als PAKs 
met vier of meer aromatische ringen in de lucht komen, zijn ze vooral geassocieerd 
met deeltjes. De geïnhaleerde deeltjes worden door het slijm van het boven- en 
middendeel van het ademhalingssysteem ingevangen. Via transport naar de 
keelholte worden ze dan ingeslikt. 
Epidemiologisch onderzoek heeft aangetoond dat het roken van tabak 
oorzakelijk verbonden is met kanker van de ademhalingsorganen, het bovenste 
deel van het spijsverteringskanaal, de alvleesklier, nierbekken en baarmoederhals 
(IARC, 1986). Bij beroepsmatig blootgestelde mensen is een overmaat aan 
leukemie, long- en scrotumkanker en kanker van het gastro-intestinale stelsel 
gevonden. Het metabolisme van PAKs vindt voornamelijk plaats via oxidatie door 
het cytochroom P450 afhankelijke mono-oxygenase systeem (Nebert & Gonzalez, 
1987). Bepaalde 'bay region' diol-epoxides zijn de belangrijkste DNA-bindende 
metabolieten van B(a)P (Sims et al., 1974). Deze worden verantwoordelijk geacht 
voor de initiatie van kanker. 
Ten slotte worden in Hoofdstuk I mogelijkheden besproken van interactie 
tussen ethanol en PAKs: deze kan plaatsvinden in de absorptiefase, de 
biotransformatiefase en bij de DNA-adductvorming. 
Hoofdstuk II gaat over het ontwikkelen van een methode om ratten 
gedurende langere tijd aan matige hoeveelheden ethanol bloot te stellen via hun 
dagelijkse voeding. Er werd een dieet gekozen van standaard voedselpellets die 
weinig vet en veel koolhydraat bevatten, in combinatie met ethanol in het 
drinkwater. Omdat ratten moeten wennen aan de ethanol, werd de concentratie in 
drie weken geleidelijk opgevoerd van 2% tot 15%. Vervolgens kregen de ratten 
drie weken 15% ethanol in hun drinkwater. Deze methode leidt tot een 
ethanolopname van 6-14 g/kg lichaamsgewicht/dag. Dit is 20% van de dagelijkse 
calorie-opname. Alcoholisten worden gedefinieerd als diegenen die chronisch ten 
minste 20% van hun dagelijkse calorieën opnemen in de vorm van ethanol 
(Lelbach, 1974). Dit proefdiermodel lijkt in dit opzicht een hoge blootstelling te 
realiseren. De resulterende bloedalcohol-waarden zijn echter niet zo hoog. 
Electronenmicroscopische opnames van de rattelevers bevestigden 
proliferatie van het glad endoplasmatisch reticulum tengevolge van 
ethanolblootstelling. De levers van aan ethanol blootgestelde vrouwtjesratten 
bevatten meer vetdruppels dan die van de gelijkelijk behandelde mannetjesratten. 
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Er werden geen effecten gevonden op de mitochondria, noch pathologische 
effecten als levernecrose en levercirrhose. De groei van de ratten was blijkens de 
lichaamsgewichtcurves, tijdens de behandeling normaal. De verhouding 
levergewicht/lichaamsgewicht bij de met ethanol behandelde ratten was niet 
significant verschillend van die bij de onbehandelde. 
We gebruiken dit model voor verdere studies naar de effecten van 
langdurige ethanol blootstelling op de toxicokinetiek en DNA-adductvorming van 
B(a)P. 
In Hoofdstuk III wordt de excretie van B(a)P en metabolieten in urine en faeces 
van ratten beschreven. De invloed van de toedieningsweg van B(a)P, het geslacht 
van de ratten en het effect van langdurige ethanolblootstelling is bestudeerd. De 
toedieningsweg bepaalde in belangrijke mate de totale uitgescheiden hoeveelheid 
B(a)P (metabolieten). Zowel na orale (p.o.) als na intraperitoneale (i.p.) 
toediening, werden veel meer metabolieten gevonden in de faeces dan in de urine. 
Naast de relatief grote hoeveelheid faecaal uitgescheiden ongemetaboliseerd 
Β(σ)Ρ, was de hoeveelheid faecale metabolieten en mutagene producten veel hoger 
na p.o. toediening van B(a)P, dan na i.p. toediening. De snelheid van B(a)P 
(metaboliet)uitscheidtng was ook hoger na p.o. toediening. 
Mannetjesratten vertoonden een grotere urinaire uitscheiding van 
mutagene componenten en fenol metabolieten dan vrouwtjesratten. 
In de vier onderzochte groepen (vrouwtjes i.p., mannetjes i.p., vrouwtjes 
p.o., mannetjes p.o., van elke groep kreeg de helft ethanol) veroorzaakte de 
toediening van ethanol een verlaagde uitscheiding van 3-hydroxy-B(a)P in de 
faeces. Bij vrouwtjesratten die een i.p. dosis B(a)P kregen toegediend, resulteerde 
de ethanolbehandeling in een statistisch significante afname van de uitscheiding 
van 9-hydroxy-B(a)P en 3-hydroxy-B(a)P in de urine. 
In dit onderzoek bleken de invloed van het geslacht en die van de 
toedieningsweg van B(a)P meer uitgesproken te zijn op de uitscheiding van 
B(a)P-metabolieten dan het effect van de ethanolbehandeling. 
De verminderde hoeveelheid B(a)P-metabolieten in urine of faeces na 
ethanolbehandeling kan het gevolg zijn van veranderingen in absorptie, 
biotransformatie of excretie. Mogelijke veranderingen in biotransformatie zijn 
verder onderzocht zoals beschreven in hoofdstuk IV. De invloed van langdurige 
blootstelling aan ethanol op de in vitro biotransformatie van B(a)P werd 
bestudeerd in enzymbevattende orgaanfracties van lever, longen en dunne darm 
van mannetjes- en vrouwtjesratten. De, in alle organen gevormde, kwantitatief 
belangrijkste metaboliet 3-hydroxy-B(o)P maakte 70-85% van de totale 
hoeveelheid gemeten metabolieten uit. Dit stemde overeen met de bevindingen uit 
ons in vivo onderzoek. In de dunne-darmfracties was 9-hydroxy-B(a)P de tweede 
belangrijke metaboliet. In longfracties was het B(a)P-7,8-dihydrodiol en in 
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leverfracties B(a)P-9,10-dihydrodiol. Er waren grote verschillen in metabole 
activiteit tussen de fracties van de drie organen. Het sexe-verschil in 
B(a)P-metabolisme, gevonden in het in vivo onderzoek, bleek bij in vitro 
onderzoek orgaanafhankelijk te zijn. In leverfracties van mannetjesratten was de 
vorming van diolen en fenolen 2 tot 5 keer zo hoog als bij de vrouwtjesratten. Er is 
echter geen geslachtsverschil gevonden in metabole activiteit van longfracties, en 
slechts een klein geslachtsverschil in die van dunne-darmfracties. 
Een direct bewijs voor de betrokkenheid van het 'male-specific' iso-enzym 
van P450 bij B(a)P-biotransformatie in de lever werd verkregen met behulp van 
het antilichaam van P4502C11/C6. We waren in staat 20-80% van het 
B(a)P-metabolisme te remmen, afhankelijk van de gemeten metaboliet. Blijkbaar 
speelt P4502C11/C6 een belangrijke rol in de B(a)P-biotransformatie bij zowel 
ongeïnduceerde als aan ethanol blootgestelde mannetjesratten. 
Het effect van de blootstelling aan ethanol was verschillend in de drie 
organen. In de leverfracties nam de 3- en 9-hydroxylering van B(a)P significant af. 
Van verschillende 'klassieke' P450-inducers, zoals fenobarbital, 
3-methylcholanthreen of PCBs, is bekend dat ze de sexe-specifieke P450-iso-
enzymen hetzij niet beïnvloeden hetzij remmen (Wortelboer, 1991). Die laatste 
mogelijkheid lijkt op te gaan voor ethanol. Als antilichamen voor P4502C11/C6 
werden gebruikt, was het percentage overgebleven activiteit 
(B(a)P-metabolietvorming) significant hoger in met ethanol behandelde ratten, 
vergeleken met controleratten. Dit bevestigde de mogelijke 'down-regulatie' van 
ethanol op de sexe-specifieke iso-enzymactiviteit van P450 en daaraan gekoppelde 
B(a)P-biorransformatie. In longfracties werd een tendens tot verlaging van B(a)P-
metabolisme waargenomen na ethanolbehandeling. In dunne-darmfracties werd 
daarentegen een significante toename van de vorming van B(o)P-fenol 
metabolieten gemeten ( +50% in de mannetjesraten, +20% in de vrouwtjesratten) 
na ethanolbehandeling. 
Om het effect van de ethanolbehandeling op de biotransformatie verder te 
bestuderen werden verschillende enzymactiviteiten gemeten in leverfracties van 
mannetjes- en vrouwtjesratten. (Hoofdstuk V). Er werd een significante inductie 
van P450- en aniline-4-hydroxylase-activiteit (P4502E1) gevonden. De activiteit 
van ethoxy-resorufme-0-deethylase (EROD) veranderde niet. Deze activiteit is 
geassocieerd met P4501A1, dus er is geen indicatie voor een verandering in 
P4501Al-activiteit. Als meerdere doses B(a)P worden gegeven, met of zonder 
ethanol, is het zelf-inducerende effect van B(a)P duidelijk door het toenemen van 
de EROD activiteit met een factor 6. 
Pentoxy-resorufme-O-deethylase-activiteit (PROD) (P4502B1/1B2) werd 
niet beïnvloed door ethanolbehandeling. Het testosteronmetabolisme werd 
gedifferentieerd beïnvloed door ethanolbehandeling. Een duidelijke daling van 
25% in de vorming van 6ß-hydroxytestosteron werd gemeten in leverfracties van 
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mannetjesratten. Vorming van deze metaboliet representeert de activiteit van de 
'male specific' P450-isoenzymen P4503A2 en P4502C13. In vrouwtjesratten was 
de 12ß-hydroxytestosteronvorming verlaagd tot 50% van de oorspronkelijke 
waarde (onbekend iso-enzym). De constitutief aanwezige geslachtspecifieke P450-
iso-enzymen in mannetjes- en vrouwtjesratten zijn waarschijnlijk verantwoordelijk 
voor het grootste deel van de B(a)P-biotransformatieactiviteit in niet-geïnduceerde 
ratten (Kato et ai, 1986). Sexeverschillen in testosteronmetabolisme zijn 
beschreven door o.a. Kobliakov (1991). Hij vond in mannetjesratten meer vorming 
van 16a-hydroxytestosteron en 6ß-hydroxytestosteron per tijdseenheid. Wij 
vonden dat vijf van de negen testosteronmetabolieten (waaronder 16a en 6ß) in 
grotere hoeveelheden gevormd worden in levers van mannetjesratten als in levers 
van vrouwtjesratten. Voor twee metabolieten gold het omgekeerde. 
De eerder waargenomen vermindering in de uitscheiding {Hoofdstuk 111) 
en in in vitro vorming {Hoofdstuk IV) van B(a)P-metabolieten in aan ethanol 
blootgestelde ratten kan gecorreleerd worden met de enzymmetingen {Hoofdstuk 
V). B(a)P- metabolisme is grotendeels afhankelijk van de sexe-specifieke P450s, 
zoals aangetoond door inhibitie met het P4502Cll/2C6-antilichaam. Na 
ethanolbehandeling was het P4502Cll/2C6-afhankelijke B(a)P-metabolisme 
verlaagd. In lijn hiermee verwachtten we een verminderde vorming van 
16a-hydroxytestosteron en 2a-hydroxytestosteron na toediening van ethanol, 
aangezien dit de testosteronmetabolieten zijn die met name door P4502C11 
gevormd zouden worden. Echter, gemeten werd een verlaagde in vitro vorming 
van de testosteronmetaboliet 6ß-hydroxytestosteron. Dit is een indicatie voor de 
reductie van een ander sexe-specifiek P450: P4502C13/3A2. 
De fase Il-enzymen die belangrijk zijn voor de biotransformatie van 
B(a)P, glutathion-S-transferase en epoxide-hydrolase, werden beide beïnvloed 
door ethanol. Blijkens onze metingen was de activiteit van glutathion-S-transferase 
niet veranderd, maar de hoeveelheid subunit 1 was in mannetjes- en 
vrouwtjesratten significant verlaagd. De pie-familie (GST subunits 7-7) is 
beschreven als het belangrijkste iso-enzym in het conjugeren van an//-BPDE en 
andere electrofiele metabolieten van stoffen als benz(a)anthraceen en chryseen 
(Jernström, 1989). In dat geval zou een afname in subunit 1 (alpha-familie) geen 
grote invloed hebben op de geconjugeerde hoeveelheid o«//-BPDE. 
Epoxide-hydrolase is belangrijk voor twee stappen van het B(a)P-
metabolisme; de vorming van diolen uit B(a)P-epoxides en de vorming van 
tetrolen uit B(o)P-dihydrodiol-epoxides. De epoxide-hydrolase-activiteit werd 
aanzienlijk verlaagd door toediening van ethanol. In in vivo en in vitro onderzoek 
hebben wij verlaagde hoeveelheden van fenol- en diol-metabolieten van B(a)P 
gemeten. Het is voorstelbaar dat verlaging van de epoxide-hydrolase-activiteit een 
effect heeft op de hoeveelheid reactief anti-ΒΡΌΈ dat uit het Β(σ)Ρ 7,8-diol 
9,10-epoxide wordt gevormd. 
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In Hoofdstuk VI en Hoofdstuk VII wordt de invloed van ethanol op 
B(a)P-DNA-adductvorming beschreven. We maten DNA-adductvorming in lever 
en dunne darmcellen van ratten na een of verscheidene doses B(a)P. 
Behandeling met ethanol beïnvloedde de hoeveelheid van bepaalde DNA-
adducten in lever en dunne darm. Er is een significante verhoging van het 
belangrijkste leveradduct gevonden. In de darm leidde de ethanoltoediening tot 
een tegengesteld effect. Mogelijk beïnvloedt ethanol darmepitheelweefsel zodanig 
dat het beter doorlaatbaar wordt voor niet-gemetaboliseerd B(a)P (Persson, 1991). 
Dit zou kunnen leiden tot een lager adduct-niveau in het dunne-darmepitheel 
terwijl dan de hoeveelheid B(a)P die de lever bereikt, verhoogd zal zijn, waardoor 
hier meer reactieve metabolieten gevormd kunnen worden. 
Uit combinatie van de in Hoofdstuk IV, VI en VII beschreven resultaten 
blijkt dat een verlaagde vorming van B(a)P-fenol-metabolieten in leverfracties 
samengaat met een toegenomen DNA-adductvorming. In dunne-darmfracties werd 
een toename van de vorming van B(oJP-fenol metabolieten en een verlaagd 
DNA-adductniveau gemeten. 
Voor verbindingen als nitrosamines is er experimenteel bewijs dat ethanol 
als een promotor kan werken op het metabole niveau. De biotransformatie-
enzymen die het procarcinogeen omzetten in een carcinogeen worden 
geïnduceerd. Dit geldt echter alleen voor verbindingen als nitrosamines en kleine 
organocyclische moleculen die substraat zijn voor het door ethanol induceerbare 
P4502E1. B(a)P is geen substraat voor dit iso-enzym, zoals beschreven in 
Hoofdstuk IV, dus de toegenomen vorming van B(o)P-DNA-adducten in de lever 
kan niet via het mechanisme van verhoogde biotransformatie verklaard worden. 
Ook de verminderde fenolvorming duidt eerder op een verlaagde fase I 
biotransformatie. 
Ethanol kan de enzymen beïnvloeden die reactieve intermediairen 
de-activeren, zoals epoxide-hydrolase. In de lever was dit enzym verlaagd na 
ethanolbehandeling. Het is voorstelbaar dat dit effect leidt tot het hogere 
B(o)P-DNA adducmiveau zoals door ons werd gemeten. 
Adductniveaus zijn een resultaat van vorming en afbraak. Afbraak van 
adducten wordt veroorzaakt door DNA-reparatiemechanismen, afsterven van 
cellen en celdeling. Ethanol kan DNA-reparatie inhiberen en sister chromatid 
exchanges beïnvloeden, waardoor een promoverende werking ontstaat (Obe & 
Ristow, 1979; Garro, 1986). Dit zou orgaanspecifiek kunnen werken. 
Epitheliale cellen van het gastro-intestinale apparaat hebben een relatief 
hoge turnoversnelheid. De snellere daling van adductniveaus in de dunne darm 
van met ethanol behandelde ratten kan gedeeltelijk verklaard worden door het feit 
dat deze turnover nog gestimuleerd wordt door ethanol. DNA-adducten kunnen zo 
gemakkelijk 'verdund' worden. In de lever worden DNA-adducten beter 
geconserveerd door de lage celturnover in dit orgaan. 
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absorptie 
verdeling 
eliminatie 
metabolisme 
effect 
fenol and diol metabolieten in unne and faeces 
-fenol and diol metabolieten van B(a)P verlaagd 
na ЕЮН 
enzymhoudende fracties van de lever 
-verlaagde vorming van B(a)P fenolen na EtOH 
enzymhoudende fracties van de long 
-verlaagde vorming van fenolen na EtOH 
enzymhoudende fracties van de dunne darm 
-verhoogde vorming van fenolen na EtOH 
met anti-lichaam P4502C11/2C6 
21-83% inhibitie van B(a)P-metabolisme, afhankelijk van 
de gemeten metaboliet 
enzymen in leverfracties 
-Fase I 
P450 totaal toegenomen na EtOH 
P4502E1 (An4-H) toegenomen na EtOH 
P4501A1 (EROD) onveranderd na ЕЮН 
P4502B1/2B2 (PROD) onveranderd na EtOH 
P4503A2/2C13 (бй-ΟΗη verlaagd (*) na EtOH 
P450 ? (12U-OHT) verlaagd (**) na EtOH 
P4502C11 (16aOHT) onveranderd (*) na EtOH 
P4502C11 (2ot-OHT) onveranderd (*) na EtOH 
P4502C6 ? 
-Fase II 
glutalhion-S-transferase onveranderd na EtOH 
microsomaal epoxide-hydrolase verlaagd na EtOH 
DNA-adducten na EtOH 
-in lever toegenomen 
-long toegenomen 
•dunne darm verlaagd 
hoofdstuk 
III 
hoofdstuk 
IV 
hoofdstuk 
IV 
hoofdstuk 
V 
hoofdstuk 
VI, VII 
Tabel 1 Beknopte weergave van interactie-niveaus van ethanol en 
B(a)P en bevindingen van de hier beschreven studies 
* bij mannetjes ratten, ** bij vrouwtjesratten 
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De resultaten van ons onderzoek staan gecomprimeerd weergegeven in tabel 1 
Deze figuur is een invulling van tabel 3 uit paragraaf 5 van de General 
Introduction. 
We bestudeerden de invloed van blootstelling aan ethanol op de activering 
en inactivering van het carcinogene B(a)P, door het meten van excretieproducten, 
het meten van metabole activiteit in verschillende orgaanfracties en het bepalen 
van soort en hoeveelheid DNA-adducten. Niet alle denkbare mogelijkheden van 
interactie tussen ethanol en B(a)P zijn bestudeerd. Dit is aangegeven in figuur 1 
(identiek aan figuur 6 uit de General Introduction) 
De betekenis van onze observaties voor de effecten bij de mens moet nog 
worden vastgesteld Ons proefdieronderzoek leverde geen bewijs voor de 
hypothese dat het verhoogde kankerrisico van alcoholgebruikers te wijten is aan de 
verhoogde bioactivenng van B(a)P door ethanol-inductie. Integendeel, de P450 
iso-enzymen die belangrijk zijn bij het B(a)P-metabolisme zijn minder actief Een 
verandering m het fase II-metabolisme kan echter een rol spelen De gemeten 
vermindering m epoxide-hydrolase activiteit kan (mede) oorzaak zijn van de 
toegenomen hoeveelheden DNA-adducten in de lever van met ethanol behandelde 
ratten. 
Epidemiologisch is een synergistisch effect aangetoond van alcohol- en 
tabaksconsumptie, met een toenemende kans op kanker van verscheidene organen 
als gevolg Verschillende additionele technieken en monsters, ook van menselijke 
oorsprong, zullen in m vitro en in ¡η vivo onderzoek gebruikt moeten worden om 
het mechanisme van dit effect volledig op te helderen 
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Figuur 1 Schema van twee-staps carcinogencse en mogelijke 
aangrijpingspunten van ethanol (naar Seitz, 1988) Onderstreepte 
ïnteractiemogehjkheden waren onderweφ van deze studie 
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NAWOORD 
Nederland was blijkbaar het laatste bolwerk waarin het schrijven van een 
proefschrift nog als levenswerk werd beschouwd (NRC Handelsblad, 9Ι9Γ93). 
Binnen een niet al te nauw omschreven thema had de promovenda volop ruimte bij 
de invulling van het onderzoek. Met de komst van de AIO is het promoveren een 
meer gerationaliseerd studie-onderdeel geworden. Volgens sommigen terecht, 
maar ik vond het prettig het onderzoek voor een groot deel zelf in te vullen en het 
te combineren met zaken als het onderwijs aan studenten Gezondheids­
wetenschappen. Ook naast mijn huidige baan bij de Gezondheidsraad is nog het 
nodige gelezen en geschreven over het onderwerp van dit boekje. 
Het bedrijven van toxicologie is een fascinerende bezigheid. Aan de ene 
kant staat het abstracte modelmatige mechanismewerk achter de PC, aan de andere 
kant de onderbouwing van concrete maatregelen op het beleidsterrein van 
volksgezondheid en milieu. 
Combinatietoxicologie staat volop in de belangstelling. Alleen al over de 
vraag hoe de realiteit van gelijktijdige blootstelling aan veel verschillende stoffen 
te benaderen, nee, óf deze realiteit wel meegewogen moet worden bij de humane 
risicoschatting lopen de meningen uiteen. Wetenschappelijk gezien was het in elk 
geval interessant een minuscuul onderdeel van het ons omringende interagerende 
stoffen-universum te bestuderen. 
Voor de standaard voorbehandeling van de ratten met ethanol kon ik goed terecht 
bij de buren; het centrale proefdierlaboratorium van de Nijmeegse universiteit. 
Geert Poelen, Hennie Broekman, Theo van den Ing en Gerne Grutters: bedankt 
voor de dagelijkse verzorging van de proefdieren, voor het uitprepareren van 
organen na behandeling met B(a)P in de toxunit en het catheteriseren ten behoeve 
van het online meten van bloedalcohol-waarden. Bij het methodologische 
hoofdstuk hoorde ook het bestuderen van leverslices onder de 
electronenmicroscoop. Doctor Copius Peereboom-Stegeman, beste Jenny, howel 
je wel eens meer 'interessante abnormaliteiten' zag dan mij lief was, moet men 
geprolifereerd SER toch ook eens met eigen ogen zien. Jeanne Pertijs maakt nog 
steeds de coupes en Arnold Meyer was de student die aan dit onderdeel het meest 
heeft bijgedragen. 
Carla Duijf heeft in de aanloopfase van het onderzoek prima ondersteuning 
gegeven. Daarna werd Peter Fijneman een constante meewerkende factor. De 
prettige samenwerking met hem blijkt uit zijn co-auteurschap bij de meeste 
artikelen. 
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Een andere constante factor was natuurlijk doctor Bos. Beste Rob, je hebt een 
belangrijke rol gespeeld als bindmiddel voor de vakgroep in het interregnum. 
Hooggeleerde Henderson, beste Pie: jammer dat je al zo snel naar Maastricht 
vertrok. Hooggeleerde Noordhoek, beste Jan: jouw kritische blik, met name op het 
in vitro werk, was heel nuttig. 
I would like to thank Dr. H.V. Gelboin of the Cancer Institute of the National 
Institutes of Health (Bethesda, MD, USA) for his stimulating suggestions at the 
Stockholm congress on Microsomes and Drug oxidations in Stockholm, 1990. 
Without his kind gift of several antibodies of the P450 isoenzymes, the work 
described in chapter IV would not have been possible. 
Vier studenten hebben een belangrijke bijdrage geleverd aan het in vitro 
werk: de gezondheidswetenschappers Bart Teeuw en Marly Meuwissen, en de 
chemici Michel Elshof en Heimen Kooy. 
Ook mensen van andere Universiteiten en onderzoeksinstituten in Nederland ben 
ik dankbaar voor hun morele of praktische ondersteuning. In Utrecht (RITOX) Bas 
Blaauboer, Heleen Wortelboer en Els de Groene (bij het tot stand komen van het 
hoofdstuk over enzymactiviteiten). In Zeist (ITV) Ben van Ommen (voor alle 
metingen aan glutathion-transferase). In Bilthoven (RIVM) Dinant Kroese en 
André Muller (bij het meten van DNA-adducten met de Phosphorimager). Ook de 
studente Yvonne Jansma heeft hier veel werk verzet. In Rijswijk (MBL-TNO) zijn 
Jacqueline Gielen en Nasser Ajubi een halfjaar in de weer en in de leer geweest 
om DNA-adducten te bepalen met de postlabelling-techniek. Zij werden 
enthousiast ondersteund door Marie-José Steenwinkel. Rob Baan was hun externe 
begeleider. 
Mijn huidige collega's bij de Gezondheidsraad toonden steeds hun belangstelling, 
en over combinatietoxicologie zijn we zeker nog niet uitgepraat. 
Diverse familieleden, vrienden en bekenden zijn in het verleden gepromoveerd of 
werken nog aan hun thesis. Dat geeft herkenning en steun. De anderen ben ik juist 
erg dankbaar voor het vermijden van dit soort activiteiten. 
De juiste doses relativering en stimulans, een snufje open-haard-gegenereerde 
PAKs, gevoegd bij een ethanolhoudend likeurtje; het vinden van het juiste recept 
om een promovenda op de been te houden, is traditioneel in de eerste plaats 
natuurlijk toebedacht aan de echtgenoot. Ingenieur doctorandus Nieuwesteeg, 
liefste Michael. 
Gouda, 9І9Г97, 
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STELLINGEN 
1 Over de wijze waarop de gezamenlijke toxiciteit van een groot aantal stoffen 
waaraan de mens tegelijkertijd blootstaat moet worden betrokken in de 
normstelling, bestaat nog steeds de onzekerheid die in 1985 is 
gesignaleerd in het advies van de Gezondheidsraad over uitgangspunten 
voor normstelling. 
Gezondheidsraad Commissie Uitgangspunten voor normstelling Uitgangspunten voor 
normstelling de inzichtelijke opbouw van advieswaarden voor niet-mutagene, 
niet-carcinogene en met-immunotoxische stoffen Den Haag Gezondheidsraad, 1985, 
pubhkatienr 1985/31 
2 Als men proefdieren wil blootstellen aan een in te nemen stof met een zekere 
calorische waarde, zoals ethanol, dient men een bewuste keuze te maken 
tussen een isonutriënt dieet of een isocalorisch dieet voor blootgestelde en 
niet-blootgestelde dieren en die keuze te vermelden in de beschrijving van 
de proefopzet. 
International Agency for Research on Cancer Alcohol drinking Lyon, France, IARC 
monograph nr 44, 1988 
3 Inductie van een specifiek iso-enzym van P450 (P4502E1) door ethanol in 
de lever van proefdieren, gaat samen met een verlaging van constitutieve 
P450 ïso-enzymen. 
Dit proefschrift 
4 Blijkens de uitkomsten van onderzoek bij proefdieren is, in termen van de 
teratogene potentie, de dagelijkse inname van de 'reference dose' voor 
TCDD van de Environmental Protection Agency (6 fg per kg 
lichaamsgewicht) equivalent met de consumptie van één glas bier per 
8000 jaar 
BN Ames et al, Science 1978,236 271-280 
В N Ames, Environmental and Molecular Mutagenesis 1989,14 66-77 
5. De geldigheid ал de stelling 'Medical research has been biased by taking 
the male as typical of the species - among humans as well as among 
animals' kan worden uitgebreid tot (vrijwel) alle vakgebieden. 
The Economist, Science & Technology, 20/3/"93. 
6. Door Seitz et al. is diverse malen een samengaan gerapporteerd van 
verhoogde activiteit van benzo(a)pyreen-hydroxylase en verhoogde 
vorming van mutagene B(o)P-metabolieten in lever- en dunne 
darmfracties van met ethanol behandelde proefdieren. De hierop door de 
onderzoekers gebaseerde verklaring van een toegenomen kankerrisico bij 
gecombineerde blootstelling aan alcohol en tabaksrook behoeft op z'n 
minst enige nuancering. 
H.K. Scitz el al, Biochemical and Biophysical Research Communications 1978;85 
1061-1066 
Η К Scttze/я/., Cancer Letters 1981;13:97-102. 
7. De gecombineerde blootstelling aan tabaksrook en alcohol, mits in de juiste 
sociaal-economische matrix, leidt slechts tot 'dancing fever'. 
Fourth European ISSX meeting. Toxicological Evaluation of Chemical Interactions: 
Relevance of Social, Environmental and Occupational Factors Royal Hotel Carlton. 
July 3-6, 1992, Bologna, Italy. 
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